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Abstract 
The RNAi response suppresses gene expression at the post-transcriptional level and 
the potential of this technique to give control of insect pests in crops has been 
recognised for a decade.  
This project focuses on a comparison of RNAi responses in insects of different 
orders by injecting and feeding dsRNA directed against thread (APIN) and V-Type-
ATPase E homologues in the target species. The results showed systemic RNAi 
responses, and mortality, occurred in larvae of the Tribolium castaneum (T. 
castaneum), Coleopteran, but not a Hemipteran, the Acyrthosiphon pisum (A. pisum), 
where comparatively low levels of gene down-regulation were only achieved by 
injection of dsRNA. DsRNA injection produced both a lethal phenotype and gene down-
regulation in larvae of the dipteran species Musca domestica (M. domestica), and Delia 
radicum (D. radicum), although the effects were found to be stage dependent. 
Rapid dsRNA degradation in the extracellular environment could lead to a 
limitation of RNAi reponses. In vitro experiments show that dsRNA was degraded 
rapidly by A. pisum haemolymph and gut extracts, and less rapidly by D. radicum larval 
extracts. However, T. castaneum larval extracts differ in both the amount and 
qualitative nature of their RNase activity; dsRNA was degraded at a slow rate, 
predominantly by exonuclease activity rather than endonuclease activity. 
A strategy using recombinant proteins was used to address limitations of RNAi 
effects after feeding dsRNA in insects. A recombinant protein containing an RNA 
binding domain (RBD) was selected to conjugate dsRNA forming a protein-RNA 
complex. The complexed protein enhanced the stability of dsRNA and protected it from 
degradation from insect extracts. A fusion protein containing snowdrop lectin (GNA) 
linked to RBD was also developed to produce a "systemic" RNAi effect, by transporting 
the protein-RNA complex to the insect haemolymph using the lectin as a "carrier".	
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Chapter 1 Introduction 
 
1.1 Crop protection against insect pests  
According to the United Nations (UN), the world population, currently at 7.2 billion, will 
reach to 9.6 billion people in 2050. Most of the growth of population will take place in 
developing countries, particularly in Africa. As a consequence, food demand will be 
increased. The FAO (2009) estimated that overall a 70% increase in agriculture food 
production will need to be achieved for feeding 9.1 billion people. However, this goal 
faces many challenges such as soil fertility depletion, arable land limitation, water 
resources and global warming (FAO, 2011).  
As well as limitations to crop production by nutrients, water and other abiotic stresses, 
crop losses occur due to competition from animal pests, weeds, bacteria and viruses. 
Insects from orders of Orthoptera, Isoptera, Hemiptera, Thysanoptera, Diptera, 
Coleoptera, Lepidoptera and Hymenoptera can cause direct damage by eating leaves, 
buds, fruit and root or feeding on plant juice (Matthews 1999). Insect pests like aphids 
are also able to cause indirect effects by transmitting bacterial, viral or fungal infections 
(Kennedy and Collier (2000); Eleftherianos et al. (2008)). According to the data 
investigated by The Global Crop Diversity Trust, approx. 30%-40% of the world’s crop 
yield is lost due to the damage by insect pests and crop diseases (Garthwaite et al. 
2008).  
Pest management through the use of applied insecticides can significantly improve 
crop production. Although early insecticides exploited naturally occurring compounds, 
the use of synthetic chemistry to produce more active compounds was a key 
component in the development of modern intensive agriculture. In 2007, Environmental 
Protection Agency (EPA) reported that the annual expenditures on insecticides 
reached $10.25 billion globally, which accounted for 29% of the total crop market value 
(Grube et al. 2011). The commonly used commercial insecticides for controlling insect 
pests target nervous systems (Casida and Durkin 2013), and include molecular targets 
such as acetylcholinesterase enzymes (organophosphates and carbamates) (Fukuto 
1990); voltage-gated sodium channels (e.g. organochlorides and pyrethroids); and 
neurotransmitter- gated nicotinic acetylcholine (e.g. neonicotinoids), γ-aminobutyric 
acid – GABA (e.g. phenylpyrazoles) and L-glutamate (e.g. avermectins) receptors 
(Raymond-Delpech et al. 2005).   
The use of such insecticides has largely contributed to increass food production in the 
past, however, their effects on human health, ecosystems and wildlife populations are 
poorly understood (Koehler and Triebskorn 2013). In addition, the widespread and 
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long-time use of chemicals with the same range of molecular targets has resulted in 
evolution of resistance in insects. Pesticide-resistant insects have been observed in 
many species which are major crop pests, which can contain mutations on sites of 
interaction in target proteins, gene duplication/ increased expression of detoxifying 
enzymes (e.g.,carboxylesterase and P450), or improved systems of excretion of toxic 
compounds from cells (Heckel (2012); Ffrench-Constant (2013)). Concerns about the 
environmental effects of synthetic chemical pesticides, and increasing levels of 
resistance in the target pests, have led to a need for new types of pesticides.  
One alternative technology is the development of biological pesticide or biopesticides, 
which are developed from natural sources including plants, minerals and 
microorganisms.  Spinosad, a mixture containing the secondary metabolites spinosyn 
A and spinosyn D from the Actinomycete Saccharopolyspora spinosa, is the most 
commonly used biopesticide (Kirst et al. 1992). Spinosyn is effective against a broad 
spectrum of insects (Lepidoptera, Coleopteran, Dipteran and Orthopteran) through 
contact or ingestion. It is believed to target a subtype of the nicotinic acetycholine 
receptor (Orr et al. 2009). Another widely-used biopesticide is the crystal proteins (Cry) 
from the entomopathogenic soil bacterium Bacillus thuringiensis. These proteins are 
pore-forming toxins, which interact with receptors in insect and lead to midgut lysis and 
osmotic shock, result in insect death. These toxins have been widely used as 
biopesticides for at least 50 years and are particularly effective against Lepidopteran, 
Coleopteran and Dipteran larvae (Crickmore et al. 1998). Since the Bt toxins are 
proteins, they are good subjects for production via a transgenic organism; genetically 
engineered crops expressing Bacillus thuringiensis (Bt) toxins are widely applied in 
global agriculture (Toenniessen et al. 2003). Bt toxins combine effectiveness against 
insect pests and safety to non-target organisms, and as a result the area planted with 
transgenic Bt-expressing crops such as soybean, maize, cotton and canola has been 
expanded from 1.1 million hectares (ha) in 1996 to 181.6 million ha in 2011 (James et 
al.,  2015). However, due to the lack of appropriate receptors in the insect to interact 
with Cry toxin, GM Bt crops cannot be used for controlling hemipteran insect pests 
such as aphids (Porcar et al. 2009).  Furthermore, evolving resistance to Bt crops in 
insects has been reported (Baum et al. 2007). Therefore, there is still a requirement for 
new strategies, which protect crops against insect pests.  
 
 
1.2 RNA interference 
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1.2.1 A short history of the discovery of RNAi 
The phenomenon of dsRNA-induced gene silencing was first discovered by Napoli et al. 
in 1990. They overexpressed chalcone synthase in petunias by introducing a construct 
containing the coding sequence of the gene and a constitutive promoter to identify 
whether chalcone synthase (CHS) was key enzyme in anthocyanin biosynthesis. The 
anthocyanin biosynthesis pathway is crucial for the deep violet coloration in petunias. 
Unexpectedly, the overexpression of CHS by introducing a chimeric CHS gene resulted 
in white petunia and the level of endogenous CHS was 50-fold lower than in wild-type 
petunia (Napoli et al. 1990). Napoli et al. (1990) described this phenomenon as ‘co-
suppression’. A similar phenomenon in Neurospora crassa (an ascomycete fungus) 
was reported by Romano and Macino. They noticed that introduction of homologous 
RNA sequences caused ‘quelling’ of the endogenous gene (Romano and Macino 1992). 
When they transformed albino-3 (al-3) and albino-1 (al-1) genes in Neurospora, low 
level of expression of endogenous al-1 and al-3 gene were detected. Several years 
later, mRNA silencing by sense and antisense RNA was found in the animal model, 
Caenorhabditis elegans (Guo and Kemphues 1995). Guo and Kemphues were 
attempting to knock down PAR-1 (partition 1) gene by introducing antisense (ss)RNA. 
However, gene silencing was also detected in a control group which was treated with 
sense RNA. 
 
The mechanism of the gene silencing by both sense and antisense RNA was unknown 
until 1998 when Andrew Fire and Craig Mello elucidated that it is double-stranded RNA 
(dsRNA) as the trigger for gene silencing (Fire et al. 1998). This also provided the 
explanation for previous gene silencing observations. Fire et al. suggested that in the 
case of studies conducted by Guo and Kemphues that effects observed in C. elegans 
following the introduction of ssRNA were actually due to the presence of contaminating 
dsRNA, produced during the preparation of ssRNA (Fire et al. 1998). They purified 
sense and antisense single-stranded RNA molecules against C. elegans unc-22 gene 
product gene resulted in a twitching phenotype in C. elegans. Their results showed that 
ssRNAs were significantly less effective than dsRNA targeting the same mRNA. 
Moreover, ssRNAs was only effective only when sense strand was injected into worms, 
followed by the antisense strand RNA (Fire et al. 1998) reviewed in Sen and Blau 
(2006). 
 
 
1.2.2 Identification of ‘dicing’ and ‘slicing’ 
The term RNAi is used to describe inhibition of gene expression in a sequence-specific 
manner by introduction of double-stranded RNAs. It is a conserved mechanism in 
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many eukaryotes (Geley and Müller 2004). In order to identify the mechanism which 
dsRNA directs the degradation of endogenous mRNA, Hamilton and Baulcombe (1999) 
detected antisense RNA with estimated length of 25 nucleotides (nt) in tissue in gene 
silencing experiment and they suggested that this length was necessary for RNAi 
specificity. Later, researchers found that 21-23 nt RNA always copurified with RNAi 
activity by using a Drosophila melanogaster cell culture system (Hammond et al. 2000)  
(Zamore and Haley 2005). These findings suggest that dsRNA was converted to short 
interfering RNAs (siRNAs) before binding to target mRNAs. To confirm that the 21-23nt 
dsRNA are the effectors for gene silencing, Elbashir et al. (2001a) synthesized 21-22nt 
dsRNAs with sequence identity to part of the firefly luciferase transcript and incubated 
the dsRNA with Drosophila cell extracts containing firefly luciferase mRNA. They found 
that these short interfering RNAs, or siRNAs, functioned as guides for cleavage of the 
mRNA near the centre of the region encompassed by the 21-22nt RNAs, 11 or 12 nt 
downstream of the first base pair between the siRNA and mRNA. Moreover, siRNAs 
with 2-3nt overhangs on their 3’ ends were proved to be more efficient in silencing 
mRNA than siRNAs with blunt ends (Elbashir et al. 2001b). 
Further research characterised the enzymes that were responsible for converting 
dsRNA into siRNAs (‘dicing’) and the destruction of complementary mRNAs (‘slicing’). 
Bernstein et al identified two enzymatic activities in Drosophila cell extracts by high-
speed centrifugation (Bernstein et al. 2001). The activity that degraded the target 
mRNA, which was referred as RNA-induced silencing complex (RISC), was pelleted by 
centrifugation whereas the activity that convert dsRNA into siRNA remained in the 
supernatant (Bernstein et al. 2001). They designated these two phases of the RNAi 
pathway as initiator phase (cleavage of dsRNA into siRNA) and effector phase (RISC-
mediated degradation of target mRNA). The activity in the supernatant was caused by 
a type III RNase III enzyme, named Dicer, which was shown to be able to cleave 
dsRNA into 21-23nt siRNA. Depletion of Dicer using dsRNAs resulted in loss of 
dsRNA-induced gene silencing of other genes (Hammond et al. 2000). Identification of 
enzymes that were responsible for RISC-mediated mRNA cleavage resulted in two 
protein candidates, Argonaute 1 and Argonaute 2, which were found to have the ability 
of cleaving mRNA by a co-immunoprecipitation study in mammalian cells (Martinez et 
al. 2002). The ‘slicer’ activity of Argonaute enzymes was not confirmed until Song et al. 
(2004) crystallized an Argonaute protein from the archaebacterium Pyrococcus furiosus, 
and found significant similarity in the Argonaute PIWI (P-element induced wimpy testis) 
domain to the conserved secondary structure of RNase H enzymes, which hydrolyze 
the RNA of RNA/DNA hybrids (Cerritelli and Crouch 2009). Moreover, the ‘slicer’ 
activity, like RNase H enzyme activity, is dependent on divalent cations and leaves 3’-
OH and 5’-phosphate termini (Martinez and Tuschl 2004). Argonaute 2 (Ago2) appears 
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to be the enzyme with ‘slicer’ activity present in the active RISC complex; 
immunoprecipitation of tagged Ago 1, 2, 3 and 4 from human cells showed that all the 
proteins were able to bind to siRNA, but only Ago2 retained mRNA cleavage activity 
(Liu et al. 2004).  
Studies on the assembly of the RISC in D. melanogaster have broadened our 
understanding, and shown that additional proteins are involved in this process. SiRNAs 
are loaded on to RISC with the aid of RISC-loading complex (RLC) which contains 
Dicer-2 (Dcr-2) and a partner protein R2D2 (Zamore and Haley 2005). Addition of 
recombinant Dcr-2 and R2D2 to recombinant Ago2 and duplex siRNA induced RISC 
activity (Liu et al. 2009). Moreover, a RISC enhancer C3PO (component 3 promoter of 
RISC), which contains translin and TRAX (translin-associated factor-X) was identified 
as necessary for in vivo RNAi in D. melanogaster. Liu et al. (2009) confirmed the 
ribonuclease activity of C3PO and proposed that Dcr-2-R2D2 associated with C3PO to 
form the active RISC complex and remove the passenger strand of siRNA, releasing 
the guide strand siRNA to Ago2.  
 
1.2.3 Multiple RNAi pathways 
In addition to the exogenous (or siRNA-mediated) RNAi pathway observed by Fire et al 
(1998), further pathways utilising many of the same components have been identified 
in eukaryotic organisms; these are the endogenous RNAi pathway (mediated by micro 
RNAs; miRNA), the piRNA (Piwi-interacting short RNA) pathway and RNAi effects 
mediated by endogenous siRNA (esiRNAs) (Matranga and Zamore 2007). Each 
pathway has distinct role: the exogenous RNAi response to foreign nucleic acids forms 
a primary anti-viral defence, while endogenous RNAi acts as one of many controls on 
endogenous gene expression, and piRNAs protect the genome against transposable 
elements (Obbard et al. 2009). 
In the exogenous RNAi pathway, dsRNAs (either experimentally introduced dsRNA or 
viral RNAs) are cleaved by Dicer dsRNA-specific endonucleases into double stranded 
fragments 21-23 nucleotides in length which contain a 5’ phosphate and 2’, 3’ hydroxyl 
termini (named as siRNAs). One strand of the siRNA (guide strand) is loaded into an 
RNA-induced silencing complex (RISC) with the involvement of an additional argonaute 
multi-domain protein, which contains an RNaseH-like domain responsible for target 
mRNA degradation (Filipowicz (2005) and Martinez et al. (2002)).The siRNA 
assembled into a RISC can bind anywhere within the target mRNA sequence provided 
that there is perfectly matched base pairing. Argonaute protein then cleaves the target 
mRNA at the position of nt 10 and nt 11 of the siRNA to cause mRNA degradation. The 
cleaved mRNA is subsequently degraded by cytoplasmic nucleases (Tolia and Joshua-
Tor 2007).  
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Endogenous RNAi functions in the post-transcriptional regulation of eukaryotic gene 
expression (described in reviews by Du and Zamore (2005); Pillai et al. (2007); 
Matranga and Zamore (2007); Chapman and Carrington (2007)). The endogenous 
siRNA (esiRNA) pathway has been discovered to function to regulate host gene 
expression and to control transposable element (TE) levels (Obbard et al. 2009). 
Instead of silencing mRNA, the target for esiRNA is endogenously produced dsRNAs; 
either TEs, overlapping 3-UTRs from genes on opposite strands or stem-loop 
structures. RNAi pathway mediated silencing endogenous dsRNA processes in a 
similar way to the silencing of exogenous dsRNAs in the siRNA pathway. Argonaute-2 
and Dicer-2 are involved in the pathway (Chung et al. (2008); Czech et al. (2008)).  
 
MiRNAs are conserved in both plants and animnals, and are thought to be a vital 
component of gene regulation (Siomi et al. 2011). They are usually produced 
endogenously by host genomes. They are transcribed by RNA polymerase II into 
primary miRNAs followed by processing in the nucleus by proteins from Drosha family 
to form short stem loops, which are termed immature miRNAs. Mature miRNA, 
containing a 5’ phosphate and 3’ hydroxyl is processed by another Dicer family protein, 
Dicer-1, which preferably binds to dsRNAs with imperfectly matching sequences (Lee 
et al. 2004), and a dsRNA-binding domain (dsRBD) protein, Loquacious after the 
immature RNAs are exported in the cytoplasm. Similar to siRNA, of strand of mature 
miRNA are loaded into the RNA-induced silencing complex (RISC) and binds to its 
complementary sequence in endogenous mRNA transcripts, or inhibits translation 
initiation. The other strand from miRNA duplex is released and degraded. Plants 
miRNAs are perfectly complementary to the target mRNA they regulate, and result in 
mRNA cleavage and degradation (Obbard et al. 2009) whereas animal miRNAs are 
less complementary to their target sequence, which results in translation inhibition 
(Pillai et al. 2007). 
 
PIWI-interacting RNAs (piRNAs) are longest small RNAs, and also the largest class in 
small non-coding RNAs expressed in animal cells (Aravin et al. 2007). They are distinct 
from miRNA in size (24-30 nucleotides in piRNAs), lack of sequence conservation, and 
increased complexity (Aravin et al. (2007); Seto et al. (2007).  They are produced by a 
Dicer-independent mechanism; they are found in the germ cells of animals, associated 
with piwi-class Argonaute proteins, participate in in both epigenetic and post-
transcriptional gene silencing (Hartig et al. (2007); Aravin et al. (2007); Klattenhoff and 
Theurkauf (2008)). They are thought to be generated from single-stranded precursor 
RNAs (Matranga and Zamore 2007). PiRNAs contain 5´ monophosphate and 2´-O-
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methyl, 3´hydroxy termini, are thought to arise from loci rich in transposons and act to 
silence dispersed copies of the selfish genetic elements present in the original trigger 
locus (Matranga and Zamore 2007). piRNAs are also implicated to act in silencing 
transposons during mammalian spermatogenesis (Aravin et al. 2007).  
 
 
 
1.3 RNAi in insects 
 
1.3.1 Amplification and spreading of silencing  
The RNAi-mediated down-regulation of gene expression which has been discovered in 
plants (Palauqui et al. 1997) and nematodes (Fire et al. 1998) shows systemic effects, 
in which gene suppression spreads throughout the organism and persists over different 
developmental stages. The systemic RNAi effect in C. elegans involves multiple steps 
including export of siRNAs from cells that are exposed to the original RNA signal and a 
transmission of the effect to other cells. The synthesis of new RNAs (RNA triggers) by 
an export process enables an amplification of the RNAi effect, which can be persistent 
with time in the organism, leading to transmission to progeny (Gatehouse and Price 
2011). The systemic RNAi effect in C. elegans is determined by an RNA-dependent 
RNA polymerase (RdRP) which can interact with the RISC complex and produce new 
dsRNA based on partially degraded target template through using the hybridized 
siRNA strands as primers (Price and Gatehouse 2008). The synthesized dsRNA is 
then cleaved by Dicer to produce new siRNAs (Secondary siRNAs), thus functioning as 
an amplification step. A domain, designated PF05183 is characterized as RdRP, and 
has been found in gene products of many eukaryotic microorganisms, fungi, plants, 
nematodes, but not in insects. In Drosophila, RNAi-mediated gene knockdown is 
limited to the location where dsRNA is delivered and systemic long-lasting RNAi effects 
like C. elegans have not been observed (Figure 1-1).  
As well as a possible amplification mechanism, the mechanisms of export of RNAs 
across the cell membrane are not yet fully understood. Currently, three genes, sid-1,-2 
and -3 are identified as important for RNAs transportation (Winston et al. 2002). The 
product of sid-1 was characterized as trans-membrane protein in cell plasma 
membrane. It is predicted that sid-1 products may function as either a channel for 
dsRNAs and/or siRNAs or a receptor which is responsible for their endocytosis. SID-2 
was identified in intestine, and functions as trans-membrane protein necessary for 
import of dsRNAs from gut lumen into body cavity in nematode. The function of SID-2 
was demonstrated in nematode Caenorhabditis briggsae, which is defective in uptake 
of dsRNA from the gut lumen. A systemic RNAi phenotype was restored after 
  
  
8 
transformation of C. elegans sid-2 into C. briggsae (Winston et al. 2002). In the model 
insect D. melanogaster, a homologue of SID-1 is not present, and no systemic RNAi 
effects are observed. The absence of RdRP in D. melanogaster may indicate that 
systemic RNAi effects from endogenously produced dsRNA will become a limitation for 
down-regulation of a target gene through a plant host. Sid-2 homologues have only 
been identified in nematodes closely related to C. elegans. However, and promisingly, 
homologues of the C.elegans sid-1 gene have been found in insects like Tribolium 
castaneum, Bombyx mori and Apis mellifera, and systemic RNAi effects were observed 
in the T. castaneum , T. castaneum, which can be transmitted to progeny. Tomoyasu 
and Denell (2004) injected dsRNA of a homologue of the Drosophila sensory bristle-
forming gene Tc-achaete-scute (Tc-ASH) into larvae, which caused ‘loss-of-bristle’ 
phenotype over the whole life of adult insects. Three genes: Distalless (leg 
development gene), maxillopedia (homeotic gene) and proboscipedia (relevant with 
labial and maxillary palps formation) were used to construct dsRNA for injection in 
another study. The phenotype changes caused by the RNAi effect were observed both 
in injected insects and progeny embryos (Bucher et al. 2002). Due to the robust 
systemic RNAi response and the completion its genome sequence, T. castaneum is 
becoming a model for the study of systemic RNAi in insects. The comparison of 
genome sequence of C. elegans and T. castaneum revealed that T. castaneum lacks a 
C. elegans-like RdRP which would mediate a systemic RNAi effect (Tomoyasu et al. 
2008). These results suggest that the RNA amplification in T. castaneum is occurring 
by a mechanism different from that in C. elegans, although the mechanism in insects is 
still unclear. 
 
A possible reason for RNAi systemic effects observed in T. castaneum could be the 
presence of three homologues of sid-1 gene in the genome, whereas the lack of 
systemic effects in Drosophila might be due to the lack of sid-1 homologous gene. 
However, recent studies suggests that in Drosophila S2 cells revealed that dsRNA 
uptake does not involve a sid-1 based pathway but occurs by receptor-mediated 
endocytosis (Saleh et al. 2006). The result shows pharmacological inhibition of 
endocytosis also inhibited RNAi effects. A similar phenomenon was also observed in C. 
elegans, in that knockdown of components of the endocytotic pathway by RNAi 
resulted in ‘loss-of-RNAi-function’ phenotype (Ulvila et al. 2006). Moreover, another 
study in Locus migratoria stated that silencing of the LmSID-1 gene did not influence 
RNAi effects of other genes through in vivo experiments (Luo et al. 2012). Further, in 
vitro experiments showed that the LmSID-1 protein in Drosophila S2 cells could not 
enhance dsRNA uptake, confirming that it is not involved in systemic RNAi effects (Luo 
et al. 2012). The author concluded that the mechanism of insect systemic RNAi is 
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different from C. elegans. Homologues of the C.elegans SID-1 gene have been 
identified in aphids (Xu and Han 2008) but the evidence presented above shows that 
the presence of SID-1 homologues in insects cannot be the only criteria for robust 
systemic RNAi effects (Tomoyasu et al. 2008).  
 
1.3.2 Insect sensitivity to RNAi 
The presence of systemic RNAi effects has been found to vary considerably between 
insect species, although C. elegans exhibited a robust systemic RNAi response. In 
insects, successful suppression of endogenous gene expression by RNAi has been 
proposed to depend on intrinsic properties of insects such as species, tissue type and 
genes (reviewed in Bellés (2010)). As stated, in species such as T. castaneum, strong 
RNAi effects are observed, with the effect even spreading into subsequent generations 
by germ line transmission (Bucher et al. (2002);  Liu et al. (2004);  Lynch and Desplan 
(2006); Mito et al. (2011); Ronco et al. (2008)). In contrast, studies using dipteran and 
lepidopteran species found them to be refractory to systemic RNAi. In some 
lepidopteran species, even dsRNA delivered by microinjection into insects were not 
able to provoke RNAi effect (reviewed in Terenius et al. (2011)). 
Recent studies have focused on the extracellular degradation mechanisms in insects 
that are able to remove or degrade alien dsRNA before it is able to enter cells. 
DNA/RNase non-specific activity distinct from that of Dicer has been identified in 
several lepidopteran species. Arimatsu et al. (2007) separated a dsRNase from the 
digestive juice of the silkworm larvae, Bombyx mori. The cDNA they cloned encoded a 
51kDa precursor protein containing three domains: a signal peptide, an N-terminal 
propeptide and a mature Bm-dsRNase which was characterized as a Mg2+ dependent 
alkaline nuclease degrading both DNA and dsRNA, and had conserved catalytic amino 
acid residues. The identified precursor has an Arg-Ser cleavage site, which generates 
the 43kDa mature/processed protein by post-translational processing, the mature 
protein was produced in gut tissue of Day 2 fifth instar larvae, and was coincidently 
secreted into the gut lumen. Mature proteins were localized in the apical side of midgut 
cells for extracellular secretion. The identified 43kDa protein is proposed to be 
responsible for digestion of nucleic acids in the alkaline environment of the midgut of 
Lepidoptera. Later, Jisheng Liu et al. (2012) confirmed that the digestive properties of 
processed BmdsRNase could interfere with the RNAi response by a reporter assay 
targeted by transfected homologous dsRNA. Jisheng Liu et al. (2012) concluded that 
BmdsRNase could be involved in the regulation of nucleic acid metabolism in the 
cytoplasm and the property of degrading dsRNA could be related to an immune 
response against alien RNA such as RNA viruses. Garbutt et al. (2013) demonstrated 
that the rapid degradation of dsRNA in insect haemolymph could be one of the reasons 
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for the unsuccessful RNAi. The persistence of dsRNA was compared between tobacco 
hornworm, Manduca sexta, which is an RNAi insensitive insect and German cockroach, 
Blattella germanica, which is known to be highly susceptible to RNAi. They found that 
the exogenous dsRNA was rapidly degraded in hornworm haemolymph whereas 
dsRNA persisted much longer in the cockroach haemolymph.  Saliva of tarnished plant 
bug, Lygus lineolaris, a Hemipteran species was shown to digest dsRNA by Allen and 
Walker Iii (2012). The authors proposed that this could be the reason for an inactive 
RNAi response when dsRNA is delivered by feeding to tarnished plant bug.  
The type of insect tissue can be another factor influencing RNAi efficiency. Ciudad et al. 
(2007) observed that the RNAi response was much faster and transient in the fat body 
than in the ovary of German cockroach. A recent study by Ren et al. (2014) 
investigated the RNAi response in migratory locust, Locusta migratoria. The migratory 
locust is considered to be a susceptible species to RNAi, but its ovary was found to be 
completely insensitive. They proved that the ovariole sheath was permeable to dsRNA 
by tracking the labelled dsRNA, but dsRNA was not taken up by follicle cells and 
oocytes. Salivary glands are generally less sensitive to RNAi than other type of tissues. 
Boisson et al. (2006) demonstrated that the low level expression of Dicer and 
Argonaute genes in salivary glands resulted in a high dose of dsRNA being necessary 
for inducing an RNAi effect in the mosquito A. gambiae.  
Finally, the type of genes can also affect the RNAi response in insects.  Ciudad et al. 
(2007) proposed that genes with efficient feedback mechanisms of regulation might 
lead to faster rates of transcription of the target mRNA which might counteract the 
effect of depletion. They observed that lipophorin receptor mRNA levels recovered fast 
in fat body of German cockroach after RNAi. Moreover, mRNAs with transient 
expression might make RNAi effects impossible due to a time lag in generating siRNAs. 
For example, B. germanica yellow-g expression gives an acute mRNA peak lasing only 
a few hours in the ovary, and cannot be knocked down by RNAi procedures, although 
down-regulation of many other genes in the ovary has been achieved by RNAi (Irles et 
al. 2009).  
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Figure 1-1 functional stages of RNAi pathway in cells of lower animals.  
Exogenous dsRNA is cleaved by Dicer into small interfering RNA (siRNA) after 
entering into the cells. SiRNA is then assembled with argonaute protein into RNA-
induced silencing complex (RISC). The RISC complex degrades target mRNA based 
on the guide strand sequence of siRNA. Systemic RNAi are mediated by RNA-
dependent RNA polymerase (RdRP) which produce new dsRNAs by useing the target 
RNA as template primed by siRNA strands. The amplified dsRNA can be exported and 
spread RNAi effects among cells. SID-1 and SID2 have been identified in C. elegans 
which are responsible for dsRNA transportation, as has the RdRP enzyme. Systemic 
RNAi effect in insects could be limited by dsRNases in digestive tract and Haemolymph. 
Source: Gatehouse and Price (2011). 
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1.3.3 RNAi for insect pest control 
In insects, research on RNAi has involved delivery of dsRNAs synthesized in vitro into 
embryos or the haemolymph by microinjection. This method of dsRNA delivery has 
become a powerful tool for investigating gene function in insect species lacking well-
developed genetics. However, in terms of using RNAi-based approaches for crop 
protection in the field, a robust feeding method in insects that mimics the results 
obtained in C. elegans, where efficient gene suppression and a resulting phenotype 
can be achieved by orally feeding dsRNA, need to be developed. Two studies 
published in 2006 performed by Araujo et al. (2006) and Turner et al. (2006) suggest 
that RNAi effects can be achieved in insects by oral administration of dsRNA. Araujo et 
al. (2006) produced dsRNA against the gene encoding the anticoagulant heme-binding 
protein nitrophorin 2 of triatomine bug Rhodnius prolixus. The level of anticoagulant 
activity in salivary glands of nymphs was significantly reduced after feeding dsRNA.  
Turner et al. (2006) demonstrated an RNAi effect after dsRNA feeding in larvae of the 
light brown apple moth (Epiphyas postvittana). Third instar larvae of the light brown 
apple moth were fed with dsRNA against carboxyesterases incorporated into artificial 
diet.  Down-regulation of gene expression was detected as early as two days after 
feeding, and repression reached a maximum after several days feeding. Gene 
downregulation was detected not only in the gut, but also in adult antenna after feeding 
dsRNA to larvae, suggesting that the persistence of the RNAi effect throughout the 
larval and adult stages, and a systemic transport signal of RNAi from the midgut cells 
to the eye/antennae disc. These two studies demonstrated that systemic RNAi can be 
induced by oral administration of dsRNA. Subsequently, RNAi induced in insects by 
topical application of dsRNA was demonstrated in the mosquito Aedes aegypti. 
Pridgeon et al. (2008) demonstrated that expression of an inhibitor of apoptosis protein 
1 gene (AaeIAP1) was significantly reduced and result in mortality by applying dsRNA 
in diluted acetone to the dorsal thorax of adult females. Another study by Wang et al. 
(2011) investigating RNAi in the Asian corn borer Ostrinia furnacalis Guenee 
demonstrated that RNAi-induced larval development stunting or death was achieved by 
spraying with an aqueous solution of dsRNA. Evidence showed that eggs soaked in 
dsRNA solution caused delayed rates of hatching compared to control treatment. 
Moreover, the fluorescently labelled dsRNA could be found in larval gut, haemocytes 
and silk fibre after delivery to eggs, indicating that topical application of dsRNA could 
lead to gene repression in other types of tissue cells via the tracheal system. These 
observations show a promising future of using RNAi for crop protection, as dsRNA 
delivery is not limited by oral administration to insect midgut where is not protected by 
chitin (Gu and Knipple 2013). 
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In most RNAi studies of insects, dsRNA are produced through in vitro transcription 
synthesis or chemical synthesis. However, this is not practical for field application for 
pest control due to the high cost. Previous researchers have developed several 
alternative systems for the production of dsRNA in vivo via vector constructs 
harbouring segments of target gene sequence. These systems involve using bacteria, 
host plants and host plant viruses to produce dsRNA, and have made significant 
progress toward using RNAi as tool for crop protection against insect pests.  
In the bacterial expression system, dsRNAs against insect genes are prepared by in 
vivo transcription using a plasmid with T7 promoters in inverted orientation flanking the 
inserted cDNA sequence targetting an insect gene in an engineered E.coli strain 
containing a chromosomal gene encoding T7 polymerase. DsRNA is produced in the 
induced bacterial cells and both strands of dsRNA are annealed at the same time. The 
ingestion of bacteria cells expressing dsRNA has been shown to induce gene 
repression as well as a phenotype in Spodoptera frugiperda (Tian et al. 2009), 
Bactrocera dorsalis Hendel (Li et al. 2011) and Leptinotarsa decemlineata (Zhu et al. 
2011). Although the gene silencing effects in all three studies were caused by feeding, 
the silenced signals were observed beyond the gut which indicate a systemic spread 
RNAi effect. 
 
Alternatively, transgenic plants capable of inducing RNAi in insect pests have been 
produced. The host plants are transformed via Agrobacterium tumefaciens with vectors 
containing inverted repeats of target insect gene sequences. The genes are 
transcribed to form hairpin RNAs (hpRNAs) in transgenic plants that are functionally 
equivalent to linear dsRNAs, followed by cleavage of hpRNAs into siRNA by 
endogenous plant Dicer enzymes. These plants expressing hpRNA deliver sufficient 
amounts of intact dsRNA for oral uptake by insect pests to show enhanced resistance, 
and protection against several economically important agricultural pests from different 
insect orders has been claimed. This approach has been used to cause mortality in the 
western corn rootworm (WCR) Diabrotic virgifera by expressing dsRNA against V-type 
ATPase A gene (Baum et al. 2007). The rapid downregulation of endogenous mRNA 
can be detected as early as 24h after ingestion of dsRNA at low concentration. A 
systemic silencing of genes was triggered by orally delivered dsRNA. Knockdown of V-
type ATPase A results in disruption of electrochemical gradients across the insect gut 
epithelia, affecting the insect's ability to transport nutrients out of the gut, which leads to 
high mortality as a consequence. To investigate the specificity of RNAi-mediated 
insecticidal effects, dsRNA directed against b-tubulin, V-ATPase A and V-ATPase E of 
WCR were delivered to other coleopteran pests: Southern corn rootworm (SCR) 
Diabrotica undecimpunctata, Colorado potato beetle (CPB) Leptinotarsa decemlineata, 
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and cotton boll weevil Anthonomus grandis. Significant larval mortality in SCR and CPB 
were achieved with higher concentration of dsRNA than those used in WCR but cotton 
boll weevil was completely insensitive, emphasizing the species-specificity of RNAi 
effects, which require a high level of sequence identity between the dsRNA and the 
target gene. Mao et al. (2007) engineered Tobacco and Arabidopsis plants to express 
dsRNA against a cytochrome P450 gene, CYP6AE14, which is highly expressed in the 
insect midgut. The expression of CYP6AE14 is related to tolerance to gossypol, a 
cotton secondary metabolite, via detoxification of this compound. Knockdown of 
CYP6AE14 could increase the sensitivity of the insect larvae to gossypol. In larvae 
feeding on plants expressing the CYP6AE14 dsRNA, effective gene silencing of 
endogenous CYP6AE14 gene was found, and the insects showed enhanced sensitivity 
to gossypol. Interestingly, knocking out the Arabidopsis dicer genes DCL2, DCL3 and 
DCL4 in transgenic plants producing dsRNA resulted in substantially higher levels of 
long dsRNA and resulted in more effective repression of the CYP6AE14 gene, 
indicating that longer dsRNA shows more efficient RNAi in the insect than siRNA 
already cleaved and processed by the host plant (Mao et al. 2007). Subsequently, 
several studies using transgenic plants expressing dsRNA were published, using 
tobacco hornworm Manduca Sexta (Kumar et al. 2012) and two phloem sap feeders, 
the brown plant hopper Nilaparvata lugens (Zha et al. 2011) and the green peach aphid 
Myzus persicae (Pitino et al. 2011). Instead of focusing on silencing gut specific genes, 
a gene to produce dsRNA directed against aphid salivary gland genes was constructed 
and expressed in transgenic plants. This also achieved effective gene suppression, 
suggesting systemic RNAi in aphid (Pitino et al. (2011); Kumar et al. (2012)).  
Finally, in plants, virus-induced gene silencing (VIGS) provides a more simple and 
efficient alternative to knockdown of endogenous gene expression (Gu and Knipple 
2013). Infection of host plants by recombinant viruses containing target sequences 
triggers the antiviral RNA-silencing pathway with slight viral disease symptoms in the 
host plants (Bachan and Dinesh-Kumar 2012). Kumar et al. (2012) demonstrated a 
rapid and robust RNAi effect was achieved against an herbivore Manduca sexta by this 
VIGS system. The author Agro-infiltrated Nicotiana attenuate with tobacco rattle virus 
(TRV), a bipartite positive-sense RNA virus, as the silencing vector to target three 
cytochrome P450 (CYP) genes expressed in insect mid-gut. Transgenic plant mediated 
RNAi was also developed for comparison. Both stable and transient expression of CYP 
dsRNA resulted in specific and robust RNAi in M. sexta larvae. But, the advantage of 
VIGS system is the speed of this technique taking only 4-5 weeks to complete, 
whereas transgenic lines are much time-consuming. Therefore, this system is more 
suitable for high throughput screening of potential targets in insect pests (Bachan and 
Dinesh-Kumar 2012). 
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1.4 Targets in Insects for RNAi 
 
1.4.1 Inhibitor of apoptosis 
Apoptosis is an evolutionarily conserved pathway of programmed cell suicide triggered 
by a large number of extracellular and intracellular stimuli including developmental 
signals, environmental and intracellular stress (Reviewed by Berthelet and Dubrez 
(2013). Apoptosis is a genetically controlled process, which is significant for normal 
development and tissue homeostasis (Vaux et al. 1994). It is recognized as an 
important mechanism for removal of supernumerary, undesirable or damaged cells. It 
also involved in immune responses and antivirus defence (Clarke and Clem 2003). In 
order to overcome the protection mechanism, viruses have developed strategies to 
allow replication and spreading. Inhibitor of Apoptosis (IAP) has been identified as a 
potent inhibitor of apoptosis in insect cells (Crook et al. 1993). IAP was originally 
discovered in insect baculoviruses (Cydia pomonella granulosis virus and Orgyia 
pseudotsugata nuclear polyhedrosis virus) (Crook et al. 1993), (Birnbaum et al. 1994). 
Subsequent studies revealed that IAPs also existed as endogenous genes in insects 
(Wang et al. 1999), yeast (Walter et al. 2006), and human (Ambrosini et al. 1997), 
(Vitte-Mony et al. 1997). However, only a subset of IAPs are functionally involved in 
apoptosis regulation, with many genes encoding proteins with similar sequences 
having non-apoptosis functions (Marivin et al. 2012); (Beug et al. 2012). For example, 
Drosophila IAP2 (DIAP2) has been shown to be involved in Tumour Necrosis Factor 
(TNF) Receptor (TNFR) superfamily and Nuclear Factor-kappaB (NF-kB) activating 
signalling pathways (Gyrd-Hansen and Meier 2010); (Wertz and Dixit 2010); (Silke and 
Brink 2010), regulating cell differentiation (Dupoux et al. 2009) cell motility (Dogan et al. 
2008), and pro-inflammatory and immune responses (Beug et al. 2012). 
 
1.4.1.1 Structure of IAPs 
The Drosophila melanogaster (Dipteran) gene thread (th) encodes a protein referred to 
as DIAP1 (Drosophila Inhibitor of Apoptosis Protein 1) (Figure 1-2). The IAP family is 
identified by the presence of 1-3 Baculovirus Iap Repeat (BIR) domains at the N-
terminal, each of which contains about 70 residues with a consensus Cys/His motif 
coordinating a single zinc ion ((Birnbaum et al. 1994); (Hinds et al. 1999). BIRs function 
as protein interacting modules with specific binding properties (Eckelman et al. 2008). 
The BIR hydrophobic groove can only bind processed, activated caspases. Type II 
BIRs are functionally involved in anti-apoptotic properties of IAPs whereas Type I BIRs 
are found to be essential for cell signalling pathways (Lu et al. 2007). Another 
conserved motif present in IAPs is the C-terminal RING zinc-finger that exhibits an E3-
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ubiquitin ligase activity. This motif enables IAPs to catalyse the covalent conjugation of 
ubiquitin to a lysine of target partner proteins, such as NEDD8 (neural precursor cell 
expressed developmentally downregulated protein 8) (Broemer et al. 2010);(Zhuang et 
al. 2013); the conjugation can result in addition of a single ubiquitin molecule 
(monoubiquination) or polyubiquitin chains. Furthermore, IAPs can mediate their own 
ubiquitination as well (Silke et al. 2005).  
 
 
 
Figure 1-2 Drosophila IAP1 involved in the regulation of apoptosis. Type II BIRs 
highlighted in brown contain a surface hydrophobic groove that binds a tetrapeptide 
motif called IAP Binding Motifs (IBM) observed in caspase sub-units and IAP 
antagonists. The RING domain offers IAP with an E3-ubiquitin ligase activity. Source: 
Berthelet and Dubrez (2013). 
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1.4.1.2 Drosophila IAPs as Caspase Inhibitors 
In Drosophila, the apoptotic initiator caspase DRONC (DROsophila Nedde-2-like 
Caspase) takes part in all forms of apoptosis (Meier et al. 2000). It is activated by the 
Apaf-1 (Apoptotic protease activating factor 1) orthologue DARK (Drosophila Apaf-1 
related killer) at the caspase-activating platform apoptosome (Yuan et al. 2011). 
Following a death signal, signalling caspases is activated by proteolytic processing, 
then these signal caspases proteolytially activate effector caspases which will cleave 
and degrade targets such as lamins, kinases, DNA repair enzymes and proteins 
involved in mRNA splicing and DNA replication, and this is presumed to trigger many of 
the morphological processes of cell death defined as apoptosis (Thornberry and 
Lazebnik 1998). When the apoptotic signal is absent, the cell death machinery is frozen 
by several regulatory mechanisms which involve the inhibition of assembly of 
apoptosome and caspase cascade activation by IAPs (Orme and Meier 2009). 
Therefore, inhibition of caspase activity inhibits apoptosis. In D. melanogaster, DIAP1, 
referred as a ‘gatekeeper of death’ (Orme and Meier 2009), interacts with the caspase 
DRONC (Drosophila Nedd-2-like caspase) through BIR2 and prevents activation of 
protease either by binding to the pro-region of the protease or blocking the active site 
of the enzyme. DRONC is capable of self-activation through an oligomerising factor 
DARK. During apoptosis, DIAP activity is inhibited by the protein products of reaper, 
hid and grim genes, which induce DIAP ubiquitinylation and subsequent degradation, 
thus releasing DRONC, leading to apoptosis activation. Loss-of-function mutations in 
thread (gene encoding DIAP1) result in early embryonic death with a caspase-
dependent apoptosis (Wang et al. 1999); (Lisi et al. 2000) and (Chandraratna et al. 
2007).  
There have been several studies on the effectiveness of inhibitor of apoptosis genes as 
a target for RNAi, in dipteran (Drosophila, Aedes aegypti), and Heteropteran (Lygus 
lineolaris) species. Igaki et al. (2002) reported that cell death in Drosophila S2 cells 
was achieved through downregulation of DIAP1 by introduction of dsRNA. And DIAP1 
downregulation induced cell death was proved to be depended on the loss of DRONC 
and Dark function.  Another study on Aedes aegypti showed that topically applied 
AaeIAP1 double-stranded RNA products were able to kill female adults. Three different 
IAP1 isoforms (IAP1-B, IAP1-C, IAP1-D) were targetted, and dsRNA was delivered 
using two carriers, acetone and transIT-siQUEST transfection reagent (Mirus Bio 
Corporation, Madison, WI), which is proprietary cationic polymer/lipid formulation 
supplied in ethanol. TransIT-siQUEST has been successfully applied in transfection of 
cell culture with siRNA (Pridgeon et al. 2008). The result showed that IAP1-D dsRNA 
with siQUEST caused the highest level of AaeIAP1 mRNA suppression. DNA 
fragmentation assays were applied for the confirmation of specific RNAi effects. They 
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also concluded that a specific formulation could be developed as an efficient carrier for 
introducing dsRNA into insects, allowing dsRNA to be sprayed as a pesticide. 
 
1.4.2 V- type ATPase 
The eukaryotic vacuolar-type adenosine triphosphatase (V-ATPase) is a multi-subunit 
membrane protein complex that functions as a rotary proton-pumping nano-motor by 
transforming the energy of ATP hydrolysis to electrochemical potential differences of 
protons across various biological membranes. V-type ATPases and F-ATPases are 
evolutionary related with similar structural and functional characters (Nishi and Forgac 
2002). F-ATPases produce ATP and V-ATPases consume ATP. When the ionic 
electrochemical potential is greater than the free energy of ATP hydrolysis, ATP is 
synthesized. In contrast, ATP is hydrolysed to drive the uphill transport of ions when 
free energy of ATP hydrolysis is greater than the ionic electrochemical potential 
(Beyenbach and Wieczorek 2006). 
 
1.4.2.1 Structure and mechanism of V-type ATPase 
Eukaryotic V-type ATPases are multi-subunit proteins that consist up to 14 different 
polypeptides have a bipartite structure which assemble as two major ring structures: a 
soluble cytoplasmic V1 sector (A3B3CDEFG2H1-2 ,400-600 kDa) that interacts with ATP, 
ADP and inorganic phosphate and a membrane-integrated V0 sector (ac4c’c’’de, 150-
350kDa) that mediates the transport of H+. V1 and V0 are connected to assemble V1V0 
holocomplex. As shown in Figure 1-3 A, the subunits of V1 and V0 are distinguished by 
large and small letters. The V1 complex consists of: (1) a globular structure contains 
three alternating copies of A and B subunits to form a ring. Subunit A and B mediate 
the hydrolysis of ATP at three reaction sties. (2) a central stalk contain single copies of 
subunit D and F and (3) a peripheral stalk composed of subunit C, E, G and H. Both 
the central rational stalk and peripheral stalk connected V1 complex with central 
hydrophobic c ring structure (c,c’,c’’) consist of six or more c subunits of proton 
transporting V0 complex. V1 complex is hold in place by fixed peripheral stalk and 
subunits B and C which are capable of binding to actin to stabilize the structure 
(Vitavska et al. 2005). It is recognized that V-type ATPase contains a stationary and a 
mobile parts, named as stator and rotor (Figure 1-3 B). Subunits D, F and c-ring belong 
to rotor and rest of subunits are considered as stator. Reviewed by Beyenbach and 
Wieczorek (2006). 
During the process of ATP-driven proton pumping, conformational changes of subunits 
A and B of V1 are caused by ATP hydrolysis that drives the rotation of c-ring. There is a 
H+ binding site on each c subunit of the c-ring and inner half channel of subunit and the 
middle of the lipid bilayer enable cytoplasmic H+ to bind to glutamate residues on the c-
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ring. After 360° clockwise rotation of the c-ring when viewed from the cytoplasm (Meier 
et al. 2005), H+ is released and exited the membrane though middle of the lipid bilayer 
and other side of the membrane (Junge et al. (1997); Junge and Nelson (2005)). As a 
consequence, an electrochemical proton gradient of proton motive force (pmf) is 
generated across the membrane, which will lead to acidification of intracellular 
compartments (Marshansky et al. 2014). V-ATPase dependent acidic luminal pH is 
necessary for all intracellular compartments of eukaryotic cells (Marshansky and Futai 
2008). Moreover, V-ATPase is essential for vesicular trafficking along both the 
exocytotic and endocytotic pathways of eukaryotic cells (Marshansky and Futai 2008). 
 
1.4.2.2 Regulation of the V-type ATPase 
A unique fundamental character of V-type ATPase is the reversible assembly/ 
disassembly of the V1 and V0 complexes.  It was first identified during the process of 
molting of M.sexta, revealing the relationship of transepithelial transport of V-type 
ATPase and insect growth (Sumner et al. (1995); Beyenbach and Wieczorek (2006) ). 
In M. sexta, secreting K+ into the lumen of the midgut drives growth through inducing 
feeding activity. High activity of V-ATPase at the apical membrane proved by large 
transepithelial, lumen-positive voltages across the midgut, offers the electrical force for 
K+ secretion through 2H+/k+ antiport, In response to ceased feeding or starvation in 
M.sexta, transepithelial voltage drops to zero, and the hydrolysis of V-type ATPase as 
well as ATP-dependent proton transport decreased to less than 15%, suggesting the 
inactivation of the V-type ATPase (Beyenbach and Wieczorek 2006). Later, separation 
of V1 and V0 complexes was observed by gel electrophoresis and immunoblot (Sumner 
et al. 1995).The dissociation of holoenzyme was identified in yeast Saccharomyces 
cerevisiae (S. cerevisiae) as well (Kane (1995); Kane (2000); Kane (2012)). 70% 
dissociation of holoenzyme is observed after glucose deprivation for as short as 5 min, 
and reassembly of V1 and V0 complexes is recovered after addition of glucose.  
Interestingly, new protein synthesis is not required for dissociation or reassociation of 
holoenzyme of V-type ATPase. And V-type ATPase V1 and V0 complexes 
association/dissociation is now considered as a universal regulatory mechanism of V-
type ATPases.  
 
1.4.2.3 V-type ATPase knockouts 
Due to the function involvement in fundamental cellular mechanism, intact v-type 
ATPase are required for the normal function of the Golgi complex, endoplasmic 
reticulum, vacuoles and endocytotic and exocytotic vesicles in almost every eukaryotic 
cell (Beyenbach and Wieczorek 2006). Disruption of genes encoding the V1 subunit B 
or the V0 subunit c in yeast lead to failure to survive at physiological pH (Nelson and 
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Nelson 1990). Subsequently, inactivation of subunit B in Drosophila and subunit c in 
mice were proved to cause lethal phenotypes (Davies et al. (1996); Inoue et al. (1999)). 
Different subunit isoforms are normally observed at different locations, when a V-type 
ATPase subunit is encoded by more than one gene (Beyenbach and Wieczorek 2006). 
In multicellular higher eukaryotes, several subunit isoforms were found to be expressed 
in various cell types and located in specific tissues. For example, several subunit 
isoforms in mammals have been identified in the kidney (Chung et al. 2008), inner ear 
(Dou et al. 2003) and brain (Murata et al. 2002). Disruption of tissue-specific isoforms 
may not lead to lethal phenotype, but could cause inherited disorders. As mentioned 
above, ingestion of dsRNA against V-type ATPase A subunit lead to mortality in 
western corn rootworm, which suggest that knockdown of midgut V-type ATPase A 
subunit affects the electrochemical gradient across the gut epithelia and results in the 
subsequent lethal phenotype (Baum et al. 2007). A similar effect was also observed in 
Leptinotarsa decemlineata. V-type ATPase E subunit mRNA was expressed 
consistently at high level in ileum and rectum, moderately in Malpighian tubules,  
midgut and foregut, and less expressed in fat body, ventral ganglion, epidermis and 
haemolymph of fourth instar larvae (Fu et al. 2014). Larval growth and survival were 
significantly affected after continuously ingested dsRNA against V-type ATPase E 
subunit (Fu et al. 2014). 
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Figure 1-3 V-type ATPase in eukaryotic cell membrane.  
(A) Molecular model. Eight different subunits labelled with capital letters A-H are 
identified in V1 complex. Subunit G presents as the dimer G2. Four different subunits 
shown as small letters (a,c,d,e) are found in integral membrane V0 complex. H+-
binding rotor ring (c-ring) composed of c subunit and its isoforms c’ and c’’. Subunit B 
and C has acting binding site. 
(B) Mechanistic model.  V1 and V0 complexes are connected by central stalk (subunit 
D, F) and a peripheral stationary stalk (subunit C,E,G,H,a).  Rotor sector consists of 
central stalk of V1 complex and c-ring of V0 complex (highlighted in red), and rest of 
the subunits are considered as stator (highlighted in grey). Hydrolysis of ATP releases 
energy and drive the rotation of central stalk and c-ring. H+ is transported from the 
inner half channel to the outer half channel with the aid of H+ binding step to on c 
subunit. Inhibitors of V-type ATPase like pleomacrolides bafilomycin, concanomycin, 
and macrolactone archazolid bind to the c subunit in V0 complex (Beyenbach and 
Wieczorek 2006).  
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1.5 Using GNA as a molecular carrier 
Lectins are sugar-binding proteins, which comprise a group of proteins that are found in 
all plants, and many other organisms, including bacteria. In plants, they are considered 
as nitrogen-storage proteins and involved in plant defence against biotic stresses. They 
also present deleterious effects against several invertebrates (Peumans and Van 
Damme 1995). The mannose-specific lectin from snowdrop (Galanthus nivalis 
agglutinin: GNA) (Figure 1-4) is a 50kDa tetrameric protein composed of 12.5kDa 
subunits, which agglutinates rabbit erythrocytes (Van Damme et al. 1987). The gene 
and mRNA code for a 157 amino acid polypeptide, with 23 residues forming an N-
terminal signal sequence and 29 residues composing C-terminal extension. Mature 
GNA is formed when C-terminal peptide is cleaved during post-translational processing. 
Mature GNA is highly resistant to proteolytic activity in the insect gut and binds 
specifically to terminal mannose residue of insect gut epithelial glycoproteins. Binding 
to the gut surface results in effective transport by endocytosis, which allows the protein 
to cross the midgut epithelium of insects. After feeding, the transported GNA was 
observed in haemolymph, fat bodies and ovarioles in brown plant hopper Nilaparvata 
lugens (Hemipteran) (Powell et al. 1998). The ability of GNA transport to the 
haemolymph after oral administration to insects has also demonstrated in other orders 
such as Coleopteran, Neuropteran and Lepidoptera (Hogervorst et al. 2006); (Fitches 
et al. 2001). However, the mechanism behind this phenomenon is still not fully 
characterised.  
The ability of GNA to transport across insect midgut barrier after orally ingestion by 
insects opened the potential possibility of delivering toxic molecules to the effective site 
in insect by fusing them to GNA. Fitches et al. (2004) developed a fusion protein which 
contained SFI1, a spider toxin from Segestria florentina to GNA. Injection of SFI1 into 
Heliothis virescens (Lepidoptera) induces paralysis (Lipkin et al. 2002) whereas orally 
feeding to larvae failed to induce toxic activity. 100% mortality was observed in 
Nilaparvata lugens after feeding artificial diet containing the fusion protein SFI1/GNA 
after 7 days and 49% survival was recored in Myzus persicae after 14 days  (Down et 
al. 2006). Other insecticidal peptides were also fused with GNA and tested against 
several insect species; the fusion proteins showed effective toxicity in rice brown 
planthopper Nilaparvata lugens (Trung et al. 2006), T. castaneum (Fitches et al. 2010). 
More recently, insect calcium channel blocker ω-ACTX-Hv1a was selected to fuse with 
GNA. Fitches et al. (2012) demonstrated that GNA was delivering ω-ACTX-Hv1a to its 
target sites in the central nervous systems (CNS) of M.sexta. 
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Figure 1-4 GNA tetramer Structure. Each subunit is distinguished in colour (green, 
orange, yellow and purple). High affinity carbohydrate binding sites in each subunit 
contains a bound sugar molecule. Source: Hester et al. (1995) 
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1.6 Aims and objectives 
The present project explores the RNAi responses in insects of three orders, including T. 
castaneum (Coleopteran), M. domestica and D. radicum (Dipteran) and A. pisum    
(Hemipteran). Potential effectors for various RNAi responses in insects were 
investigated. In order to apply RNAi as a potential method for crop protection, 
recombinant proteins containing a dsRNA binding domain, RBD3, derived from the 
Drosophila staufen protein were produced and evaluated for their ability to protect 
dsRNA against degradation. A fusion protein containing RBD3 and Galanthus nivalis 
agglutinin was designed to both protect dsRNA and transport it across the insect gut 
after feeding. This fusion protein was produced and evaluated for controlling insect 
pests. 
The objectives are: 
1. To produce dsRNAs against V-type ATPase E subunit and APIN gene of 3 
insects species for the evaluation of RNAi responses by injection and feeding 
(Results are shown in chapter 3).  
2. To investigate the stability and persistence of introduced dsRNAs affecting 
RNAi responses in insect haemolymph and gut tissues (Results are shown in 
chapter 5).  
3. To express Trx/RBD and Trx/RBD/GNA proteins in E. coli and P. pastoris 
system for testing dsRNA binding abilities (Results are shown in chapter 4). 
4. To improve the dsRNA stability in insects tissues by conjugation with Trx/RBD 
Trx/RBD/GNA and RBD and RBD/GNA proteins (Results are shown in chapter 
5). 
5. To evaluate the RNAi reponse of dsRNA-Trx/RBD conjugates in insects 
(Results are shown in chapter 5). 
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Chapter 2  Methods and materials 
 
2.1 Insects cultures 
Acyrthosiphon pisum (A. pisum) were maintained on broad bean plants (Vicia faba) at 
25°C, under a lighting regime of 16h: 8h (L: D). Before the bioassays, adults were 
collected and transferred from plants to chambers containing artificial diet described by 
(Febvay et al. 1988). The liquid diets (50µl) was sealed between two layers of parafilm 
in a feeding chamber described by (Down et al. 1996). Neonate nymphs were collected 
with paint brush after 24 hours for feeding assays, and 5 days old aphids were used for 
injection assays with dsRNA. 
Tribolium castaneum (T. castaneum) larvae and adults were reared continuously in 
whole flour containing 5% brewer’s yeast at 25°C, under a lighting regime of 16h:8h 
(L:D) with 75% relative humidity. For the feeding assays, flour was passed through a 
sieve with aperture size 300µm (Glenammer Engineering) in order to separate the 
larvae and eggs. Newly hatched larvae less than 1 week old were used for feeding 
assay whereas pre-pupa stage larvae were used for injection assays. 
Musca domestica (M. domestica) eggs were kindly supplied from FERA and larvae 
were fed on an organic bran based diet (0.2g/g bran; 0.1g/g grassmeal w/w; 0.05g/g 
dried brewers yeast; 0.015g/g malt extract [Stortex 70D] and 0.015g/g skimmed dried 
milk powder; 0.62ml/g water). Delia radicum (D. radicum) cultures were kept according 
to (Finch and Coaker 1969). The larvae were fed on organic swede covered by sand, 
whereas adults were maintained in a bug dorm (Megaview Science Education Services 
Co., Ltd) supplied with cotton wool swabs soaked with solutions of sugar (10% [w/v]), 
yeast extract (1.25% [w/v]) and dried milk powder. Both M. domestica and D. radicum 
were kept in same environment as T. castaneum. 
 
2.2 RNA extraction and complementary DNA (cDNA) synthesis 
Total RNA was purified from whole insect bodies at different stages by using Quick-
RNATM Miniprep from ZYMO Research according to the manufacturer’s protocol. 
Insects were placed in 1.5ml microcentrifuge tubes and submerged in liquid nitrogen to 
‘snap freeze’ the samples. Insect tissue homogenisation was performed by grinding the 
tissue by using RNase-free pellet pestle (Anachem) in lysis buffer provided by kit. DNA 
contamination was removed by using on column digestion provided by RNA extraction 
kit. RNA was quantified by using Nano-drop spectrophotometer (Model ND-1000, 
Thermo Scientific). cDNA synthesis was performed from 1µg total RNA by using a 
mixture of oligo-d(T) and random hexamer primers from SensiFASTTM, and the 
components of a cDNA synthesis kit (Bioline) as described in the protocol supplied.  
  
  
26 
2.3 Isolation of target gene sequence from M. domestica and D. 
radicum 
For isolating the APIN gene in M. domestica and D. radicum, degenerate primers 
(Table 2) were designed based on the conserved amino acid sequence alignment 
among several dipteran species, including Drosophila melanogaster, Anopheles 
gambiae, Aedes aegyptica and Culex pipiens. The same primer pair was used for both 
M. domestica and D. radicum. PCR conditions were: 94 °C for 5 minutes (1 cycle), 
94 °C for 30 seconds, 58 °C for 30 seconds, 72 °C for 30 seconds (30 cycles) and 
72 °C for 7 minutes (1 cycle). The primer pair gives a predicted PCR product of 470bp 
followed by extraction (QIAquick Gel Extraction kit, QIAGEN) from agarose gel and 
cloned into pJET1.2 (CloneJET PCR Cloning kit, Thermo Scientific Life Science 
Research) as described in the manufacturer's protocol. The identity of the resulting 
DNA fragments was confirmed by DNA sequencing based on Sanger sequencing 
method.  Based on the partial coding sequences obtained, the following gene specific 
primers used for amplification of RNAi region were designed (错误 ! 未找到引用源。 ). 
 
2.4 RACE for obtaining full-length genes from M. domestica and D. 
radicum 
For obtain the full-length APIN gene from M. domestica and D. radicum. 3’ and 5’ 
primer RACE of M. domestica and D. radicum APIN gene was prepared and 
sequenced. First-strand cDNA synthesis was prepared from incubating 1µg total RNA 
with 1µl 12µM 3-CDS primer A (Listed in Table 1) at 70°C for 2 minutes, the volume 
was adjusted to 5µl with PCR-grade water. The reaction was then transferred to ice for 
2 minutes. 10µl reaction was carried out according to the manufacturer’s protocol from 
TAKARA Primer Script. RACE PCR reaction was prepared according to Advantage 2 
polymerase Mix from Clontech. RACE cDNA was amplified by 10X Universal Primer 
Mix and gene-specific primer listed in Table 1. The conditions are: 94 °C 30 seconds 
repeated 5 cycles; 94 °C 30 seconds, 70 °C 30 seconds, 72 °C 3 minutes, repeated 5 
cycles followed by 94 °C 30 seconds, 68 °C 30 seconds 72 °C 3 minutes repeated 30 
cycles. PCR product was eluted from agarose gel by using QIAquick gel extraction kit 
metioned above and ligated with pJET1.2 vector for sequencing. Sequences are 
assembled by Sequencher 5.0. 
 
2.5 Cloning of gene templates for Double-stranded RNA (dsRNA) 
V-type ATPase E subunit and thread transcripts from insects were amplified from 
200ng cDNA template using synthetic oligonucleotides from IDT (Integrated DNA 
Technologies http://www.idtdna.com/CodonOpt ). All the primers for cloning including 
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restriction enzyme sites (Xhol and Xbal) (Fermentas) are listed in Table 2. A sequence 
from a kanamycin-resistance gene (nptII) from the plasmid PSC-A-amp/Kan vector 
(Ahgilent Technologies) was amplified as a negative control. PCR amplification was 
performed by using Phusion High-Fidelity DNA polymerase (Thermo Scientific) with 
conditions as follows: 98 °C for 30s, followed by 15 cycles of 10s 98°C, 30s at 58°C 
and 30s at 72°C, final extension step was 72°C for 10min. The amplified PCR product 
of 277bp or 254bp were separated by 1% DNA agarose gel and eluted from gel by 
using QIAquick column (Qiagen). Eluted PCR products were ligated with pJET1.2 
vector (CloneJET PCR cloning kit, Thermo Scientific Life Science Research) following 
the manufacturer’s protocol. The ligation was then transformed into one shot E. coli 
TOP10 competent cells (Invitrogen) and plated on selective Carbenicillin (50µg/ml) LB 
media. Colonies were screened by colony PCR with standard Taq polymerase using 
pJET1.2 forward and reverse sequencing primers provided by the kit. The conditions 
were 94°C For 10 mins, followed by 25 cycles of denaturation at 94°C for 30s, 
annealing at 60°C for 30s, and extension at 70°C for 1 min, with a final extension at 
72°C for 7 mins. Selected colonies giving a PCR product of the predicted size (400 bp) 
were picked off. Recombinant plasmids containing confirmed DNA sequences were 
minipreped by using Wizard plus SV Minipreps (Promega) followed by double digestion 
with Xho I and Xba I restriction enzymes. The digested products were ligated to RNAi 
vector L4440 that had been digested with same two enzymes. The ligation mixture was 
then transformed into E. coli TOP10 and HT115 (DE3) competent cells. Positive 
colonies were screened by colony PCR described above using T7 promoter and 
terminator primers. The selective recombinant clone was verified by DNA sequencing 
again.  
 
2.6 In vitro transcription 
Recombinant plasmids containing confirmed DNA sequence were extracted from cells 
and linearized with either XhoI or XbaI restriction enzymes for production of sense and 
antisense strands of the dsRNA. Both digestion reactions were performed in 1X tango 
buffer overnight at 37°C.  Linear plasmids were precipitated with 3M NaOAc (Sodium 
acetate, 1/10 reaction volume) and three volumes of absolute ethanol in -20°C 
overnight. The pellets were then collected by centrifuge and resuspended in nucleases 
free water. Sense and antisense RNA were prepared by in vitro T7 RNA polymerase 
transcription separately (Megascript T7 transcription kit, Ambion). 1µg linearised DNA 
templated were used for sense and antisense reactions in a total volume of 20µl, 
following the manufacturer’s protocol. The reactions were incubated at 37 °C for 6 
hours. Remaining DNA templates in the reactions were removed by DNase digestion 
(Enzyme provided by transcription kit). Single-strand RNAs produced were then 
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purified by phenol chloroform extraction and precipitated with 3M NaOAc described 
above. The pellets were collected by centrifuge and then washed with 70% ethanol. 
Finally, the pellets were air-dried and resuspended in nuclease free water. 
Single stranded RNAs were quantified by using Nano-drop spectrophotometer (Model 
ND-1000, Thermo Scientific) and equal amount of sense and antisense RNAs were 
mixed together. The mixture was then annealed by heating at 85°C for 5 mins and then 
slowly cooled down to room temperature. Resulting dsRNAs was analysed by agarose 
gel electrophoresis to confirm the size and quality. The yield of ssRNA from 1µg of 
DNA template was routinely around 100µg.  
 
2.7 Quantitative real-time PCR (qRT-PCR) 
Total RNA was isolated from 3-5 individual insects after injection or feeding using 
Quick-RNATM Miniprep from (ZYMO Research). DNA contamination was digested with 
DNase provided by the kit.  The quality of isolated RNA was validated by Nano-drop. 
cDNA synthesis was performed from 1µg total RNA by using a mixture of poly-T oligo 
d(T) and random hexamer primers from SensiFASTTM cDNA synthesis kit (Bioline) 
described in the protocol supplied. Quantitative real-time PCR was performed on 96 
wells ABI Step one Plus real-time PCR instrument by using GoTaq® qPCR Master Mix 
(Promega). CXR was used as reference dye in each reaction. GAPDH was used as the 
endogenous control for normalisation of target gene expression and triplicates were 
performed for each sample. qPCR primers listed in  
 were designed using ABI primer express software for real-time PCR.  
 
2.8 Biotin-labelled RNA 
RNA biotinylation was performed by using PierceTM RNA 3’ End Biotinylation kit from 
Thermo scientific. ssRNAs generated from in vitro transcription were first heated at 
85°C for 5 minutes and placed on ice immediately. 10pmol ssRNAs was used in 30µl 
biotin ligation reaction prepared according to the manufacturer’s protocol. The 
reactions were incubated at 16°C for 2 hours followed by adding 70µl of nuclease-free 
water. Same volume of chloroform: isomyl alcohol was mixed to extract the RNA ligase 
by centrifuge 3 minutes at 12,000xg in a microcentrifuge to separate the phases. Top 
the aqueous phase was collected and concentrated by ethanol precipitation. The biotin-
ssRNAs were finally stored in 20µl nuclease-free water. Biotin-dsRNAs were prepared 
by heating a mixture of biotin-sense and biotin-antisense RNA at 85°C and cool down 
to room temperature slowly. 50pmol dsRNA which prepared from in vivo transcription 
also used to perform labelling reaction.  
Labelling efficiency was determined by dot blotting using Thermo Scientific 
Chemiluminescent Nucleic Acid Detection Module. Briefly, 2500-fold diluted biotin-
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ssRNAs, biotin-dsRNAs as well as control biotinylated IRE RNAs were dotted on 
positively charged nylon membrane which was equilibrated with TE buffer. Excess 
buffer was absorbed by dry paper towel followed by crosslinking the membrane for 60 
seconds at 120mJ/cm2 by UV-light crosslinking instrument. The immobilized nucleic 
acids were first blocked on positively charged nylon membrane by incubated with 
blocking buffer provided by detection kit. Then the biotinylated RNAs were conjugated 
with stabilized streptavidin-horseradish peroxidase. The membrane was incubated in a 
mixture of luminol enhancer solution and stable peroxide solution for 5 minutes after 
washing. Membrane was then placed in a film cassette and exposed to X-ray film for 2-
5 minutes to obtain the desired signal. 
Biotinylated dsRNA was also checked on 6% polyacrylamide gel in 0.5XTBE 
(45mM Tris, 45mM boric acid, 1mM EDTA, pH8.3) under 100V for 8X8X0.1cm gel for 
4hours at 4°C. After electrophoresis completed, gel and nylon membrane were 
sandwiched in a clean electrophoretic transfer unit. Transfer was performed at 400mM 
(35V) for 30 minutes at 4 °C. The membrane was crosslinked and detected according 
to the method mentioned above.  
 
2.9 RNA Electrophoretic Mobility Shift Assays (RMSA) to detect 
protein-RNA interactions 
RNA mobility shift assays were applied using LightShift Chemiluminescent RNA EMSA 
kit from Thermo scientific. The binding reactions which contain binding buffer (10mM 
HEPES, pH 7.3, 10mM KCL, 1mM MgCl2 and 1mMDTT), glycerol and tRNA were 
performed using same amount of biotinylated dsRNA (10ng) with different protein 
samples or various amounts (ng-µg) of a particular protein sample. Control binding 
reactions which used control biotinylated IRE-RNA (28bp) and liver extract provided by 
the kit was performed as a positive control. The binding reactions were incubated at 
room temperature for 30 minutes and mixed with 5Xlodaing buffer provided by the kit. 
The reactions were electrophoresed, transferred and detected according to the steps 
described before. 
 
2.10 FITC labelled dsRNA 
Instead of using linearized DNA template, purified PCR products containing T7 
promoter sequences on each strand was used as template for in vitro transcription. 
Primers used for PCR amplification are shown in Table 2. PCR products amplified 
using gene specific sequences with T7 promoter sequences on both strands was 
checked and extracted from agarose gel followed by ethanol precipitation. In vitro 
transcription reaction was performed on a 20µl scale with 1µg purified PCR template 
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according to the manufacturers’ protocol; 0.08mM 5’-deoxy-5’-hydrazinylguanosine 
initiator 1 (from a 50 mM stock in 50 mM NaOH) was added in the reaction. The 
reagents were mixed and collected in the bottom of the tube by brief centrifugation. The 
reaction was incubated at 37°C for 4 hours followed by DNase treatment. To remove 
any precipitated inorganic pyrophosphate, the mixture was centrifuged at 1500g for 30 
seconds. The reaction was then precipitated by adding 30µl 7.5M lithium chloride and 
30µl water and kept at -20°C overnight. After centrifugation, the pellet was washed with 
75% ethanol and dissolved in 20µl nuclease-free water. The quality of dsRNA was 
checked on agarose gel and the concentration value was measured by nanodrop 
before continuing to the next step.  
 The pH of the dsRNA solution was increased by adding 3.75µl 1M sodium 
carbonate (pH 10.7). Ninety-seven nanogram fluorescein isothiocyanate (FITC, isomer 
I, Sigma) was weighed and resuspended in 25µl DMF to make 0.1M stock solution.  
The dsRNA extract was mixed with 1µl prepared FITC and covered by foil. The 
reaction was allowed to proceed overnight at 4°C on end over end rotator. The reaction 
was quenched by addition of 7.5µl 1M sodium acetate and then precipitated with 5µl 
7.5M lithium chloride and 90µl 100% ethanol in -20°C overnight. The mixture was then 
centrifuged into pellet, followed by washing with 75% ethanol. The FITC-dsRNA pellet 
was resuspended in water and purified by ZebaTM spin desalting column, 7K MWCO 
(Thermo scientific) according to the manufacturer’s protocol. Finally, the FITC-dsRNA 
was stored in 70µl nuclease-free water and kept in dark at -20 °C. FITC-dsRNA was 
checked on 6% TBE polyacrylamide gel and visualized on Typhoon phosphorimager. 
Once the electrophoresis was completed, the polyacrylamide gel was fixed in 10% 
methanol and 7% acetic acid for 15 minutes. The signal was detected at wavelength 
520nm laser with cy2 blue module. 
 
2.11 FITC-dsRNA Electrophoresis Mobility shift assays 
The binding reactions were prepared in 20µl reaction which contains 1Xbinding buffer 
(50mM Tris-HCL (pH 8), 5mM EDTA, 1mM DTT, 100ug/ml BSA and 5% glycerol).  For 
visualizing FITC-dsRNA mobility shift based on the signal of FITC dye, 5ng FITC-
dsRNA was incubated with much excess of Trx/RBD3 protein extract (1-8µg in 1XPBS), 
and allowed to react for 30 minutes at room temperature before loaded onto 6%TBE 
polyacrylamide gel. Binding reactions containing 100ng FITC-dsRNA and Trx/RBD3 
protein extract (1-8µg in 1XPBS) loaded on 6% polyacrylamide gel was also stained 
with ethidium bromide at final concentration of 0.5mg/ml in 200ml 0.5XTBE buffer for 
visualization.  
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2.12 RNAi experiment with T. castaneum 
 
2.12.1 Injection of dsRNA into T. castaneum larvae 
Larvae were gassed with CO2 for at least 1min and were then aligned on a sticky tape. 
In terms of the injection bioassays, glass capillaries (3.5’’ Drummond＃3-000-203-G/X ) 
were prepared with a needle puller (PC-10 puller, Narishige Group), programmed as: 
weight heavy 100g, temperature 58°C. Tips of the needles were broken off with a 
forceps to create a sharp end. The needles were filled with mineral oil without any 
bubbles and assembled into a Nanoject IITM injector (Drummond Scientific Company). 
dsRNAs were loaded onto the needles through the end and injected as summarised in 
Table 2. dsRNA was injected into dorsal side of the segment of each larva. After 
injection, larvae were carefully removed from the tape by using forceps and raised in 
whole wheat flour (with 5% yeast) at the condition described above. For analysing 
TcVTE and TcAPIN gene expression pattern in developmental stages, larvae were 
collected every 5 days started from 5 days old larvae to adults. 50ng TcAPIN dsRNA 
and TcVTE dsRNA were injected into pre-pupa stage larvae. Injected larvae were 
collected at 48h and 10days post injection for investigating the duration of RNAi effect. 
Mortality data of dsRNA injected larvae was also performed, 100ng TcAPIN dsRNA 
and TcVTE dsRNA were injected. The survival data was recorded for 13 days. Less 
dose 10ng TcAPIN dsRNA were also injected and larvae were collected after 24h and 
48h. The amount of 150ng and 300ng dsRNA against V-type ATPase E subunit from 
beetle T. confusum were also injected into T. castaneum pre-pupa stage larvae to 
validate the cross species RNAi effect. Samples were collected at 48h and 10days post 
injection followed by q-PCR analysis. To investigate the efficiency of RNAi response in 
T. castaneum, 10ng TcAPIN dsRNA was injected into pre-pupa stage larvae and 
injected samples were collected at 2h, 5h, 48h and 10 days post injection, followed by 
q-PCR. Insect injection bioassays are summarised in Table 4. 
 
2.12.2 Feeding dsRNA to T.castaneum larvae 
For T. castaneum feeding assays, TcAPIN dsRNA and TcVTE dsRNA were delivered 
by flour discs prepared as described by Xie et al. (1996). 12.5µg and 25µg dsRNAs 
(Kan, TcAPIN and TcVTE) in 200µl volume of nuclease-free water were mixed to 50mg 
of sieved whole wheat flour (with 5% yeast). Ten microlitre of the mixture was added to 
each well of 96-well microtiter plate with a flat bottom. The mixture was then allowed to 
dry in a Laminar flow hood for 8h. The final concentration of dsRNAs were 250ng/mg 
and 500ng/mg. Less than 1 week old T. castaneum larva was added to each well. The 
feeding assay was carried out for 30 days. Fed larvae were collected for qPCR 
analysis after 5 days post feeding. Insect feeding bioassays are summarised in Table 5. 
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2.12.3 Stability of dsRNA in T. castaneum diet 
Stability of dsRNA in T. castaneum diet was evaluated with the presence of larvae. The 
flour disc was prepared as described above with the TcAPIN dsRNA concentration of 
250ng/mg. Five 1week old larvae were added to each wells. Larvae were removed 
after different time points (1h, 3h, 20h, 48h, 72h and 120h) from each wells post 
feeding. The flour diet were then resuspend in 10µl Nucleases-free water followed by 
vortex briefly and centrifuge for 10min at room temperature. 2µl of clear supernatant 
were loaded from 6 samples on 1% agarose gel. 
 
2.13 RNAi experiments with M. domestica and D. radicum 
 
2.13.1 Injection of MdAPIN and DrAPIN dsRNA into M. domestica and D. radicum 
larvae and M. domestica adult. 
For injecting M. domestica and D. radicum larvae, pre-pupa stage larvae were gassed 
with CO2 for 20s prior to injection. Larvae surface were dried on tissue and then placed 
on sticky tape adhered to the back of pertri dish. The larvae were positioned ventral 
side down and were injected on their dorsal side using a glass needle and a 
Drummond injector. Initial assays were based on observations of subsequent mortality 
of insects, over a period up to 7 days, comparing insects injected with APIN dsRNA 
with insects injected with KandsRNA. Subsequent assays investigated a range of 
RNAi-induced effects, depending on the developmental stage of the insects assayed. 
APIN gene downregulation in M. domestica and D. radicum were subsequently 
investigated by qPCR. Doses at 150ng and 500ng APIN dsRNA were injected to pre-
pupa stage (3rd instar) larvae. Injected larvae were frozen at 24h and 48h post injection.   
For investigating whether the RNAi effect could be effective on closely related 
Dipteran species, 150ng and 500ng DrAPIN dsRNA were cross-injected into 3rd M. 
domestica larvae. Initial injection bioassays were recorded for 5 days period for 
phenotype observation. Subsequent experiment of injected larvae with same doses 
were collected after 48h and 72h post injection. Collected samples were used for 
investigating changes of APIN mRNA by quantitative Real time-PCR (qRT-PCR) 
described above.  
The RNAi experiment was also investigated in M. domestica adult. Newly 
emerged M. domestica adults were gassed with CO2 for 1min prior to injection. 150ng 
and 500ng MdAPIN dsRNA were injected into fly haemolymph through thorax using a 
10µl syringe (Hamilton, 701N).  After injection, flies were supplied with 20% sucrose 
solution. Injected samples were collected at 48h and 72h for detecting RNAi induced 
effect in gene expression by qPCR. 
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2.13.2 Feeding dsRNA to M. domestica larvae 
Two different feeding methods were developed for administering dsRNA to M. 
domestica larvae through feeding. Three days old M. domestica larvae were used for 
feeding assays.  Initially, MdAPIN dsRNA were simply mixed with bran based diet at 
final concentration of 100ng/mg (dry weight). This was based on the does necessary to 
show RNAi response by injection. Briefly, this was done by adding 100µg dsRNA in a 
volume of 5ml nuclease-free water to 1,000mg dry diet. Ten larvae were placed in each 
pot and 20 larvae in total were assayed for each treatment. The survival data was 
recorded for 7 days after oral feeding dsRNA mixed in artificial diet. 
A subsequent feeding experiment was performed by adding induced bacteria that 
expressing dsRNA in diet. The yield of 50ml induced HT115 E. coli cells is 
approx.100µg. After collecting induced cell pellet by centrifugation. Pellet was washed 
twice with 1XPBS. Pellet from 100ml cell culture was resuspended in 5ml volume of 
nucleases-free water and mixed with 1,000mg diet. The final concentration was 
200ng/mg. Ten larvae were placed in each pot and 20 larvae in total were assayed for 
each treatment. The survival data was recorded for 7 days after oral feeding dsRNA 
mixed in artificial diet. 
 
2.14 RNAi experiments with A. pisum 
 
2.14.1 Injection of dsRNA into A. pisum    
For the RNAi experiments in A. pisum, both microinjection as well as feeding were 
used to administer the dsRNA to aphids of different stages. 5 days old aphids were 
prepared by rearing aphid’s mothers on artificial diet (Based on the protocol described 
by Douglas and Prosser (1992) for 24h, neonates were removed next day and fed on 
artificial diet.  
 ApVTE dsRNA, ApAPIN dsRNA and control Kan dsRNA were delivered to five days 
old aphid nymphs through microinjection under the dissecting microscope (SX-45, 
Vision). Aphids were first chilled on ice for 15 minutes prior to injection. 30ng, 15ng and 
7.5ng dsRNA were injected into abdomen on the ventral side of each aphid and then 
aphids were supplied with artificial diet in the close chamber. Aphid samples were 
collected at 24h, 48h and 72h post injection for detecting the target gene expression 
change.  
 
2.14.2 Feeding dsRNA in A. pisum    
ApVTE dsRNA and Kan dsRNA were administered to neonate aphid nymphs through 
feeding assay. dsRNAs were mixed to aphid artificial diet at a final concentration of 
7.5ng/µl and 100ng/µl between two layers of Parafilm sachet, nymphal survival and 
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development were followed. After initial feeding for 2 days, diet without dsRNA was 
replaced in order to avoid contamination. The size of fed aphids were recorded after 7 
days. Details are described in Table 5. 
 
2.14.3 The stability of dsRNA in A. pisum liquid diet 
For investigating the stability of dsRNA in aphid diet, 2µg FITC-labelled ApVTE dsRNA 
was mixed in 50µl artificial diet.  10 newly born nymphs were placed in dsRNA 
treatments and control treatments were prepared without aphids. Diet was collected 
after 5h and 72h followed by phenol chloroform isoamyl alcohol extraction. The extracts 
were then electrophoresis on 6% TBE polyacrylamide gel. Labelled dsRNA were 
visualised by Typhoon phosphorimager described before. 
 
2.14.4 The stability of dsRNA in A. pisum honeydew in vitro 
Honeydew was prepared by collecting 20 late stage A. pisum in 1.5ml centrifuge tube. 
Aphids were removed from the tube after 2 hours until enough honeydew was collected. 
1XPBS was used for diluting honeydew followed by vortex and centrifugation. Total 
protein was estimated with BCA assay described above. The concentration of total 
protein in honeydew was 10µg/µl in 30µl volume. For testing the persistence of dsRNA 
in A. pisum honeydew, 200ng dsRNA were incubated with 20µg, 50µg and 100µg total 
protein from honeydew in 20µl reaction at 25°C for 30min. dsRNA in 1XPBS was used 
as positive control and honeydew containing 100µg total protein was treated as 
negative control.  
 
2.15 The stability of dsRNA against insect tissues 
 
2.15.1 Insect haemolymph and gut extract preparation 
Insect haemolymph samples were collected in ice cold 1XPBS in 1.5ml Eppendorf 
tubes containing 1 mg phenylthiourea (PTU) to inactivate polyphenol oxidase and 
prevent the haemolymph sample from melanisation (Arakawa,1995). To collect 
haemolymph for A. pisum, legs of aphid are all removed and the body was squeezed 
gently by forceps to collect the clear liquid exuded. For flour beetle larvae and D. 
radicum larvae, a fine steel needle was used to stab a small hole on their skin, and 
exuded haemolymph was collected. Haemocytes were removed from all haemolymph 
samples by centrifugation at 17500g for 20 minutes at 4°C. 
Insect gut extracts (including contents) were prepared by extraction in 1xPBS. 
For aphids and flour beetle larvae, when heads are removed from their body with 
forceps, the gut remains attached to insect head and will be pulled out with the head. In 
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D. radicum larvae, the skin of the larvae was gently torn apart by forceps, and the 
hook-shaped mouthparts were pulled out with the guts. Gut samples were then 
homogenized by grinding in a clean micro-pestle, followed by centrifugation as 
described above, discarding the pellet.  
The concentrations of total protein in haemolymph samples and gut extracts 
were estimated by BCA assay using BSA as a standard.  
For investigating the persistence of dsRNA in different insect gut extracts, 
dsRNA were firstly incubated with different amount of protein from different insect 
species. For A. pisum gut extract, 200ng dsRNA were incubated with total protein from 
1µg, 2µg, 4µg, 8µg and 10µg in 20µl reaction and incubated for 30min at 25°C. D. 
radicum and T. castaneum larval gut extracts containing total protein 3µg, 7µg, 14µg, 
21µg and 28µg were used for incubation with dsRNA. 200ng dsRNA incubated in 
1XPBS was used as positive control whereas gut samples alone ran on the gel were 
used as negative control. After incubation, the integrity of the dsRNA subsequently 
analysed on 2% agarose gel. 
 
2.15.2 Comparison of the rate of persistence of dsRNA against insect 
haemolymph and gut extracts 
For comparing the ability of dsRNA degradation of RNases presented in different insect 
species. Total proteins from 3 insect gut extracts were normalised to same amount 
(3µg). 200ng dsRNA were used for incubating with gut extracts for various time: 1min, 
5min, 15min and 30min at 25°C. Another assay regarding insect gut extracts were 
performed by using 200ng dsRNA incubated with total protein from insects equal to 
single insect gut to three insects. The incubation were performed for 1min, 15min and 
30min at 25°C. 200ng dsRNA incubated in 1XPBS was used as positive control 
whereas gut samples alone ran on the gel were used as negative control. 
Similar assay was carried out with insect haemolymph samples. For comparing 
the dsRNA degradation ability of RNases presented in haemolymph from insects, 
200ng dsRNA was mixed with haemolymph samples contain 25µg protein from three 
different insects in 20µl reaction and incubated at 25°C for 1min, 5min, 15min and 
30min. dsRNA incubated with 1XPBS containing PTU was used as positive control and 
haemolymph samples only were used as negative control. After incubation, the 
reactions were mixed with DNA loading dye and run on a 2% agarose EtBr gel. 
Visualization of dsRNA using a UV transilluminator.  
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2.16 Recombinant Proteins preparation in E. coli 
 
2.16.1 Preparation of constructs encoding Trx/RBD1 and Trx/RBD3 fusion 
proteins for expression in E. coli 
Coding sequences for the RNA-binding domains RBD1 and RBD3 from the D. 
melanogaster staufen gene (NP_476751.1) (Figure 4-1) were codon-optimised for 
expression in yeast by using an online website tool from Integrated DNA 
Technologies (http://www.idtdna.com/CodonOpt). The resulting sequences were 
synthesised directly by Shinegene (Figure 4-2).  The sequences were supplied as 
inserts in pUC57 plasmid cloning vector. The coding sequences were extracted from 
the plasmid supplied by PCR, using RBD1/3 forward and reverse primers containing 
BamH1 and HindIII restriction enzymes (Table 2). PCR products were amplified by 
Phusion DNA polymerase. PCR conditions were: pre-treatment at 98°C for 30s, 
followed by 30 cycles of denaturation at 98°C for 30s, annealing at 58°C for 30s, and 
extension at 72°C for 30s, with a final incubation at 72°C for 10 mins. The PCR 
product was separated by 1% agarose gel electrophoresis, giving a band at 219 bp 
as predicted, which was excised. DNA was eluted from the gel by using QIAquick 
column (QIAGEN) according to the manufacturers’ instructions and ligated with pET 
32α vector which was restricted with BamH1 and HindIII resctriction enzymes. 
Samples from the ligation mixture were transformed into one shot E. coli TOPO10 
competent cells (Invitrogen) and plated on selective Carbenicillin LB media. Colonies 
were screened by colony PCR using T7 promoter and terminator primers. The 
conditions were 94°C For 10 mins, followed by 25 cycles of denaturation at 94°C for 
30s, annealing at 60°C for 30s, and extension at 70°C for 1 min, with a final 
extension at 72°C for 7 mins. Selected colonies giving a PCR product of the 
predicted size (1200 bp) were picked off. Plasmid DNA was prepared from the 
selected clones by using Wizard plus SV Minipreps (Promega) and was analysed by 
DNA sequencing. Confirmed RBD1- and RBD3-containing plasmids were then 
transformed into the expression host, E. coli BL21(DE3) by chemical transformation 
using commercial competent cells (Invitrogen), according to the manufacturer’s 
protocol. 
 
2.16.2 Preparation of constructs encoding Trx/RBD1/GNA and Trx/RBD3/GNA 
fusion proteins for expression in E. coli 
The GNA coding sequence, amino acids 1-105 of the mature GNA polypeptide (as 
described in Fitches et al. (2004) was prepared by PCR amplification from a plasmid 
containing a NotI restriction site which was kindly provided by Dr Prashant Pyati. The 
template was amplified by using pGAP forward primers and specific reverse primer 
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XhoI (3' end) restriction sites. Phusion DNA polymerase was used to minimise PCR 
errors. PCR conditions were as follows: 25 cycles of denaturation at 98°C for 30s, 
annealing at 58°C for 20s, extension at 72°C for 1min, followed by a final incubation at 
72°C for 7 min. The PCR product was separated by agarose gel electrophoresis, giving 
a band at 1000bp as predicted, which was excised. DNA was extracted using QIAquick 
column (QIAGEN). The PCR product, and DNA from the recombinant Trx/RBD1 pET32 
plasmid, were digested separately with the restriction enzymes NotI and XhoI at 37°C 
for 2h. The digested products were combined and ligated using T4 DNA ligase 
overnight at 4°C. Samples from the ligation reaction were then transformed into 
competent cells of E. coli strain TOPO10 (Invitrogen)  by electroporation accoding to 
the manufacturers’ protocol, and plated on carbenicilin LB media. Colonies were 
screened by PCR using T7 promoter and terminator sequence primers and selected 
colonies giving a PCR product of the predicted size 1200bp were picked off. Plasmid 
DNA was prepared from the selected clones by the standard miniprep protocol, and 
was analysed by DNA sequencing. DNA from a plasmid which gave the correct RBD1-
GNA coding sequence (Figure 4-5) was then transformed into E. coli expression strain 
BL21(DE3) by standard chemical transformation. Clones containing the expression 
construct were obtained by plating on selective carbenicillin media, and screened by 
colony PCR using T7 promoter and terminator primers. Clones giving a product of the 
predicted size (1200 bp) for the Trx/RBD1/GNA fusion protein coding sequence were 
selected.  
The expression construct encoding Trx/RBD3/GNA in pET32 was prepared in a 
similar manner, ligating the GNA coding sequence as described above into the 
Trx/RBD3 pET32 plasmid, and similarly verified by DNA sequencing prior to 
transformation into the expression host.  
 
2.16.3 Expression of Trx/RBD1,Trx/RBD3, Trx/RBD1/GNA and Trx/RBD3/GNA 
fusion proteins in E. coli 
Two mililitre of an overnight cell culture of a verified expression construct clone were 
added into 100ml LB medium with carbenicilin at final concentration 50µg/ml. The 
cultures were incubated at 37°C with shaking at 225rpm until the OD at 600nm reached 
0.6. The culture were induced by adding IPTG to a final concentration of 0.5mM, 1mM, 
2mM and 2.5mM and incubated at varying temperatures (15°C - 30°C) to allow 
recombinant protein expression. The induced empty pET32 vector was used as a 
negtive control. After induction, cultures were centrifuged at 4°C 4000g for 10 minutes. 
The cell pellets were collected and resuspended in 2.5ml 1X "Bugbuster" reagent 
(Novagen) to release proteins from the cell. The reactions were incubated with gentle 
shaking for 20 minutes at room temperature, followed by centrifugation to separate 
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soluble and insoluble material at 4°C, 22,000g for 15 minutes. The supernatant after 
this centrifugation was taken as the soluble protein fraction. The pellet formed the 
insoluble protein fraction, which was solubilised by adding 2.5 ml 6M urea and mixing 
using a vortex mixer. The mixture was then centrifuged again as same conditon, and 
the supernatant was collected. Protein fractions were analysed by SDS-polyacrylamide 
gel electrophoresis (Laemmli 1970), followed by staining with Coomassie blue. 
 
2.16.4 Purification of Trx/RBD1, Trx/RBD3, Trx/RBD1/GNA and Trx/RBD3/GNA 
recombinant proteins in E.coli by Ni-NTA affinity chromatography 
Culture supernatant containing soluble recombinant proteins were subsequently diluted 
with 4Xbinding buffer (BB) which contained 0.02M sodium phosphate buffer, 0.4M 
sodium chloride, pH7.4 to 1XBB. The culture supernatant was loaded onto 5ml HisTrap 
crude nickel columns (GE healthcare) with a flow rate of 5ml/min for 2-3 hours after 
clarifying by filtration through 0.7µM glass fibre filters (GFF Whatman). The columns 
containing Trx/RBD1 and Trx/RBD/GNA fusion proteins were first washed with 1XBB 
until the OD came to a baseline on FPLC recorder and then washed with 1XBB 
containing 0.01M imidazole. Recombinant proteins were eluted with 1XBB with 0.4M 
imidazole. Eluted proteins as well as washed fractions were analysed by SDS-PAGE 
gel electrophoresis stained by Coomassie Blue. In terms of Trx/RBD3, column 
containing fusion protein was washed with 1XBB containing 0.025M and 0.2M 
imidazole. Trx/RBD3 fusion protein was eluted with 1XBB containing 0.4M imidazole. 
Induced Thioredoxin cell supernatant used as negtive control was first washed with 
1XBB containing 0.025M imidazole and eluted with 1XBB containing 0.2M imidazole.  
 
2.16.5 Protein desalting by dialysis and PD-10 column 
Purified Trx/RBD3/GNA fractions were then pooled and dialysed against a 5 times 
dilution of sodium chloride, sodium phosphate and 10% glycerol after identification on 
SDS-PAGE. The starting concentration of sodium chloride and sodium phosphate were 
0.4M and 0.02M (pH: 7.4) and protein sample was stored at 0.05M sodium chloride 
and 10% glycerol. All the procedures were carried out at 4°C. Protein samples were 
then centrifuged at 20.000g for 1min at 4°C and pellets were resuspended in 6M urea. 
Both dialysed supernatant and pellet were checked on SDS-PAGE.  
 Eluted Thioredoxin, Trx/RBD3 and Trx/RBD3/GNA were desalted using a PD-
10 column (GE Healthcare) according to the manufacturer's protocol. The column was 
first equilibrated with deionised water and then 2.5ml of purified fusion proteins in 1XBB 
containing 0.2M/0.4M imidazole were loaded onto the columns. Proteins were eluted 
with 3.5ml deionised water in 6X1.5ml eppendorf tubes (around 600µl each). Each 
fraction was checked on SDS-PAGE. Eluted Thioredoxin and Trx/RBD3 fractions in 
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1XBB containing 0.2M imidazole were also dialysed against deionised water at 4°C 
and freeze dried as powder. 
 
2.16.6 Refolding of induced insoluble Trx/RBD1 and Trx/RBD/GNA fusion protein 
by dialysis 
The insoluble Trx/RBD1 and Trx/RBD/GNA fusion proteins in 6M urea were first 
renatured by dialysis against 20mM sodium phosphate buffer (pH 7.4) containing 
decreasing concentrations of DDT at each change, from 1mM, 0.5mM to 0.1mM. Each 
dialysis step was carried out at 4°C for a hour. Finally protein samples were stored in 
20mM sodium phosphate buffer (pH7.4). The dialysed Trx/RBD1 and Trx/RBD/GNA 
protein samples were then centrifuged at 20,000g for 1min.  Clear supernatants of 
renatured dialysed fusion proteins were analyzed on SDS-PAGE with known amounts 
of GNA as standards. Alternatively, insoluble Trx/RBD1 and Trx/RBD/GNA dissolved in 
6M urea were dialysed against a series dilution of urea containing 1mM DTT. The urea 
concentraion was reduced from 6M to 0.5M over 6 dialysis changes. DTT 
concentration was reduced to 0.5mM at the last diaysis step. Protein samples were 
stored in 0.5M urea and 0.5mM DTT.  Insoluble Trx/RBD1 was also diluted 10 times 
and dialysed against deionized water overnight, followed by lyophilisation. 
 
2.16.7 Preparation of constructs encoding pelB/RBD3/GNA fusion proteins for 
expression in PET22b+ in  E. coli 
The RBD3/GNA coding sequence was assembled into the vector PET22b+ which 
contains the pelB signal sequence, directing secretion of the recombinant protein into 
the periplasm. To assemble the plasmid, the RBD3/GNA sequence was amplified with 
primers shown in table 2; the forward primer contains BamHI restriction enzyme 
sequence with an extra C added into the sequence to correct the reading frame, 
whereas the reverse primer contains XhoI sequence (Table 1). The PCR product was 
amplified by Phusion DNA polymerase with annealing at 60 °C for 30s. The PCR 
product was then separated by 1% agarose gel electrophoresis, giving a band around 
220bp, followed by gel extraction. The extracted PCR product was then ligated with 
pet22b+ vector which had been double digested with BamHI and Xhol. The ligation 
mixture was then transformed into E. coli BL21(DE3) expression host by chemical 
transformation. The sequence was confirmed by DNA sequencing (Figure 4-19). 
 
2.16.8 Expression of pelB/RBD3/GNA fusion protein in PET22b+ in E. coli 
Two mililitre of E. coli overnight cell culture harbouring construct RBD3/GNA in 
PET22b+ was inoculated into 100ml LB medium with carbenicilin at final concentration 
50µg/ml and incubated at 37°C overnight with shaking at 225rpm until the absorbance 
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at OD600 reached 0.6. IPTG was added to a final concentration of 1mM and culture 
was induced for 4 hours with constant shaking at 225rpm. The culture was then cooled 
prior to centrifugation at 8,000g for 10 minutes to collect the supernatant and cells. The 
cell pellet was used for extraction of periplasmic proteins. 
The osmotic shock method was performed for the extraction of periplasmic protein 
(Nossal and Heppel 1966). The cell pellet was re-suspended in hypertonic buffer which 
contains 20% sucrose, Tris/HCL (pH 8.0) and Na2EDTA. After incubation with gentle 
shaking at 4°C for 30 minutes, cells were harvested by centrifugation for 10 min at 
17,000Xg at 4°C. The supernatant was saved and checked on SDS-PAGE as 
periplasmic fraction. Cell pellet was then re-suspended in hypotonic solution which 
contain 5mM MgSO4 and was incubated with vigorous shaking at 4°C for 30 min. Cell 
pellet and the supernatant were separated by centrifugation for 10 min at 17,000xg at 
4°C. The supernatant was treated as cytoplasmic fraction. The insoluble pellet was 
saved and re-suspended in same volume of 6M urea and was treated as insoluble 
fraction. 
 
2.17 Recombinant Proteins preparation in P. pastoris 
 
2.17.1 Preparation of constructs encoding RBD3/GNA fusion proteins for 
expression in P. pastoris 
RBD3 coding sequence was amplified by primers containing restriction enzymes (see 
错误 ! 未找到引用源。 ) to introduce PstI and NotI restriction sites on each side, 
followed by extraction from agarose gel. The extracted PCR product was double 
digested with PstI and NotI. Expression vector pGAPZαB containing a GNA coding 
sequence (described in Yang et al. (2014)) was digested with same restriction 
enzymes. Ligation of insert and vector using T4 DNA ligase followed standard 
procedures. The expression cassette was transformed into TOP10 E. coli cells followed 
by plasmid extraction and sequencing. 
 Plasmid DNA was prepared from confirmed RBD3/GNA clones by mini-prep. 
Isolated plasmid DNAs from 5X10ml LB were pooled and linearized with BlnI restriction 
enzyme, following standard restriction protocol. The plasmid was checked on agarose 
gel for confirmation of linearization. Linearized plasmid DNA was ethanol precipitated 
overnight. The pellet was collected by centrifugation at 12,000xg for 15 minutes at 4°C, 
and then washed with 70% ethanol. Finally, pellet was re-suspended in nuclease free 
water. More than 3µg linearized plasmid in 10µl was transformed into 50µl competent 
cells of protease deficient P. pastoris (SMD1168 Invitrogen) according to the 
manufacturer’s protocol. One mililitre solution II was added into the mixture and 
incubated at 30°C for 1 hour with intermittent mixing-vortexing after every 15 minutes. 
  
  
41 
The cells were then heat shocked in water bath at 42°C for 10 minutes. The plasmid/ 
cell mixture was transferred into 15ml falcon tube containing 2ml YPG culture. The 
cells were incubated at 30°C for 2 hours to allow expression of Zeocin resistance. Cells 
were then centrifuged at 3000g for 5 minutes at room temperature and pellet was 
washed with 1ml solution III gently.  The cells were centrifuged again as above and 
pellet was re-suspended in 100-150µl solution III. The transformed cells were then 
plated on 25µg/ml Zeocin YPG-agar plate and incubated at 30 °C for 2-4 days.  
 Selected transformant clones were streaked out and grown in 10ml liquid YPG 
with Zeocin at final concentration 25µg/ml for 2-3 days at 30°C with shaking. Cultures 
were centrifuged at 4,000xg for 15 minutes at room temperature. Thirty microlitre 
supernatant was then separated by SDS-PAGE followed by western blotting. 
Supernatant from plasmid pGAPαB without insert was included during screening as an 
expression background control. The best-expressing clone was selected for large-scale 
fermentation. 
 
2.17.2 Large-scale expression (Fermentation) of recombinant proteins in P. 
pastoris.  
Three replicates of 100ml liquid YPG media containing the selected clones for 
expression of RBD3 or RBD3/GNA were inoculated in 250ml baffled flasks at 30 °C for 
2-3 days with shaking. These cultures were then added into 2.5L of sterile minimal 
media (Higgins and Cregg 1998) supplemented with PTM1 salts (Cino 1999) growing 
in a 5L Bio-Control ADI1010 bench-top fermenter (APPLIKON BIOTECHNOLOGY, 
Holland). The method was modified from Fitches et al. (2004). The fermentation was 
cultured at 30 °C with continuous agitation. The dissolved oxygen level was maintained 
at 30% at pH 4-5.  Fifty percent glycerol (v/v with distilled water) feed (5-10ml/h) was 
initiated when 30% dissolved oxygen could not be preserved. After 3-4 days, when the 
dissolved oxygen level began to rise indicating yeast growth had stopped, the 
fermentation run was terminated. Culture supernatant from fermentor was collected 
after centrifugation at 8,000rpm for 30 minutes at 4 °C. The supernatant was then 
filtered through 2.7µM, and 0.7µM glass microfiber filters (Whatman, UK) using a 
vacuum manifold. 
 
2.17.3 Purification of recombinant protein RBD3 from P. pastoris culture 
supernatant by Ni-NTA column chromatography. 
RBD3 fermented supernatant was adjusted to 0.02M sodium phosphate buffer, 0.4M 
sodium chloride, pH7.4 by adding 4Xbuffer stock. RBD3 recombinant protein was 
purified by metal affinity chromatography. Culture supernatant was loaded onto a 5ml 
Ni-NTA column for 3 hours and washed with 10-fold column volume of 1XBB followed 
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by washing with 1XBB containing 0.01M imidazole. RBD3 was eluted by 1XBB 
containing 0.4M imidazole. A second purification was performed by washing the 
column with 1XBB containing 0.025M imidazole followed by elution with 0.4M imidazole. 
Wash and eluted fractions from both purification experiments were checked by SDS-
PAGE followed by CBB stain as described earlier. Protein fractions containing RBD3 
were pooled, diluted twice and dialysed against water overnight (9 changes). Dialysed 
RBD3 was concentrated using a centrifugal concentrator (5,000 MWCO; Vivascience). 
Concentrated RBD3 was diluted in 1XREMSA buffer and centrifuged at bench speed 
for 2 minutes at room temperature. Supernatant and pellet were re-suspended in 
1XREMSA buffer. All protein fractions were checked by SDS-PAGE.  
 
2.17.4 Purification of recombinant protein RBD3/GNA P. pastoris culture 
supernatant by Ni-NTA column chromatography. 
 
A.  Purification of RBD3/GNA under native condition at different pH 
Purification of RBD3/GNA from P. pastoris culture supernatant was performed by using 
Ni-NTA column, as described for RBD3. Culture supernatant was diluted to 0.02M 
sodium phosphate buffer, 0.4M sodium chloride, pH7.4 by adding 4XBB. RBD3/GNA 
culture supernatant was normally loaded for 3 hours followed by washing with 1XBB, 
0.01M imidazole and eluted with 0.2M imidazole. 0.4M imidazole was used for eluting 
any tightly bound protein. The purified fractions were pooled and separated into 2 
samples. One sample was dialysed against distilled water. Another sample was 
dialysed against 0.02M sodium phosphate buffer overnight at 4°C.  
 To improve RBD3/GNA fusion protein purification efficiency, modified methods 
were applied. First, the pH of culture supernatant was adjusted by adding 4XBB to pH 
9. The final pH of adjusted culture supernatant before loading onto nickel column was 
5.5. Loaded RBD3/GNA was purified by washing with 0.01M imidazole and eluted with 
0.2M imidazole as above. Fractions containing RBD3/GNA were pooled and dialysed 
against 0.02M sodium phosphate buffer. In a second experiment, culture supernatant 
containing RBD3/GNA was dialysed against water overnight with 5-6 changes at 4 °C 
followed by freeze drying. The freeze dried supernatant powder was then re-
suspended in 1XBB, pH 7.4. Purification was performed as described above. Fractions 
containing RBD3/GNA were pooled and dialysed against distilled water or 0.02M 
sodium phosphate buffer. All purifications were performed from 300ml culture 
supernatant, and elution was normally repeated twice until most of RBD3/GNA was 
eluted. All fractions were checked on SDS-PAGE and RBD3/GNA identity was 
confirmed by western blotting. 
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B．  Purification of RBD3/GNA by gel filtration chromatography. 
Three grams freeze-dried culture supernatant powder (see above) containing approx. 
6mg RBD3/GNA recombinant protein was re-suspended in 7ml 20mM sodium 
phosphate buffer. The sample was then centrifuged at 12,000xg for 2 minutes at room 
temperature to remove any insoluble material. RBD3/GNA solution was loaded onto a 
Sephacryl S-200 (Amersham) column which was equilibrated with 20mM sodium 
phosphate buffer to separate the RBD3/GNA from yeast background proteins.  
RBD3/GNA was eluted in 20mM sodium phosphate buffer at a flow rate of 0.4ml/min, 
monitoring absorbance at 280nm in the eluate. Fourty-six separated fractions were 
collected in total and 12 fractions from 21-44 (a green colour indicative of the presence 
of yeast pigment was observed in fractions) were checked on SDS-PAGE. 
  
C．  Purification of RBD3/GNA under denaturing condition 
RBD3/GNA culture supernatant was adjusted to pH 6, 6M urea by adding 4XBB pH 9 
and solid urea. The solution was loaded onto a nickel-NTA column as described above, 
and the column was washed with 1XBB containing 6M urea and 0.01M imidazole 
containing 6M urea. RBD3/GNA was finally eluted in 0.2M imidazole containing 6M 
urea. Fractions containing RBD3/GNA were pooled and dialysed against a gradient 
dilution of urea in 0.02M sodium phosphate buffer overnight at 4°C. The dialysed 
RBD3/GNA solution was finally stored in 0.02M sodium phosphate buffer and the 
presence of recombinant protein in soluble and insoluble fractions was analysed by 
SDS-PAGE and western blotting. 
 
2.18 Confirmation of Protein activity by Agglutination 
Five mililitre of Alsever’s solution containing 1/30 volume anticoagulant was added to 
equal volume of venous whole rabbit blood in a 10ml heparinized tube which already 
contains 5ml of Alsever’s-anticoagulant. 40µl of the mixture was re-suspended in 1ml 
1XPBS followed by quick spin (12,000Xg, 30 sec).  The supernatant was discarded 
and pellet was re-suspended in 1ml 1XPBS to make 2% erythrocyte suspension.  
50µl 1XPBS was added to each well in round (U) bottom microtitre plate. 50ul of tested 
protein with known concentration was added in first well in each row followed serially 
diluted in preceding wells. Finally, fifty microlitre 2% erythrocyte suspension was added 
to each well and gently mixed with pipette. The reaction was incubated at room 
temperature and agglutination was visualized after 2 hours. 
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2.19 Stability of dsRNA conjugated with Trx/RBD3, Trx/RBD3/GNA 
and RBD3/GNA against degradation by insect haemolymph and gut 
extract. 
Two hundards nanograms dsRNA was first mixed with 1XPBS or 10µg Trx/RBD3 in 
20µl reaction and incubated on ice for binding reaction for 15 minutes. After the 
incubation, A. pisum gut sample containing 2µg protein, T. castaneum larvae gut 
sample containing 25µg protein and D. radicum larvae gut sample containing 15µg 
protein were mixed in binding reaction for 1min, 15min, and 30min separately. In terms 
of the insect haemolymph samples, A. pisum haemolymph sample containing 5µg 
protein, T. castaneum larvae haemolymph sample containing 25µg protein and D. 
radicum larvae haemolymph sample containing 25µg protein were added in binding 
reactions and incubated for different time periods. DsRNA incubated with 10µg 
thioredoxin or GNA was used as a negative control and dsRNA in 1XPBS containing 
PTU was treated as positive control. The amount of protein from insect extracts used 
for stability assays were determined by results from previous assays. The amounts of 
protein from insects that completely degrade 200ng dsRNA were applied. The 
reactions were then extracted with phenol / chloroform/ isoamyl alcohol (25:24:1) to 
recover the residual dsRNA. The extract was then mixed with DNA loading dye and run 
on 2% agarose gel stained with EtBr for visualization. 
 
2.20 Detection of Trx/RBD3 and RBD3/GNA in insect tissue by 
western blotting. 
To investigate potential transportation of Trx/RBD3 (E. coli) and RBD3/GNA (P. 
pastoris) in A. pisum, tissues were dissected and collected from A. pisum fed on 
artificial liquid diet containing either Trx/RBD3 or RBD3/GNA. GNA was included as a 
positive control. 20µg GNA, Trx/RBD3 and RBD3/GNA were mixed in 40µl diet to make 
a final concentration of 250ng/µl. Fifteen aphids were picked for each treatment and 
feeding for 48h followed by dissection in 1XPBS. The dissection procedure was 
described above. Protein samples collected from different tissues were macerated in 
5X sample buffer and boiled at 100 °C for 10 minutes followed by separating on 17.5% 
SDS-PAGE. After electrophoresis, protein on SDS-PAGE was transferred to 
nitrocellulose membranes and screened for the presence of GNA, Trx/RBD3 and 
RBD3/GNA by western blotting. The detection of Trx/RBD3 was performed by using 
anti-His antibody whereas anti-GNA antibody for detecting GNA and RBD3/GNA. 
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2.21 Comparison of gene downregulation by injection of dsRNA 
against insect specific genes and dsRNA-Trx/RBD3 conjugates. 
Samples containing 1µg dsRNA (ApVTE, TcAPIN or DrAPIN) were prepared in 0.5µl 
volumes of nuclease-free water. Trx/RBD3 was prepared as a 3mg/ml solution in 
20mM sodium phosphate buffer. For injecting the conjugates into the insects, 5µg 
dsRNAs (ApVTE, TcAPIN or DrAPIN) was mixed with 35µg Trx/RBD3 in a volume of 
17.5µl in total. The binding reactions were performed as described above. The final 
concentration of dsRNA was 333ng/µl.  35µg Trx/RBD3 mixed with 2.5µl nuclease-free 
water was used as an additional control.  
In experiments using aphids, 15nl of the ApVTE dsRNA-Trx/RBD3 conjugates, or 
Trx/RBD3, or 5ng dsRNA, was injected into 5 days old aphid nymphs. The injected 
aphids were collected at 48h and 72h post injection. For microinjection of T. castaneum, 
30nl of TcAPIN dsRNA-Trx/RBD3 conjugates was injected in pre-pupal stage larvae. 
Each larvae received a dose of 10ng TcAPIN dsRNA. Injected larvae were collected at 
2h, 5h, 24h and 10days post injection.  For D. radicum, 300nl of DrAPIN dsRNA-
Trx/RBD3 conjugates was injected into 3rd instar larvae. Each larva received a dose of 
100ng DrAPIN dsRNA. Injected D. radicum larvae were collected at 48h and 72h after 
injection.  The injection bioassays are summarised in Table 6. In all experiments, 
insects injected with 20mM sodium phosphate buffer and Trx/RBD3 were used as 
controls. 
5 insects from different treatments were collected and subjected to RNA 
extraction followed by qRT-PCR as previously described. 
 
2.2.2 Statistical analysis 
All data were analysed using Prism (v. 5) software. Survival data were analysed using 
survival curve Log-rank (Mentel-Cox) test. Significant differences were compared to 
each treatment. Analysis of gene down-regulation was conducted using two-way 
ANOVA to determine significant differences between treatments.  
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Primer 
Name 
 Primer Sequence 
12µM 3-CDS 
primer 
5’AAGCAGTGGTATCAACGCAGAGTAC(T)30N-3’ (N=A,C,G, or T; V=A, G or C) 
10X 
Universal 
Primer Mix 
Long-UPM (0.4µM): 
5’CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-3’ 
 Short-UPM (2µM):5’-CTAATACGACTCACTATAGGGC-3’ 
M. 
domestica 
3’ RACE 
5’GCTGCGGGGGTGGTCTTAAGGACTGGGACG-3’ 
M. 
domestica 
5’ RACE 
5’ CGGACGAGGCGCATTTGGCACAGGCCAC-3’ 
D. radicum 
3’ RACE 
5’ACAGTATCGGAACAGGCTTCTCGCATACACC-3’ 
D. radicum 
5’ RACE 
5’ ACCTACAGCTTGTGCTTGTTGCAACTCCCCCTC-3’ 
Degenerate 
primers  
Fwd: 5’ GYTTCAGYTGYGGBGGWGGBY-3’ 
Rev: 5’ BACVGANGADGCGCAYTTGGC-3’ 
 
Table 1 Degenerate primers used for isolating APIN gene and RACE primers for full-
length gene sequence of M. domesitca and D. radicum APIN. 
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Table 2 Primer pairs used for cloning RNAi region prior to dsRNA production, primers 
used for cloning RBD1 and RBD3 into E. coli and P. pastoris. 
 
 
Gene Access 
code 
Template Primer sequence Size 
V-type 
ATPase E 
subunit 
XM_96552
8 
T. castaneum 
cDNA 
 
Fwd: 5’- 
TATCTCGAGACCAGGCGAGATATTCACAGC-3’ 
Rev: 5’-
TATCTCGAGACCAGGCGAGATATTCACAGC-3’ 
277bp 
V-type 
ATPase E 
subunit 
None T. confusum 
cDNA 
Fwd: 5’-
TATCTCGAGTGGTGAGAGTCAGGCAACAG-3’ 
Rev: 5’-
ATATCTAGACCAAACAAGGCCGTACGAATTTC-3’ 
253bp 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_96996
8.2 
T. castaneum 
cDNA 
Fwd: 5’-ATATCTAGACATCCGGAACGTCTCACTCT-
3’ 
Rev: 5’- 
ATACTAGACATCCGGAACGTCTCACTCT-3’ 
277bp 
V-type 
ATPase E 
subunit 
XM_00194
6489  
 
A. pisum    
cDNA 
Fwd: 5’-TAT CTCGAG GGCCGCCTGGTC-3’ 
Rev: 5’-TAT CTCGAG GGCCGCCTGGTC-3’ 
 
277bp 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_00194
4122.3 
A. pisum    
cDNA 
Fwd: 5’- 
TATCTCGAGGGTCTGAAGGACTGGGAAGAA-3’ 
Rev: 5’- 
TATCTCGAGGGTCTGAAGGACTGGGAAGAA-3’ 
277bp 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_01129
2268.1 
M. domestica 
cDNA 
Fwd: 5’-ATAGAATTCGCGGGGGTGGTCTTAAGG-3’  
Rev: 5’- TATAAGCTTGCGACTGCAACCGTTGTATG-
3’ 
277bp 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
None D. radicum 
cDNA 
Fwd: 5’-ATAGAATTCCAGCTGTGGTGGTGGTC-3’ 
Rev: 5’-TATAAGCTTGCGAGAAGCCTGTTCCG-3’ 
277bp 
Kanamycin 
resistance 
(nptII) 
JN638547 
(synthetic 
construct)  
pSC-A-
amp/kan  
 
Fwd: 5’-AGGCTATTCGGCTATGAC-3’ 
Rev: 5’-CGATAGAAGGCGATGCG-3’ 
600bp 
 
Tread (APIN: 
Inhibitor of 
Apoptosis) 
XM_96996
8.2 
T. castaneum 
cDNA (with T7 
promoter 
sequences) 
 
Fwd: 5’-TAATACGACTCACTATAGGG 
ACAAGAAGGCGCGGTTAGAG-3’ 
 
Rev: 5’-TAATACGACTCACTATAGGG 
ACATTACTCGCCGACACACC-3’ 
 
277bp 
To clone 
Staufen RBD1 
in pET32 
vector 
NP_47675
1.1 
Synthesed 
gene in 
pUC50 vector 
Fwd: 5’-ATAGGATCCAAGGCAAGACCCCA-3’ 
Rev: 5’-CGTAAGCTTATGCTTGTACATGGTTTC-3’ 
219bp 
To clone 
Staufen RBD3 
in pET32 
vector 
NP_47675
1.1 
Synthesed 
gene in 
pUC50 vector 
Fwd: 5’-ATAGGATCCGACAAGAAGTCGCCC-3’ 
Rev:  5’-CGTAAGCTTCGGCAGCTTTTGCAA-3’ 
219bp 
To clone 
Staufen RBD3 
cloned in pelB 
vector 
containing 
GNA 
NP_47675
1.1 
Synthesed 
gene in 
pUC50 vector 
Fwd: 5’-TGCTCGAGTCCAGTGGCCCAA-3’ 
Rev:  5’-TCGGATCCCGATAAGAAGTCTCC-3’ 
219bp 
To clone 
Staufen RBD3 
cloned in 
pGAPαB 
NP_47675
1.1 
Synthesed 
gene in 
pUC50 vector 
Fwd: 5’-TGAAGCTGCAGCAGATAAGAAGTCTCCA-3’ 
Rev: 5’ ATCGGCGGCCGCTGGCAACTTTTG-3’ 
219bp 
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Table 3 Primer pairs used for qPCR analysis in A. pisum, M. domestica, D. radicum 
and T. castaneum. 
 
 
 
 
 
Gene Access 
code 
Insect Primer sequence 
V-type 
ATPase E 
subunit 
XM_969968.
2 
T. castaneum Fwd: 5’-CCAAGCATTTTTAATGCA CCAC-3’ 
Rev: 5’-5-CCAAGCATTTTTAATGCA CCAC-3’ 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_969968.
2 
T. castaneum Fwd: 5- AAGCGAAAAGTTGAGGCAAGC-3’ 
Rev: 5- AACCATTGCTTTCTTACTCGAAGG-3’ 
 
GAPDH 
 
XP_974181.
1 
T. castaneum Fwd: 5’-CCGGGATGGCGTTCAG-3’ 
Rev: 5’-CCAAACGCACCGTCAAATC-3’ 
V-type 
ATPase E 
subunit 
XM_0019464
89  
 
A. pisum    Fwd: 5’-CCGAGTATAAGGCAGCATCCA-3’ 
Rev: 5’-CTTATGTGCCAACAACTCAATACCA-3’ 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_0019441
22.3 
A. pisum    Fwd: 5’-GATTATTGGCAACAAGGTGATGATC-3’ 
Rev: 5’-AACCAGCAGAAGAATCGTTAAAAAA-3’ 
GAPDH NM_0012934
74.1 
 
A. pisum    Fwd: 5’-CAATGGAAACAAGATCAAGGTGTT-3’ 
Rev: 5’-ACCAGCAGATCCCCATTGG-3’ 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
XM_0112922
68.1 
M. domestica Fwd: 5’-GGTTCCGCTGCAACAAAAGT-3’ 
Rev: 5’-GGGTGCCTGTTCGTTGGA-3’ 
GAPDH 
 
XP_0013647
34.2 
M. domestica Fwd: 5’-AGGCCATCACCGTTTTCAGT-3’ 
Rev: 5’-GCGCTGGCCCAGTTGA-3’ 
Thread (APIN: 
Inhibitor of 
Apoptosis) 
In this work D. radicum Fwd: 5’- GCCACGCAACAAGAAATAACAC 
Rev: 5’- GCCACGCAACAAGAAATAACAC-3’-3’ 
 
GAPDH 
 
In this work D. radicum Fwd: 5’- CCATGTTTGTGTGCGGTGTT-3’ 
Rev: 5’-TGCAGGAAGCATTGGAGACTAC-3’ 
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Insect dsRNA Insect age Insect 
weight 
dsRNA (ng)/insect 
A. pisum    Kan 5 days 0.7mg 7.5, 15 and 30ng 
 ApVTE dsRNA 5 days  7.5, 15 and 30ng 
 ApAPIN dsRNA 5 days  7.5, 15 and 30ng 
M. domestica Kan Pre-pupa 18mg 150, 250 and 500ng 
 DrAPIN dsRNA Pre-pupa  150, 250 and 500ng 
 Kan 1 day fly adult   150 and 500ng 
 MdAPIN dsRNA 1 day fly adult  150 and 500ng 
D. radicum Kan Pre-pupa 16.7mg 100ng 
 DrAPIN dsRNA Pre-pupa  100ng 
T. castaneum Kan Pre-pupa 3.1mg 10,50 and 100ng 
 TcAPIN dsRNA Pre-pupa  10,50 and 100ng 
 TcVTE dsRNA Pre-pupa  50 and 100ng 
 T.cfmVTE dsRNA Pre-pupa  150 and 300ng 
 
Table 4 Injection bioassays with A. pisum, M. domestica and T. castaneum. 
 
 
Insect Treatment Insect stage dsRNA concentration 
A. pisum    Kan neonate 7.5ng/µl, 100ng/µl 
 ApVTE dsRNA neonate 7.5ng/µl, 100ng/µl 
M. domestica Kan 3 days old larvae 100ng/mg, 200ng/mg 
 MdAPIN dsRNA 3 days old larvae 100ng/mg, 200ng/mg 
M. domestica Kan (Bacteria) 3 days old larvae 200ng/mg 
 MdAPIN dsRNA 
(Bacteria) 
3 days old larvae 200ng/mg 
T. castaneum Kan <one week old 250ng/mg, 500ng/mg 
 TcAPIN dsRNA <one week old 250ng/mg, 500ng/mg 
 TcVTE dsRNA <one week old 250ng/mg, 500ng/mg 
 
Table 5 Oral delivery of dsRNA to A. pisum, M. domestica and T. castaneum 
 
 
 
 
 
 
  
  
50 
 
Insect Stage DsRNA-Trx/RBD3 Volume  dsRNA/ insect 
A. pisum    5 days old ApVTE dsRNA 13.8nl 5ng 
T. castaneum Pre-pupa stage TcAPIN dsRNA 30nl 10ng 
D. radicum 3rd instar DrAPIN dsRNA 300nl 100ng 
 
Table 6 dsRNA-Trx/RBD3 conjugate injection bioassay against different insect orders 
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Chapter 3 RNAi responses in insects of different orders 
 
3.1 Introduction 
The possibility of exploiting the high level of specificity of RNAi, based on transcript 
sequences, to give insecticidal effects specific to target insect pests has led to much 
research being directed towards using an RNAi approach in crop protection. However, 
two technical problems have limited the application of this strategy in the field.  
 First, delivery of dsRNA to the insect is a significant problem; although 
successful gene knockdowns have been achieved in many cases via microinjection 
into insect haemolymph this method is not possible for practical application of 
insecticide. More effective delivery methods have been focused on topical or oral 
administration. Although oral delivery of dsRNA to produce RNAi effects is feasible in 
some insects, continuous feeding is often needed if this is to result in mortality. In this 
respect, delivering dsRNA via production in transgenic plants offers significant 
advantages. Baum et al. (2007) constructed a transgenic corn plants to express 
dsRNAs against specific target genes in Western corn rootworm (WCR), which resulted 
in significantly reduced WCR feeding damage. Similarly, Mao et al. (2007) generated 
transgenic Arabidopsis thaliana and Nicotiana tabacum engineered to express dsRNA 
specific to an insect cytochrome P450, resulting in disruption of insect's ability to 
detoxify gossypol.  
 A second problem in applying RNAi to crop protection is variable responses in 
target pests. Recent studies which have focused on differences in the RNAi efficiency 
between insect species have found that not all insect species are equally susceptible to 
the RNAi effect, and some insect species even appear to be completely insensitive 
(Terenius et al. (2011); Bellés (2010)). In this chapter, RNAi effects are compared 
between insect species of three different orders: Tribolium castaneum (T. castaneum), 
red flour beetle from Coleopteran, Musca domestica (M. domestica), housefly and 
Delia radicum (D. radicum), cabbage root fly from Dipteran, and Acyrthosiphon pisum  
(A. pisum), pea aphid from Hemiptera. RNAi was directed against two target genes, the 
thread gene which encodes Inhibitor of Apoptosis (APIN) protein, and V-type ATPase E 
subunit gene and dsRNA was delivered both by microinjection and feeding. 
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3.2 Results   
 
3.2.1 RNAi in T. castaneum  
 
3.2.1.1 TcAPIN and TcVTE gene expression pattern analysed by real time qPCR 
In order to determine appropriate developmental stages at which dsRNA administration 
could be used to show RNAi effects, the expression of the target genes was assessed 
in T. castaneum at different life stages, from early larva to adult. Total RNA was 
extracted from insects, and used to prepare cDNA. Expression of the target genes was 
estimated relative to an endogenous control, the GAPDH gene, by quantitative PCR 
(qPCR). These experiments demonstrated that V-type ATPase E subunit (VTE) gene 
was ubiquitously expressed in different life stages of T. castaneum (Figure 3-1). 
Although TcVTE transcripts were more abundant relative to GADPH in pupal stage, the 
change in ratio was less than 2-fold compare to the pre-pupa larval stage, and within 
experimental error for technical replicates. In contrast, the APIN gene (TcAPIN) was 
expressed in a much more development-specific manner, with the highest level at egg 
and pre-pupa and pupa stage and relatively low levels in other stages (Figure 3-2).  
 
3.2.1.2 Injection of dsRNA results in significant gene down regulation in T. 
castaneum larvae 
Injection of dsRNA in T. castaneum larvae at the pre-pupal stage induced robust target 
gene down-regulation. Representative results are shown in Figure 3-3 and Figure 3-4, 
and demonstrate that 50ng TcVTE dsRNA and TcAPIN dsRNA were able to reduce the 
relative levels of VTE and APIN gene transcripts by >85%. The down regulation effect 
persisted for at least 10 days post injection (latest time point assayed). Both genes 
showed significant difference in gene downregulation compared to control treatment in 
all tested time points (ANOVA with P<0.0001). The assays showed that the TcVTE 
dsRNA was approx. 2x as effective in down regulation as TcAPIN dsRNA when the 
same amount was injected (approx. 16-fold downregulation by TcVTE dsRNA, 8-fold 
by TcAPIN dsRNA); the dsRNAs were designed to be of the same length, so the 
TcVTE dsRNA was also more effective on a molar basis (i.e. effect per molecule of 
dsRNA).  Based on the qPCR result, TcVTE expression gives Ct value at 21 when 
normalised to endogenous control GAPDH (21) whereas TcAPIN expression is 26. 
This observation agreed well with the expression levels of DmVTE (CG1088) and 
DmAPIN (CG12284) in Drosophila data from Flybase (http://flyatlas.org/atlas.cgi). In 
larval tissues, DmVTE transcripts are 2-4 fold higher than DmAPIN transcripts, and 
both genes express at high level in midgut, hindgut, Malpighian tubules, salivary gland 
  
  
53 
and fat body. TcVTE dsRNA could be targeting VTE transcript more easily than APIN 
transcript due to the greater abundancy.  
 As well as down-regulation of gene expression, a phenotype was observed in 
larvae injected with both both TcVTE and TcAPIN dsRNA. Mortality was observed in 
treated larvae from 3 days post injection and continued throughout the assay. Larvae 
injected with TcAPIN dsRNA exhibit blackened symptom over whole body (Figure 
3-51C and 2). Survived larvae failed to complete pupation, showing pupal-like 
phenotype, but with larvae form (Figure 3-51D).  Control larvae were able to go through 
to the pupal stage with only low levels of mortality. A further assay was performed in 
order to record survival for larvae after injection (Figure 3-6).  Twenty larvae each at 
the pre-pupal stage were injected with 100ng TcAPIN dsRNA or TcVTE dsRNA for 
each treatment. A control treatment was made by injecting 100ng Kan dsRNA. A 
steady decline in survival from 2 days after injection was observed in treated larvae, 
resulting in 100% larval mortality by day 11 for larvae injected with TcVTE dsRNA and 
by day 12 for larvae injected with TcAPIN dsRNA. Survival curves for the treated larvae 
were significantly different (Mentel-Cox test with P<0.0001) from controls, where the 
control treatment (injected with Kan dsRNA) showed approx. 90% survival at 13 days 
post injection when the assay finished. The two survival curves for injection of TcVTE 
dsRNA or TcAPIN dsRNA were not significantly different according to Mentel-Cox test. 
 
3.2.1.3 Species-specificity of RNAi effects in Tribolium spp. 
The species-specificity of gene down-regulation caused by VTE dsRNA was assessed 
by injecting sequences specific for VTE from T. confusum (confused flour beetle), a 
closely-related Tribolium species, into T. castaneum, and assaying transcript levels in 
the injected insects by qPCR. One hundard and fifty and 300ng T. confusum VTE 
(TcfVTE) dsRNA with 253bp length were injected into T. castaneum pre-pupal stage 
larvae, and injected larvae were collected after 48h for RNA extraction. The 
subsequent qPCR results (Figure 3-7) showed effective down-regulation, with 
transcripts down-regulated by approx. 10-fold in both treatments compared to the 
control (injected with Kan dsRNA), differences are significant between control and 
TcfVTE dsRNA treatments for both doeses (ANOVA, P<0.0001). These results are 
comparable to injection of 50 ng of T. castaneum VTE dsRNA (Figure 3-4). The 
sequence used to prepare the T. confusum dsRNA (253bp) is aligned with the T. 
castaneum target in Figure 3-8; although there are sequence differences between the 
species, several stretches of ≥20 bases with sequence identity are present. The result 
suggests that cross-protection against related species by RNAi is possible, providing 
that suitable dsRNA regions are selected. 
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3.2.1.4 Time course for gene down-regulation in T. castaneum larvae. 
To determine whether dsRNA injection into T. castaneum larvae can induce an RNAi 
effect in the short term, experiments were carried out in which 10ng TcAPIN dsRNA 
was injected into pre-pupa stage larvae, followed by harvesting insects after 24h and 
48h for estimation of transcript levels by qPCR. Results are shown in Figure 3-9A 
(ANOVA, P<0.0001). RNAi effect, nearly 2-fold reduction in transcript level, was 
observed after 24h compare to control treatment; the effect only increased slightly after 
48h. Comparison to the previous assay, in which 50ng of TcAPIN dsRNA was injected, 
shows dose-dependency of the RNAi effect, in that gene down-regulation is approx. 8-
fold after 48h at the higher dose. 
 The time-course of the RNAi response was clarified in a further experiment in 
which 10ng TcAPIN dsRNA was injected into pre-pupal stage larvae, and insects were 
collected at 2h, 5h, 24h and 10 days after injection, for analysis of APIN gene 
expression by qPCR. Results are shown in Figure 3-10. These data demonstrate that 
no RNAi effect is detectable at 2h after injection, but is observed at 5h (approx. 2-fold) 
showing that the interval required observing the effect is <5h. A significant difference 
was compared between treatment of injection of TcAPIN dsRNA at 2h time point and 
5h time point (ANOVA, P<0.0001). Gene down-regulation by injected dsRNA increases 
slightly over the interval 5h to 24h (and, from the previous experiment, to 48h), but 
increases significantly (ANOVA, P<0.0001). to approx. 5-fold, after 10 days. Injection of 
control Kan dsRNA has no significant effect on expression of the target gene over the 
time points tested. These results suggest that the RNAi effect in Tribolium involves 
longer-term RNAi amplification when low doses of dsRNA are used, since levels of 
gene down-regulation are greater at 10 days (ANOVA, P<0.0001) after injection than in 
the short term. 
 
3.2.1.5 Oral feeding of dsRNA to T. castaneum larvae induces target gene down-
regulation 
Although injection of dsRNA in T. castaneum larvae gives reliable gene down-
regulation, use as a pesticide in crop protection would require a different method of 
delivery; oral delivery would be most convenient. Experiments were therefore carried 
out to evaluate this method of delivery, mixing the dsRNA into the wheat flour diet used 
for this insect. DsRNA against TcVTE and TcAPIN gene was incorporated into wheat 
flour diet at 250 ng/mg (250 ppm) and 500 ng/mg (500 ppm), with 500ng/mg Kan 
dsRNA as a control. T. castaneum larvae at ≤7 days after emergence were exposed to 
the diets for 30 days, after which period control larvae had started to pupate. Survival 
of controls fed Kan dsRNA over the complete assay period was 90%. Both dsRNA 
treatments, at both levels of incorporation, caused significant mortality (Mentel-Cox test, 
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p<0.002) when compared to control (result shown in Figure 3-11). Larvae fed with 
TcVTE dsRNA at 500 ng/mg showed a steady decline in survival over the assay, 
resulting in 100% mortality after 25 days. Larvae fed with the lower dose (250 ng/mg) 
TcVTE dsRNA also declined in survival up to 20 days feeding, with no further mortality 
over the remaining 10 days, resulting in 55% mortality at the end of the assay. Larvae 
fed with TcAPIN dsRNA at 500 ng/mg and 250 ng/mg also showed declines in survival 
which reduced at the later stages of the assay, resulting in approx. 70% and 40% 
mortality over the assay period, respectively. Both dsRNAs showed dose-dependent 
effects on survival of the T. castaneum larvae when fed, demonstrating their activities 
as biopesticides.  
 To show that oral administration of dsRNA caused down-regulation of gene 
expression, T. castaneum larvae were fed on wheat flour containing 500 ng/mg TcVTE 
dsRNA for 10 days, then collected and pooled for RNA extraction, followed by qPCR. 
Results are shown in Figure 3-12 (ANOVA, p<0.0001). Same experiment was 
performed to show APIN gene downregulation after feeding TcAPIN dsRNA (Figure 
3-13, ANOVA, p<0.0001). VTE and APIN gene transcripts were reduced by approx. 2-
fold compared to control (Kan dsRNA) treatment. This relatively low level of gene 
down-regulation compared to injection of TcVTE dsRNA (Figure 3-3) and TcAPIN 
dsRNA (Figure 3-4) may explain the more gradual decline in survival in the feeding 
assay (shown by comparing Figure 3-6 and Figure 3-11), and suggests that delivery of 
dsRNA in the field may limit insecticidal activity and thus use as a biopesticide. 
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Figure 3-1 TcVTE expression profiles in different life stages of T. castaneum. 
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to TcVTE level in adult = 1.0. Error bars indicate 
standard errors of the mean for 3 technical replicates. L1= 1st-2nd instar, L2= 2nd-3rd 
instar, L3= 3rd-4th instar, L4= 4th-5th instar, L5= 5th-6th instar (pre-pupa stage), P=pupa, 
A=adult, E=egg. Number of insects used for each stages n=5. 
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Figure 3-2 TcAPIN expression profiles in different life stages of T. castaneum. 
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to TcAPIN level in adult = 1.0. Error bars indicate 
standard errors of the mean for 3 technical replicates. L1= 1st-2nd instar, L2= 2nd-3rd 
instar, L3= 3rd-4th instar, L4= 4th-5th instar, L5= 5th-6th instar (pre-pupa stage), P=pupa, 
A=adult, E=egg. Number of insects used for each stages n=5. 
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Figure 3-3 Down-regulation of TcVTE gene in pre-pupal T. castaneum larvae. 
Larvae were injected with 50ng TcVTE dsRNA or Kan dsRNA as indicated; transcript 
levels were estimated by qPCR at different times after injection as shown. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan level in replica 1 control 48h = 1.0. Error bars indicate standard 
errors of the mean for 3 technical replicates; replicas are independent 3 biological 
replicates. Number of insects for each treatment n=5. Differences are significant 
between control and TcVTE treatment at both time points tested by ANOVA with 
p<0.0001, ****. 
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Figure 3-4 Down-regulation of TcAPIN gene in pre-pupal T. castaneum larvae. 
Larvae were injected with 50ng TcAPIN dsRNA or Kan dsRNA as indicated; transcript 
levels were estimated by qPCR at different times after injection as shown. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan level in replica 1 control 48h = 1.0. Error bars indicate standard 
errors of the mean for 3 technical replicates; replicas are 3 independent biological 
replicates. Number of insects for each treatment n=5. Differences are significant 
between control and TcAPIN treatment at both time points tested by using ANOVA with 
p<0.0001, ****. 
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Figure 3-5 Phenotypes observed after injection of TcAPIN and TcVTE dsRNA into 
pre-pupal stage larvae.  
1: Group A and B: T.castaneum larvae and pupae injected with Kan dsRNA. 
Group C and D: T.castaneum larvae and pupae injected with TcAPIN dsRNA. 
2: Control treatment: larva injected with Kan dsRNA 
Blackened larvae were observed in treatment of injection of TcAPIN dsRNA  
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Figure 3-6 Survival of T. castaneum larvae after injection with dsRNAs. Prepupal 
larvae were injected with dsRNAs as indicated, and survival was monitored daily. 
Number of insects for each treatment n=20. Mentel-Cox test with p<0.0001, ****. 
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Figure 3-7 Down-regulation of TcVTE gene in pre-pupal T. castaneum larvae 
injected with dsRNA directed against confused flour beetle VTE gene.  Five larvae 
were injected with TcfVTE dsRNA or Kan dsRNA as indicated; transcript levels were 
estimated by qPCR at different times after injection as shown. Columns show the levels 
of transcript relative to GADPH transcript (internal standard), normalised to level in 
300ng Kan level control 48h = 1.0. Error bars indicate standard errors of the mean for 3 
technical replicates. Control treatment 150ng Kan dsRNA at 10 days time point was 
contaminated; therefore it is removed from figure. ANOVA with p<0.0001, ****. 
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Figure 3-8 Sequence alignment of T. castaneum and T. confusum VTE gene 
fragments used for producing dsRNA. Asterisks indicate sequence identity. VTE 
dsRNA prepared from T. confusum is 253bp whereas 277bp in T. castaneum. 
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Figure 3-9 Down-regulation of TcAPIN gene in pre-pupal T. castaneum larvae. 
Larvae were injected with 10ng TcAPIN dsRNA or Kan dsRNA as indicated; transcript 
levels were estimated by qPCR at different times after injection as shown. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan level in control 24h = 1.0. Error bars indicate standard errors of the 
mean for 3 technical replicates.  Number of insects for each treatment n=5. ANOVA 
with p<0.0001, ****. 
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Figure 3-10 Down-regulation of TcAPIN gene in pre-pupal T. castaneum larvae. 
Larvae were injected with 10ng TcAPIN dsRNA or Kan dsRNA (control); transcript 
levels were estimated by qPCR at different times after injection as shown. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan level in 2h control = 1.0. Error bars indicate standard errors of the 
mean for 3 technical replicates. Number of insects for each treatment n=5. ANOVA 
with p<0.0001, ****. 
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Figure 3-11 Survival of T. castaneum larvae fed on flour disks containing TcVTE 
dsRNA and TcAPIN dsRNA. Less than one week old larvae were fed on disks 
containing dsRNAs as indicated; survival was monitored daily. Number of insects for 
each treatment n=20. According to Mentel-Cox test, treatments between control Kan 
250ng/mg is significant different from TcVTE 250ng/mg with P<0.02, **. Significant 
difference in treatment between Control Kan 500ng/mg and TcVTE 500ng/mg with 
P<0.0001, ****. No significant difference between Control Kan 250ng/mg and TcAPIN 
250ng/mg. Significant diffrerent with P<0.0027,** between Control Kan 500ng/mg and 
TcAPIN 500ng/mg.  
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Figure 3-12 Down-regulation of TcVTE gene in T. castaneum larvae fed on diets 
containing dsRNAs. Larvae were fed on diet containing 500 ng/mg TcVTE dsRNA or 
Kan dsRNA (control) for 10 days; transcript levels were estimated by qPCR. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan control = 1.0. Error bars indicate standard errors of the mean for 3 
technical replicates. Number of insects for each treatment n=5. Differences are 
significant between control Kan fed and TcVTE fed in 3 different biological replicas 
(Two-way ANOVA with p<0.0001, ****). 
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Figure 3-13 Down-regulation of TcAPIN gene in T. castaneum larvae fed on diets 
containing dsRNAs. Larvae were fed on diet containing 500 ng/mg TcAPIN dsRNA or 
Kan dsRNA (control) for 10 days; transcript levels were estimated by qPCR. Columns 
show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Kan control = 1.0. Error bars indicate standard errors of the mean for 3 
technical replicates. Number of insects for each treatment n=5. Differences are 
significant between control Kan fed and TcVTE fed in 3 different biological replicas 
(ANOVA with p<0.0001, ****). 
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3.2.2 RNAi in M. domestica and D. radicum 
 
3.2.2.1 Isolation of coding sequence and completion of APIN transcripts of M. 
domestica and D. radicum. 
For isolating orthologues of the selected Drosophila gene targets were present in M. 
domestica and D. radicum, degenerate primers which could potentially be functional in 
a range of dipteran species were firstly designed based on the conserved amino acid 
sequence among model dipteran D. melanogaster, and other well-characterised 
dipteran spices including Anopheles gambiae, Aedes aegyptica and Culex pipiens. 
PCR products amplified from cDNA preparations were isolated and cloned, followed by 
sequencing. Gene specific primers for dsRNA region were then designed based on the 
sequence analysis. Sequences were extended to give complete coding sequences for 
the IAP proteins of M. domestica and D. radicum by 3' and 5' RACE (Rapid 
Amplification of cDNA Ends). The assembled APIN gene sequences of M. domestica 
and D. radicum are shown in Figure 3-14 and Figure 3-15 and predicted amino acid 
sequences are shown in Figure 3-16. 
 
3.2.2.2 APIN gene expression pattern in M. domestica and D. radicum.  
To identify suitable developmental stages to evaluate RNAi effects, the expression of 
the APIN gene was evaluated by qPCR. Under the growth conditions used (25°C) the 
M. domestica larval stage lasts for approx. 10 days, whereas for D. radicum, the larval 
stage lasts for approx. 3 weeks. M. domestica and D. radicum larvae were collected at 
time intervals after egg hatch corresponding to the developmental stages 1st-2nd instar, 
2nd instar, 2nd-3rd instar and 3rd instar prepupal, followed by pupae and adult. Five 
insects per developmental stage were pooled and snap frozen in liquid nitrogen for 
RNA extraction. cDNA prepared from RNA was used as a template for evaluation of 
endogenous APIN expression by real-time quantitative PCR. The results shown in 
Figure 3-17 and Figure 3-18 demonstrate that in both species APIN gene expression 
can be detected throughout the whole life cycle, with a peak of expression at the pupal 
stage when tissue remodeling is taking place. Administering dsRNA to the pupal stage 
would be difficult as the injection process itself often causes mortality, and thus the 3rd 
instar pre-pupal stage was selected as the best developmental stage to observe RNAi 
responses. 
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3.2.2.3 Injection of APINdsRNAs induced APIN gene downregulation and 
mortality in M. domestica and D. radicum larvae 
Injection of MdAPIN dsRNA into third instar M. domestica larvae induced a significant 
APIN gene downregulation (Figure 3-19). The level of the APIN transcript was not 
affected 2h post injection, but APIN gene down-regulation, by approx. 3-fold, was 
observed after 24h compared to control treatment (ANOVA with p<0.0001).  After 48h 
post injection, a slightly increased level of gene down-regulation was shown. Similar 
results were observed when DrAPIN dsRNA was injected into third instar D. radicum 
larvae. Significant (ANOVA with p<0.0001) APIN gene downregulation (approx. 3-fold) 
was detected both 24h and 48h after injection (Figure 3-20). These data show that 
dsRNA targeting APIN gene gives an efficient RNAi response in M. domestica and D. 
radicum larvae.  
 Injection of APIN dsRNAs into M. domestica and D. radicum larvae caused 
significant mortality (Mentel-Cox test with p<0.0001), which was dose dependent when 
injections were performed with different doses of APIN dsRNAs. Results for M. 
domestica are shown in Figure 3-21(2). Surviving in control treatment (injected with 
Kan dsRNA) was 90% over 6 days, similar to insects injected with water only. In 
contrast, 100% mortality was found after 3 days in insects injected with 500ng MdAPIN, 
and after 5 days in insects injected with 250ng MdAPIN dsRNA. Injection of 125ng 
MdAPIN dsRNA resulted in 60% mortality after 6 days. A similar result was recorded in 
early third instar D. radicum larvae treated with injection of DrAPIN dsRNA in Figure 3-
22 (2), Mentel-Cox test with p<0.0001).  Less than 10% mortality was found in control 
treatment and a dose-dependent effect in DrAPIN dsRNA treatment was detected. 100% 
mortality was found in 3 days after injection of 500ng DrAPIN dsRNA, whereas 85% 
and 75% mortality were recorded in treatment with 250ng and 150ng DrAPIN dsRNA 
treatment respectively after 7 days. The results suggest that APIN gene is a good gene 
candidate for using RNAi to control dipteran species.  
 
M. domestica larvae injected with MdAPIN dsRNA exhibited blackened symptoms, 
which indicate excess apoptosis is occurring leading to necrosis (shown in Figure 3-21 
(1)). D. radicum larvae injected with DrAPIN dsRNA resulted in similar phenotype 
(Figure 3-22 (1)). Survived larvae failed to reach full pupation stage, even though 
darkening of the cuticle took place, the insects remain in larviform (phenotype of 
injected M. domestica larvae are shown in Figure 3-21 (1) C-F and D. radicum are 
shown in Figure 3-22 (1) D). Injection of MdAPIN dsRNA in M. domestica pupae also 
leads to serious developmental abnormalities, with extensive melanisation of tissues 
taking place, suggesting uncontrolled apoptosis (Figure 3-21 (1) G-H). Adult M. 
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domestica emerged from MdAPIN injected pre-pupa stage larvae, show severe 
malformation of the abdominal regions (Figure 3-21 (1) J-K). 
 
3.2.2.4 Species-specificity of RNAi effects in Dipteran spp. 
To investigate whether RNAi effects induced by injection of dsRNA can affect closely 
related Dipteran species, like the pattern observed previously in Coleopteran species, 
three different doses (150ng, 250ng and 500ng) of dsRNA against the D. radicum 
DrAPIN gene were injected into 3rd instar M. domestica larvae. Alignment of sequences 
from M. domestica and D. radicum APIN genes used in templates for dsRNA 
preparation are shown in Figure 3-23. Results are shown in Figure 3-24. Control 
survival of larvae injected with water or Kan dsRNA were >85%. The larvae injected 
with DrAPIN dsRNA showed a dose-dependent effect on larval mortality. Approx. 50% 
mortality M. domestica larvae injected with 500ng DrAPIN dsRNA was observed after 5 
days compare to Kan 500ng dsRNA (Mentel-Cox test with P=0.0478), whereas 
mortality from 150ng and 250ng doses was approx. 30% and 40% after 5 days.  
 Down-regulation of MdAPIN gene expression by injected DrAPIN dsRNA was 
confirmed. One hundard and fifty nanograms and 500ng DrAPIN dsRNA were injected 
into 3rd instar M. domestica larvae. The insect samples were collected at 48h and 72h 
post injection. qPCR results for APIN transcript levels are shown in Figure 3-25. House 
fly larvae injected with 150ng DrAPIN dsRNA showed 60% APIN gene down-regulation 
compared to control treatments after 48 (ANOVA test with P=0.040). Significant APIN 
gene down-regulation was also observed in insects injected with 500ng dsRNA 
(ANOVA test with P=0.024), although there was no dose-dependency in the degree of 
down-regulation observed. Levels of APIN gene transcripts did not decrease further 
after 72 h compared to 48h post injection.  
 
3.2.2.5 RNAi effects in M. domestica adults 
The specificity of RNAi effects to specific developmental stages in M. domestica was 
investigated by injecting newly emerged M. domestica adults with dsRNA. Flies 
injected with 150ng and 500ng MdAPIN dsRNA were firstly monitored for 6 days to 
record survival data. The results shown in Figure 3-26 give no indication of any 
mortality resulting from injection with APIN dsRNA. However, this could be due to a 
phenotype not being observed as gene expression is not essential at this 
developmental stage.  
 To show whether injection of dsRNA caused down-regulation of gene 
expression in adult flies, injected flies were also collected after 48h and 72h, and used 
to prepare cDNA for analysis of APIN transcript levels by qPCR.  Results are shown in 
Figure 3-27. In agreement with survival data, the APIN transcript was not down 
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regulated by injected APIN dsRNA in fly adult. Flies injected with 150ng dsRNA shows 
similar APIN transcript level compared to control treatment. Unexpectedly, flies injected 
with 500ng MdAPIN dsRNA show increased (approx. 2-fold) APIN gene expression 
compared to the control treatment after 48h. These results indicate that the RNAi effect 
induced by dsRNA injection is dependent on developmental stage in M. domestica, 
with larvae showing a robust effect, which is absent in adults.  
 
3.2.2.6 Oral feeding bioassays targeting APIN gene in M. domestica larvae 
A concentration of 100ng MdAPIN dsRNA/mg diet was used in a feeding bioassay to 
determine whether RNAi effects could be produced in M. domestica larvae. The 
survival data was recorded over 7 days continuous oral feeding of dsRNA mixed in 
artificial diet. No significant mortality due to the MdAPIN dsRNA was observed 
compared to control treatment，as shown in Figure 3-28; both treatment and control 
gave approx. 10% mortality.  
 In a second feeding bioassay, bacteria expressing MdAPIN dsRNA were mixed 
in diet at final concentration 200ng/mg and fed directly to M. domestica larvae. Survival 
data was recorded for 6 days. No significant differences on larval survival were found 
between treatments (Figure 3-29).  
 Insects fed on diets containing MdAPIN dsRNA were also analysed by qPCR 
after varying times of exposure. Results are shown in Figure 3-30, and confirm that the 
APIN gene was not down-regulated by this treatment; although marginal effects on 
transcript levels are observed, differences between treatment and control are not 
significant (ANOVA test) over 96 hours feeding.   
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       1  AAGCAGTGGT ATCAACGCAG AGTACGCGGG GAGTCTTCAA TTTTCTACTC 
      51  AACAAAAGAA AGAAACAAAC TTAAAACAAA AAAACTGTTA AAAATGTAAA 
     101  TGAAAAAATC AATATATTTT TTTTTATCAT GGCTGTTGTG AACAACAATC 
     151  TACAAAATAC AGCCGCAGCA ACATTTGAAT TCCTTGTAAG AAAAAACGCA 
     201  ACAACAACAC CAACAACAAC GTCATATTTT GAAAATAAAC AAGATAACAT 
     251  CAACAATTAT GAAAATGTCT GGAAATGTAG CAACCGAAAT ATGGGCCTCA 
     301  CAGCCACAGC TATGGTTGGT ACCATTCCCA AGTAATTTAT TGAAACATAT 
     351  ACCATCCAAT CCGACACCAG CAGCATTAGC AAGTGTCCCA AATCAGGACG 
     401  AAACGGATAA TAATACACAT AACGAGTTTC TACAAATTGG CCAATTAAAG 
     451  CCACGTTATG CCATGGACGA TAGATTCCAT CGTGAAGATG AACGCCTCAA 
     501  GACGTACGAA AATTGGCCAT TGAATTTCTT GGATCCCAAC GAATTGGCTC 
     551  GTTCGGGCAT GTTCTATATG GGCGAATCGG ATAAAACCAA ATGCTATTTC 
     601  TGTGAGGTGG AAATTGGCCG GTGGGAACGT GAAGATCAAC CTGTACCTGA 
     651  ACATCTGCGC TGGTCGCCCA ATTGCCCCTT GCTGAGGAGG CGCACTACCA 
     701  ACAATGTGCC CATCAATGCT GAACTCTTAG AGCGTACCTT ACCCGCCCCC 
     751  AGTTATGATA TTTGCGGAGC GAATGACATT GAAATCAGAC GAAATGCATT 
     801  TGCTGAAGGC ACCATCCCAG CACCACTAAT GTCCGATGTA CCACCTGGCT 
     851  CACCAATGGT TATGGCGGCC GGCAGCAGTA GCGCTGGTGG TGGCAGTGCA 
     901  ATGACAACTG GAGGCACATT TTTCCCCGAG GTGCCCGAAT ATGCCATCGA 
     951  AACAGCCCGT ATACGATCCT TTGCCGAATG GCCACGAAAC ATGAAACAAA 
    1001  AACCTGAACA GTTGGCCGAG GCCGGTTTCT TCTATACTGG TGTGGGCGAT 
    1051  CGTGTCAAGT GCTTCAGTTG TGGCGGTGGT CTTAAGGACT GGGACGATGA 
    1101  TGATGAACCC TGGGAACAGC ATGCCTTGTG GATGAATAAA TGTCGTTTTG 
    1151  TAAAATTGAT GAAAGGCGAT GCATTCATTG AAGCTGTGGC AAATAAATTC 
    1201  ATGAAAAATA AACCAGCTGC AAGCAACAAC AGAACTCCTA CACCAACGTC 
    1251  GGAATCGCCT CTCTCCTCGT CGGAAGAAGA GGGGGAGCCT GCAGTGCATT 
    1301  TGGCGGAGGG AAATCAAGAA ACAACACATA CAACGGTTGC AGTCGCCGGT 
    1351  TCCGCTGCAA CAAAAGTATC ATCCGCTTCA ATTCCCAAGC CTTGTTCCAA 
    1401  CGAACAGGCA CCCTCCACAA CTGCTGTCGC CGGTGTCAAT GCCTTGGAAC 
    1451  AGAAAAGGTC GAGCTCCACA ATACCCGAGG AGAAATTGTG CAAAATCTGC 
    1501  TATGCCAACG AATACAATAC AGCGTTTTTA CCCTGTGGCC ACGTTGTGGC 
    1551  CTGTGCCAAG TGCGCCTCGT CTGTTACAAA ATGTCCAATG TGTCGGAAAC 
    1601  CTTTTGCCGA TGTTATGAGG GTTTATTTCT CTTAAATTCG GAACAACAGC 
    1651  CACAACCGAG AATAATAACA GATAGCTGTA AAAAACTAAG AAAGCGTTTC 
    1701  CTCCTGATAT ACGTCGATGA TGTACATACT AATTTTATAA TACCCCGCCT 
    1751  TTGTAATACA TTTCTTCTAA TCAAACGAGT TTAACGGCCA GTTGAGATTT 
    1801  GTGCGAAACA TGCTAACGAG CTGAATGATG GGTATAAGTC TTAACTGGCC 
    1851  GTTAAATTTG CAAACAAACC AACCAACAAA GGAAGAAGAA TGAGAAGAAA 
    1901  ATAAGTTTAT TATTCCCATA AGAACTTATA ATTACATTAG GATAAAGATA 
    1951  AATCCATAAT TTATGTATAA AACCATAGAG GAAATAAATC CTTTGTAAAT 
    2001  AAAAGCATCA TTTGCAATTA CTTTAAAATA CAATTAAAAT TAATGCCCAA 
2051  CATATTTATA TTTTCACCAA CCATTGTAAT AG(A)n 
 
Figure 3-14 Assembled sequence of housfly APIN transcript.   
This sequence is 98% identical to GenBank entry XM_011292268.1 
Musca domestica apoptosis 1 inhibitor (LOC101889679), transcript variant X3, mRNA. 
Differences are as follows: 
Extra bases at 5' end (1-39) highlighted in blue 
Extra bases at 3' end (1663-2082) highlighted in green 
Two base insertion bases 76-77 
12 base deletion between bases 198-199 
Extra bases at 1336-1341 
Single base changes at bases 549, 856, 915, 927, 951, 1029, 1258. 
Coding sequence = bases 259 – 1632, highlighted in bold. 
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       1  TAGCAGATCT AATACGACTC ACTATAGGGC AAGCAGTGGT ATCAACGCAG 
      51  AGTACGCGGG GATTCGTAAA ACTGAATCTC TAATAACAAG TCATAAAAAT 
     101  ATATTTTCAA CTTACAAGTC TTAATTTTTT TTAATTTTAA ATTAAAAAGA 
     151  AAAGTAAAAA ATATGAAAGA TATATAAAAA AATATTTATC GCACTATCTG 
     201  TTTAAAACAA TTGTTAACTG TTTATCACTG TTGTAATATC GTTTCTTGAA 
     251  AACAATAGTA AAACGTATCT CAAACAAAAT GCCTGGAGAT TTATTAACGG 
     301  AAAGACCGCC GCTGTCTAAT GGCCAGGTAT TTCCAACTAA CCTATTCTAT 
     351  TCGTCCTCAA CGGGTCGTTT CAACAATCCA TTGAGTTTTA TACGAAAGTT 
     401  CTCGACTCAA GCGTTATCAC ACGGCCGGGA CGAAATTGAT AATAATACGC 
     451  ATAGTGATTT TTTGCAAACT GGCATATTTA AACCACGCTA TGAAATGAAT 
     501  GATATATTCC ATAGAGAAGA TGAACGCTTA AAAACATTTG AAAGTTGGCC 
     551  GTTGGAATGG TTGGATAAGA AACAATTGGC CATGTCGGGA ATGTTTTATA 
     601  TGGGTGATGG TGATAAGACA AAGTGTTATT TTTGTGAAGT CGAAATTGGT 
     651  CGTTGGGAAA GAGAGGATCA ACCTGTACCT GAACATCTGC GCTGGTCGCC 
     701  AAATTGTCCT CTTCTCAGAA GACGTACTAC CAACAATGTA CCCATTAATT 
     751  GTGAGGCTTT AGAGCGATTA CTACCGCCAC CCAGCTATGA CATCTGTGGT 
     801  CTCAATGAAC CCATAGAAAT ACGTCGTAAT GCTTTTGCCG AGGGCACTAT 
     851  ACCAGCTGTT AACTTTTCCG CTATGGATGT ACCACCGGGA TCACCAGCCA 
     901  ACGTTAGCTC AAGTAGTAAT AGTAGTACAG GGACATTTTA TCCCGAATTT 
     951  CCCGAATATG CTATAGAAAC TGCACGTTTA AGATCATTTG CGGAATGGCC 
    1001  GCGACATATG AAACAAAAAC CACCACAATT GGCCGAGGCT GGTTTCTTTT 
    1051  ATACCGGTGT AGGTGATCGT GTTAAATGTT TCAGTTGTGG TGGTGGTCTT 
    1101  AAGGATTGGG ATGAAGATGA CGAACCCTGG GAACAACATG CATTGTGGAT 
    1151  GGGTAAATGT CGTTTTTTGA AACTAATGAA AGGAGAAAAT TATATAGAAG 
    1201  CTGTTGTAAA TAAATTTAAA AAACCAGACG CTTCAACATC ATCCTCTACA 
    1251  TCATCACCTT CTCCTACCAA CTCCTCTACT GAAGAAGAGG GGGAGTTGCA 
    1301  ACAAGCACAA GCTGTAGGTG TAACTACTCA ACAAGTTTTA GCACAGAAAT 
    1351  CAGCAGCTAC TATCAATCTT CCAAAAGAGG AAGAGATTTT AACAGTATCG 
    1401  GAACAGGCTT CTCGCATACA CCATATGGCC ACGCAACAAG AAATAACACC 
    1451  ATCATCACAT CAAGCAGCCT CCATTACAAA TTGCTGCAAT ATAGAACAGA 
    1501  ACAAACCATC ATCATCATCG TTCTCTTCAG TCATACCCGA AGAGAAATTA 
    1551  TGCAAAATTT GTTATGCCAA CGAATACAAT ACAGCGTTTT TACCCTGCGG 
    1601  TCATGTAGTG GCTTGTGCCA AATGTGCATC GTCCGTTACA AAGTGTCCCC 
    1651  TGTGTCGAAA ACCTTTTGCC GATGTTATGC GTGTATATTT CTCTTAAGAT 
    1701  CTAACCTCAA TTATTACTAC ATATATAATC ATAGTGATTT CTATTGCAAA 
    1751  CAATTAAAAA CTGTTTTTCT ACTCTCTCTG TTTCTTTATC AACTTTCCCC 
    1801  AAATAGTTTT AGAAATGTAT ATAATTTTGT ATTAACAACC TGCCTTGAAA 
    1851  TATATTTAAA TCTAGAAAAA AGTCTTTAAC GGCCAGTTAG GATTTGTTTC 
    1901  AACATCATTC TACGATGTGA GTCTTAACTG GCCGTTAAAT TTTCTACATT 
    1951  ATATTGGCAA ACATATTGAA AGAAAATCCC AAAAACTTAC ACTATATCCA 
2001  AACAAATTTA ATTTATAAAA AAAAAAGTAA ATCAT(A)n 
 
Figure 3-15 Assembled sequence of D. radicum APIN mRNA. 
Coding sequence = bases 279 – 1694, highlighted in bold. 
Extra bases at 5' end (1-271) highlighted in blue 
Extra bases at 3' end (1697-2001) highlighted in green 
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M. domesctia APIN predicted polypeptide: 
 
  1 MKMSGNVATE IWASQPQLWL VPFPSNLLKH IPSNPTPAAL ASVPNQDETD 
 51 NNTHNEFLQI GQLKPRYAMD DRFHREDERL KTYENWPLNF LDPNELARSG 
101 MFYMGESDKT KCYFCEVEIG RWEREDQPVP EHLRWSPNCP LLRRRTTNNV 
151 PINAELLERT LPAPSYDICG ANDIEIRRNA FAEGTIPAPL MSDVPPGSPM 
201 VMAAGSSSAG GGSAMTTGGT FFPEVPEYAI ETARIRSFAE WPRNMKQKPE 
251 QLAEAGFFYT GVGDRVKCFS CGGGLKDWDD DDEPWEQHAL WMNKCRFVKL 
301 MKGDAFIEAV ANKFMKNKPA ASNNRTPTPT SESPLSSSEE EGEPAVHLAE 
351 GNQETTHTTV AVAGSAATKV SSASIPKPCS NEQAPSTTAV AGVNALEQKR 
401 SSSTIPEEKL CKICYANEYN TAFLPCGHVV ACAKCASSVT KCPMCRKPFA 
451 DVMRVYFS 
 
D. radicum APIN predicted polypeptide: 
 
  1 MPGDLLTERP PLSNGQVFPT NLFYSSSTGR FNNPLSFIRK FSTQALSHGR 
 51 DEIDNNTHSD FLQTGIFKPR YEMNDIFHRE DERLKTFESW PLEWLDKKQL 
101 AMSGMFYMGD GDKTKCYFCE VEIGRWERED QPVPEHLRWS PNCPLLRRRT 
151 TNNVPINCEA LERLLPPPSY DICGLNEPIE IRRNAFAEGT IPAVNFSAMD 
201 VPPGSPANVS SSSNSSTGTF YPEFPEYAIE TARLRSFAEW PRHMKQKPPQ 
251 LAEAGFFYTG VGDRVKCFSC GGGLKDWDED DEPWEQHALW MGKCRFLKLM 
301 KGENYIEAVV NKFKKPDAST SSSTSSPSPT NSSTEEEGEL QQAQAVGVTT 
351 QQVLAQKSAA TINLPKEEEI LTVSEQASRI HHMATQQEIT PSSHQAASIT 
411 NCCNIEQNKP SSSSFSSVIP EEKLCKICYA NEYNTAFLPC GHVVACAKCA 
451 SSVTKCPLCR KPFADVMRVY FS 
Figure 3-16 Predicted APIN gene products in M. domestica and D. radicum.  
BIR repeat domain, IPR001370 is highlighted in red and Zinc finger domain, 
RING/FYVE/PHD-type (IPR013083) is highlighted in blue.  
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Figure 3-17 MdAPIN expression profiles in different life stages of M. domestica. 
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to MdAPIN level in at stage L1 = 1.0. Error bars 
indicate standard errors of the mean for 3 technical replicates. L1 = stage 1, 1st-2nd 
larval instar; L2 = stage 2, 2nd larval instar, L3 = stage 3, 2nd-3rd larval instar, L4 = 
stage 4, 3rd larval instar prepupal, P = pupae, A = adult. Number of insects for each 
treatment n=5. 
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Figure 3-18 DrAPIN expression profiles in different life stages of D. radicum. 
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to DrAPIN level in at stage L1 = 1.0. Error bars 
indicate standard errors of the mean for 3 technical replicates. L1 = stage 1, 1st-2nd 
larval instar; L2 = stage 2, 2nd larval instar, L3 = stage 3, 2nd-3rd larval instar, L4 = 
stage 4, 3rd larval instar prepupal, P = pupae, A = adult. Number of insects for each 
treatment n=5. 
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Figure 3-19 Down-regulation of MdAPIN gene by injection of MdAPIN dsRNA.  
3rd instar M. domestica larvae were injected with 125ng dsRNA, and collected at times 
as shown after injection for estimation of transcript levels by qPCR. Error bars indicate 
standard errors of the mean for 3 technical replicates; 24 and 48h timepoints .are 
shown as 3 separate biological replicates. Number of insects for each treatment n=5. 
Significant difference was analysed by two-way ANOVA with p<0.0001, ****. 
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Figure 3-20 Down-regulation of DrAPIN gene by injection of DrAPIN dsRNA.  3rd 
instar D. radicum larvae were injected with 125ng dsRNA, and collected at times as 
shown after injection for estimation of transcript levels by qPCR. Error bars indicate 
standard errors of the mean for technical replicates; 24 and 48h timepoints .are shown 
as 3 separate biological replicates. Number of insects for each treatment n=5. 
Significant difference was analysed by ANOVA with p<0.0001, ****. 
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(1) 
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 (2) 
 
Figure 3-21 Mortality of M. domestica larvae after injection of MdAPIN dsRNA. 
N=20 
Larvae were injected with varying doses of MdAPIN dsRNA as indicated (2); 
Phenotypes observed in this experiment are shown below (1): 
A and B: Control and APIN dsRNA (respectively) injected 3rd instar larvae (300ng/larva) 
48 hours post injection.  
C & D and E & F: MdAPIN dsRNA and control (respectively) injected pupae 
(300ng/larva). G and H: Dissected pupae injected with 500ng control and MdAPIN 
dsRNA, respectively. I and J: Emerged adults injected (as pre-pupal larva) with 500ng 
control and M dAPIN dsRNA, respectively.  
K and L: Pulled-out adult injected (as pre-pupal larva) with 500ng control and MdAPIN 
dsRNA (resp.) M and N close-up pictures of K and L. 
Significant difference was analysed between control and tested treatment with same 
dsRNA dose by Mentel-Cox test with p<0.0001, ****. 
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(1) 
 
(2) 
Figure 3-22 Mortality of D. radicum larvae after injection of DrAPIN dsRNA. N=20 
Larvae were injected with varying doses of DrAPIN dsRNA as indicated (2); 
Phenotypes observed in this experiment are shown below (1): 
150ng Kan dsRNA (A) and DrAPIN dsRNA (B) injected into pre-pupal stage larvae. 
Misformed pupae were observed in DrAPIN dsRNA injected treatment (D) whereas 
healthy pupae injected with Kan dsRNA is shown in (C). Significant difference was 
analysed between control and tested treatment with same dsRNA dose by Mentel-Cox 
test with p<0.0001, ****. 
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Figure 3-23 Alignment of sequences from M. domestica and D. radicum APIN 
genes used in templates for dsRNA preparation. 
The sequences correspond to bases 1071 - 1343 of the sequences of MdAPIN mRNA, 
and bases 1081 - 1414 of the DrAPIN mRNA, given above. 
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Figure 3-24 Mortality of M. domestica larvae after injection of DrAPIN dsRNA. 
Larvae were injected with varying doses of MdAPIN dsRNA as indicated. Number of 
insects for each treatment n=20. Significant different was analysis by Mentel-Cox test 
between Kan 500ng and DrAPIN 500ng with P=0.0478, * 
 
 
 
Figure 3-25 Down-regulation of MdAPIN gene in M. domestica larvae injected with 
DrAPIN dsRNA. 3rd instar M. domestica larvae were injected with dsRNA as shown, 
and collected at times as shown after injection for estimation of transcript levels by 
qPCR. Error bars indicate standard errors of the mean for 3 technical replicates. 
Number of insects for each treatment n=5. Differences are significant in Kan150ng and 
DrAPIN150ng dsRNA treatment according to ANOVA with P=0.0040, **.  P=0.0024, ** 
in treatment between Kan500ng and DrAPIN500ng.  
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Figure 3-26 Mortality in M. domestica adults after injection of MdAPIN dsRNA. 
dsRNA was injected at two doses, as indicated. Number of insects for each treatment 
n= 20. No significant difference between treatemts (Mentel-Cox) test. 
  
 
 
Figure 3-27 Assay of APIN mRNA transcripts in M. domestica adults after 
injection of MdAPIN dsRNA. M. domestica adults were injected with dsRNA as 
shown, and collected at times as shown after injection for estimation of transcript levels 
by qPCR. Error bars indicate standard errors of the mean for 3 technical replicates. 
Number of insects for each treatment n=5. Difference is not significant analysed by 
ANOVA.  
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Figure 3-28 Survival of M. domestica larvae after feeding diet containing MdAPIN 
dsRNA. Number of insects for each treatment n=20. Difference is not significant 
analysed by ANOVA. 
 
 
 
Figure 3-29 Survival of M. domestica larvae after feeding diet containing bacteria 
expressing MdAPIN dsRNA. Number of insects for each treatment n=20. Difference 
is not significant analysed by ANOVA. 
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Figure 3-30 Assay of APIN mRNA transcripts in M. domestica larvae after feeding 
on diet containing MdAPIN dsRNA. M. domestica larvae were fed on diet containing 
dsRNA as shown, and collected at times as shown after transfer to diet for estimation 
of transcript levels by qPCR. Error bars indicate standard errors of the mean for 3 
technical replicates. Number of insects for each treatment n=5. No significant 
difference between treatemts (ANOVA test). 
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3.2.3 RNAi in A. pisum     
 
3.2.3.1 ApAPIN and ApVTE gene expression profile 
Expression profiles for the A. pisum target genes for RNAi, ApAPIN and ApVTE were 
analyzed over developmental stages by qPCR. Under insectary conditions, the life 
cycle of A. pisum, from neonate to maturity (onset of nymph production) took 10-11 
days. Newly born aphid nymphs were transferred to and reared on broad bean plants, 
collecting samples for qPCR at day 1, day 3, day 5, day 7 and day 9, for investigating 
gene expression profiles at different stages. The ApVTE gene was expressed 
throughout the whole life cycle (Figure 3-31), varying by about 2-fold relative to internal 
standard; expression was relatively low when aphids were about 7 and 9 days old. The 
ApAPIN gene (shown in Figure 3-32), was also expressed throughout the life cycle, 
and varied only about 2-fold relative to the internal standard; in this case expression 
was highest at day 7. 
 
3.2.3.2 Injection of dsRNA in A. pisum    
Injections of dsRNAs were carried out on 5 days old A. pisum, the earliest stage at 
which injection was feasible with the equipment available. Three different doses (7.5ng, 
15ng and 30ng) of ApVTE and ApAPIN dsRNA were tested. Aphids injected with 30ng 
Kan dsRNA was used as control treatment, and samples were collected at 24h, 48h 
and 72h after injection. 
  Results for ApVTE injection are shown in Figure 3-33. Although dsRNA 
injection consistently resulted in reduced levels of the target transcript after 24h and 
48h, the level of down-regulation was <2-fold relative to the Kan dsRNA injected 
control, and did not show a clear dose dependency on the amount of dsRNA injected. 
Injection of 30ng ApVTE dsRNA showed the most effective gene down-regulation 
against ApVTE gene at 24h post injection (Two-way ANOVA with p<0.0001), but not at 
48h post-injection. Results for samples collected 72h post-injection showed that the 
levels of ApVTE transcripts were not significantly different to the control treatment 
(ANOVA) The results show that RNAi effect induced by injection of ApVTE dsRNA is 
weak and transient in A. pisum.  
 Results for injection of ApAPIN dsRNA in A. pisum did not show any significant 
ApAPIN gene downregulation in any ApAPIN dsRNA treatment compared to control 
treatment (Figure 3-34). The results demonstrate that RNAi effect in A. pisum can be 
affected by the sequence of dsRNA. ApAPIN dsRNA failed to induce any measurable 
RNAi effect in A. pisum by injection whereas ApVTE dsRNA did cause VTE gene 
downregulation, although only by less than 2-fold.  
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 Although injection of ApVTE dsRNA had only a transient effect on gene 
expression, a phenotype was observed in treated aphids. Thirty nanograms ApVTE 
dsRNA was injected into 5 days old A. pisum, and survival was recorded for 7 days. 
Control aphids injected with water or Kan dsRNA showed a small decrease in survival 
(≤20%) over the first three days of the assay, However, aphids injected with 30ng 
ApVTE dsRNA showed 60% mortality over the first three days (Figure 3-35A). No 
further mortality was observed in either treatment or control after day 3. Differece is 
significant between control and 30ng ApVTE dsRNA treatment (Log-rank (Mantel-Cox) 
test with P=0.0299). By the end of the assay (corresponding to day 12 of the life cycle) 
3-5 nymphs per adult were produced from control treatments, whereas no nymphs 
were produced by surviving aphids from the ApVTE dsRNA injection treatment (Figure 
3-35 B). 
 
3.2.3.3 Oral feeding bioassays targeting ApVTE gene in A. pisum 
The artificial diet for aphids is a liquid containing sucrose, amino acids and vitamins, 
and is particularly well suited for feeding dsRNA. On the basis of injection assays, the 
ApVTE gene was selected as the target for a bioassay using orally delivered dsRNA. 
Neonate aphids were fed with artificial diet containing 7.5ng/µl and 100ng/µl ApVTE 
dsRNA for 48h, after which they were transferred to fresh diet containing no dsRNA to 
avoid any contamination. The bioassay was monitored for 12 days until nymphs were 
observed. No mortality was found in any treatment (data not shown), suggesting that 
aphid survival was unaffected. After feeding aphids for 10 days, the sizes of the aphids 
fed on ApVTE dsRNA and controls were measured to investigate whether growth was 
affected by the treatment. Aphid length and width were recorded and results are shown 
in Figure 3-36. The data show that aphids treated with ApVTE dsRNA at 100ng/µl 
(Figure 3-36A) showed significant reductions in both length (ANOVA, P<0.001) and 
width (approx. 20%, ANOVA, P<0.01) compared to controls of aphids fed Kan dsRNA. 
Compared to controls fed no dsRNA, the Kan dsRNA had only a marginal effect on 
size. The effect of dsRNA feeding on growth is shown in retardation of growth. The 
effect of the ApVTE dsRNA was dose-dependent; at 7.5 ng/µl, no significant effect on 
size compared to Kan dsRNA was observed, although both dsRNA treatments 
decreased size compared to a no dsRNA control (Figure 3-36 B). Growth has been 
significantly depressed by feeding 100ng/µl dsRNA. To show ApVTE gene down-
regulation by feeding ApVTE dsRNA, aphids were collected 24h and 48h after feeding 
on dsRNA-containing diets, and transcript levels were assessed by qPCR. 
Unexpectedly, ApVTE gene transcripts were not reduced significantly in aphids fed on 
ApVTE dsRNA (Figure 3-37). 
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Figure 3-31 ApVTE gene expression at different life stages of A. pisum. Columns 
show the levels of transcript relative to GADPH transcript (internal standard) as 
estimated by qPCR, normalised to ApVTE level in stage 1 = 1.0. Error bars indicate 
standard errors of the mean for 3 technical replicates. Number of insects for each 
treatment n=5.  
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Figure 3-32 ApAPIN gene expression at different life stages of A. pisum. Columns 
show the levels of transcript relative to GADPH transcript (internal standard) as 
estimated by qPCR, normalised to ApAPIN level in stage 1 = 1.0. Error bars indicate 
standard errors of the mean for 3 technical replicates. Number of insects for each 
treatment n=5.  
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Figure 3-33 ApVTE gene expression after injection of ApVTE dsRNA.  
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to ApVTE level in 24h control = 1.0. Error bars 
indicate standard errors of the mean for 3 technical replicates. Number of insects for 
each treatment n=5. Control Kan 30ng and ApVTE 30ng treatment show significant 
difference by ANOVA with P<0.0001, ****.  
 
 
Figure 3-34 ApAPIN gene expression after injection of ApAPIN dsRNA.  
Columns show the levels of transcript relative to GADPH transcript (internal standard) 
as estimated by qPCR, normalised to ApAPIN level in 24h control = 1.0. Error bars 
indicate standard errors of the mean for 3 technical replicates. Number of insects for 
each treatment n=5. Difference between treatments is not significant (ANOVA).  
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(A) 
 
 
(B) 
 
Figure 3-35 Phenotypes of A. pisum injected with 30ng ApVTE dsRNA. 
Panel A: Survival after injection of dsRNA as shown. Number of insects used for each 
treatment n=20. Difference between Kan 30ng and ApVTE 30ng treatment is significant 
by Log-rank (Mentel-Cox) test with P=0.0299, *. 
Panel B: Surviving aphids after 10 days; ApVTE dsRNA-fed (left dishes) and controls 
(right dishes). Surviving control aphids have produced nymphs. 
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A: A. pisum fed with 100ng/µl ApVTE dsRNA 
 
 
B: A. pisum fed with 7.5ng/µl ApVTE dsRNA 
 
Figure 3-36 Growth parameters (length and width at day 10) in aphids fed ApVTE 
dsRNA. Error bars indicate ±SE of mean.  Number of insects used for each treatment 
n=20.  Mean length in 100ng/µl ApVTE dsRNA fed aphids is significant different from 
control treatement (ANOVA, P<0.001, ***). Mean width in 100ng/µl ApVTE dsRNA fed 
aphids is significant different from control aphid (ANOVA, P<0.01, **).  
 
 
 
 
Le
ng
th
Wi
dth
0.0
0.5
1.0
1.5
2.0
m
ilim
ete
r ApVTE 7.5ng/μl
Kan 7.5ng/μl
Control
  
  
95 
 
 
Figure 3-37 ApVTE gene expression after feeding ApVTE dsRNA. Columns show 
the levels of transcript relative to GADPH transcript (internal standard) as estimated by 
qPCR, normalised to ApVTE level in 24h control = 1.0. Error bars indicate standard 
errors of the mean for 3 technical replicates. Number of insects for each treatment n=5. 
Difference between treatments is not significant (ANOVA).  
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3.3 Discussion 
RNAi experiments in T. castaneum, M. domestica, and D. radicum and A. pisum     
were conducted by both microinjection and feeding of dsRNA in order to demonstrate 
that they are differently susceptible to RNAi. V-ATPase is a membrane-bound protein 
that acts as a proton pump to establish the pH gradient within the gut lumen of many 
insects, and a previous study performed by Baum et al. (2007) demonstrated that 
silencing this gene prevents growth of Western corn rootworm larvae feeding on 
transgenic corn plants. Inhibitor of apoptosis (APIN or thread) gene is another target 
gene candidate tested. Downregulation of thread gene by RNAi has been 
demonstrated in Drosophila (Igaki et al. 2002) and mosquito Aedes aegypti (Rodriguez 
et al. 2002); down regulation in Drosophila cell cultures causes cell death by apoptosis. 
  
A successful RNAi response in insects relies on several parameters such as dsRNA 
length, concentration, sequence, gene target, tissue and different uptake mechanisms 
(Bellés 2010).  
In this work, dsRNAs against insect specific VTE and thread genes were designed to 
conform to a target length 277bp, which considered to be of sufficient length for dsRNA 
cell uptake, and to cover matching stretches of sequence in the homologous genes. 
Previous studies revealed that dsRNA between 50-100bp lengths is required for 
efficient systemic RNAi in C. elegans (Parrish et al. (2000); Winston et al. (2002)). In T. 
castaneum, injection of dsRNA against EGFP of 69bp was efficient in knocking down 
EGFP in transgenic T. castaneum larvae, but a 31bp fragment was not able to induce 
RNAi response (Miller et al. 2012),  The author concluded that the failure of activation 
of RNAi by the short fragment was due to failure of the dsRNA being taken up by the 
cells. This was shown by injecting 30bp dsRNA into T. castaneum embryos at the 
syncytial blastoderm stage, when embryogenesis cell membranes have not yet formed 
around the multiple nuclei and therefore the dsRNA can be injected directly into each 
cell. Under these conditions, the dsRNA around 30bp were capable of knocking down 
EGFP expression, as 89% of the hatched larvae showed no EGFP expression. A 
similar result in western corn rootworm was also reported by Bolognesi et al. (2012) 
who showed that at least 60bp dsRNA was required for an RNAi response in artificial 
diet bioassays. In this chapter, 50ng TcAPIN and TcVTE dsRNA (277bp) efficiently 
induced gene downregulation as well as causing significant mortality as a phenotype in 
larvae by injection and feeding (Figure 3-3, Figure 3-4, Figure 3-5 and Figure 3-6).  
Moreover, the TcVTE gene was proved to be downregulated by closely related 
Tribolium species T. confusum VTE dsRNA. Several stretches of ≥20 bases with 
sequence identity are present between T. castaneum and T. confusum VTE transcripts 
which suggest T. confusum siRNA with sufficient length complementary to T. 
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castaneum VTE gene was produced and induced a cross species RNAi effect (Figure 
3-7and Figure 3-8).  Injection of dsRNA at a lower dose was investigated, Tribolium 
larvae injected with 10ng TcAPIN dsRNA resulted in approx. 50% TcAPIN gene 
downregulation as early as 5h post injection. After 10 days, more efficient TcAPIN gene 
downregulation was detected which suggests a spreading systemic RNAi response in 
Tribolium (Figure 3-10). According to the studies investigated by Miller et al. (2012), 
injection of 7ng dsRNA (480bp length) led to 90% reduction in transcript levels whereas 
injection of 0.7ng caused 50% gene downregulation. Previous studies performed by 
Tomoyasu and Denell (2004) also showed that the injection of GFP transgenic T. 
castaneum  larvae with GFPdsRNA was able to inhibit GFP expression and inhibition 
continued through pupal and adult stages, and injected dsRNA was detected in entire 
bodies rather than being localized near the site of injection. Moreover, parental RNAi 
was also observed by Bucher et al. (2002), injection of dsRNA into mother’s 
haemolymph led to target gene knock down in offspring embryos. These results 
suggest that there could be an amplification step occurring like C. elegans through 
another mechanism due to the absence of RdRP or a efficient mechanism of take up 
and/ or store dsRNA.   
In terms of feeding, less than 1 week old T. castaneum exposed to diets containing 
dsRNA induced gene downregulation as well as mortality (Figure 3-11, Figure 3-12 and 
Figure 3-13). According to the result reported by Whyard et al. (2009), neonates 
exposed to diet containing 2.5ng TcVTE dsRNA/mg flour continuously for 7 days 
resulted in 50% mortality. Compared to the result reported by Whyard et al. (2009), 
much higher dsRNA concentrations (250ng/mg and 500ng/mg) were applied to T. 
castaneum  larvae in this work to achieve mortality. Instead of feeding dsRNA 
continuously to T. castaneum larvae for 7 days, diets containing higher concentrations 
of dsRNAs were prepared at the beginning of the assay without any changes during 
the assay. However, the result regarding the stability of dsRNA in T. castaneum diet 
reveals that only slightly degraded dsRNA were observed after 72h, and more obvious 
degradation was found after 120h (chapter 5).  A colleague from Newcastle University 
demonstrated that feeding T. castaneum with diet containing 50ng TcVTE dsRNA/mg 
diet induced detectable TcVTE gene downregulation but not mortality (Tempel Nakasu 
2014). According to the mortality assay (Figure 3-12), TcVTE dsRNA is more efficient 
in causing larval mortality in T. castaneum than TcAPIN dsRNA. This could due to the 
more abundant VTE transcript encoding a protein which is required for a fundamental 
biological process throughout the whole larvae at different developmental stages 
(Figure 3-1) whereas APIN transcripts are expressed at a high level when larvae 
approach pupation (Figure 3-2), being needed to prevent uncontrolled apoptosis 
associated with tissue remodelling.  
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In M. domestica and D. radicum, the APIN gene expresses at low levels throughout 
insect development as compared to the pre-pupal stage. APIN gene expression 
reached to the highest level during pre-pupa stage where significant gene 
downregulation was observed following injection of dsRNA. This data agrees well with 
the result from Drosophila (Chintapalli et al. 2007). Successful RNAi effects were 
achieved by microinjection of specific APIN dsRNA into M. domestica and D. radicum 
larvae (Figure 3-19 and Figure 3-20), which led to increased apoptotic activity. Injection 
bioassays revealed a dose-dependent pattern mortality for both M. domestica and D. 
radicum larvae (Figure 3-21, (2) and Figure 3-22, (2)) which indicated that the APIN 
gene is good candidate of using RNAi against dipteran insect pests. 
 
Cross injection of DrAPIN dsRNA into M. domestica larvae also resulted in significant 
MdAPIN gene downregulation which indicated that RNAi can be effective across 
closely related Dipteran species. However, when the two APIN gene sequences are 
aligned, no stretch of sequence identity of more than 20bp is found, although a stretch 
of >20bp has only a single base mismatch. Therefore, the RNAi effect in Dipterans 
appears to tolerate to small number of imperfect matches between siRNA and target 
gene sequence. However, the RNAi effect seems to be stage-dependent. In present 
work, M. domestica adult mortality and APIN gene expression was unaffected whether 
MdAPIN dsRNA was delivered via injection or feeding.   
 
In order to use RNAi as a potential method for crop protection, feeding dsRNA in 
artificial diet to larvae of M. domestica was investigated. Neither feeding purified 
dsRNA nor bacteria expressing dsRNA induced any RNAi response in M. domestica 
larvae (Figure 3-28 and Figure 3-29). Whyard et al. (2009) reported that soaking young 
stage larvae in Lipofectamine 2000 (Invitrogen) liposome-encapsulated long dsRNA for 
1h resulted in 50% reduction of β-glucuronidase (GUS) activity in larval gut of 
transgenic strain of D. melanogaster carrying a ubiquitously-expressed gus gene. They 
claimed that soaking newly hatched Drosophila larvae in gus-dsRNA for 1 hour without 
the aid of transfection reagents led to a ‘weak’ RNAi response, in which only 20% gene 
downregulation was detected. This may indicate that the transfection reagents could 
somehow protect ingested dsRNA from degradation in the very active Drosophila 
digestive system before its uptake into cells. Therefore, an efficient dsRNA delivery 
method will need to be optimised to apply RNAi as a strategy of crop protection. 
 
Compared to beetles and flies, the A. pisum exhibited a limited RNAi response. Weak 
endogenous gene downregulation (50%) can be only achieved by injection of ApVTE 
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dsRNA at high amount (30ng/nymph which equivalent to 42ng/mg insect) shown in 
Figure 3-33. In terms of the weight of injected insects, 10ng dsRNAs induces significant 
gene downregulation by injection into pre-pupa stage T. castaneum larvae weighing 
3.1mg (3 ng/mg insect), injection of 125ng dsRNA also induced downregulation M. 
domestica and D. radicum larvae which weigh 18mg and 16.7mg, respectively (6.9 and 
7.5 ng/mg insect). However, injection of 30ng dsRNA in 5 days old A. pisum that 
weighed 0.7mg can only induce weak gene downregulation. Moreover, ApVTE gene 
downregulation was transient, only lasting for 48h. ApVTE recovered to the level 
comparable to control treatment at 72h post injection. Injection of ApAPIN dsRNA failed 
to provoke any response in A. pisum which could indicate that the RNAi response in A. 
pisum may be gene-dependent. Actually, previous results regarding RNAi in aphids are 
various. Whyard et al. (2009) reported that 50% aphid mortality was achieved by 
feeding ApVTE dsRNA. However, when the same experiment was repeated by 
Christiaens et al. (2014) the later paper reported a negative result, namely that feeding 
ApVTE dsRNA to aphids failed to cause mortality. In this work, aphid fitness 
parameters (width and length) were affected by feeding 100ng/µl ApVTE dsRNA 
(Figure 3-36). Therefore, future work could perform feeding ApVTE dsRNA 
continuously to A. pisum to observe effects on fitness and reproduction.  
 
Studies investigating RNAi in aphid by delivery of dsRNA via transgenic plants, but not 
via artificial diet or microinjection, achieved more promising results. In 2012, Mao and 
Zeng developed dsRNA against A. pisum hunchback (Aphb) gene where its loss-of-
function resulted in segmentation defects in the next generation. Aphb gene was 
reported to be significantly downregulated, leading to aphid lethality by continuous 
feeding of Aphp dsRNA (Mao and Zeng 2012). Another study regarding green peach 
aphid (Myzus persicae) by Pitino et al. (2011) demonstrated that up to 60% MpC002 
(expressed in salivary glands) and Rack-1 (expressed in gut) gene expression can be 
downregulated by feeding on transgenic plants which continuously express dsRNAs. 
As a result, silenced peach aphids showed reduced fecundity.  
 
 
 
 
 
 
 
 
  
  
100 
Chapter 4 Production of recombinant protein containing 
dsRNA-binding domain in E. coli and P. pastoris 
 
4.1  Introduction  
RNA interference (RNAi) is the mechanism of downregulation of expression of specific 
genes through introducing double-stranded RNA, which has been widely used for 
investigating gene function in insects, particularly in the model insect Drosophila 
melanogaster (Kennerdell and Carthew (1998); Kennerdell and Carthew 
(2000);Misquitta and Paterson (1999)). In C. elegans, a systemic RNAi effect can be 
introduced by feeding bacteria expressing dsRNA (Timmons and Fire (1998); Timmons 
et al. (2001)) or by soaking nematodes in dsRNA solution (Tabara et al. 1998). 
However, due to the lack of genes encoding RNA-dependent RNA polymerase (RdRP), 
the enzyme involved in RNA amplification which produces systemic RNAi effects, most 
RNAi effects in insects have relied on microinjection of nanogram amounts of 
synthesised dsRNA into insect haemolymph. The absence of RdRP in insects means 
that the RNAi effect may be limited to the cells that are exposed to dsRNA; input of 
dsRNA into haemolymph is required to allow it to access cells throughout the insect. 
Previous research has identified that different insect species show variable sensitivity 
to RNAi and some species are totally insensitive (Bellés (2010); Terenius et al. (2011)). 
For achieving a successful RNAi effect by microinjection in insects, dsRNA must 
remain in a non-degraded state for a sufficient period to allow dsRNA to be taken up by 
insect cells. Rapid degradation of dsRNA by ribonucleases in the haemolymph could 
result in failure of uptake and intracellular processing of dsRNA, and lead to absence of 
an RNAi effect as a consequence. In terms of crop protection, producing an RNAi 
effect by microinjection of dsRNA is not possible in the field. In order to achieve RNAi 
effects in insects by feeding, the insect gut is the first barrier for dsRNA to survive; 
degradation of dsRNA in the gut will prevent intact dsRNA reaching any insect cells.  
 
To address potential problems of dsRNA stability in insect haemolymph and gut 
lumen, the experiments in this chapter describe the development of a dsRNA-fusion 
protein delivery system. A double-stranded RNA binding protein, the third dsRNA-
binding domain (DRBD3) from Drosophila staufen, was selected to conjugate dsRNA 
forming a protein-RNA complex that could improve the stability of dsRNA and protect it 
from degradation from insect haemolymph and gut lumen. To achieve sufficient RNAi 
effect through feeding, dsRNA must be transported from gut lumen into cells as an 
intact molecule. The snowdrop lectin, GNA, is known to act as a molecular carrier 
which is transported across the insect gut, from the lumen to the haemolymph, and has 
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been shown to co-transport other proteins, such as spider toxins (Fithes et al., 2004), 
when produced as a recombinant fusion protein. GNA fused with DRBD3, was 
developed as a recombinant protein to improve dsRNA delivery in insects, and to 
produce ‘systemic’ RNAi effect by transporting of the complex to the insect 
haemolymph.  
 
The dsRNA binding protein (DRBP) staufen was first identified in Drosophila. It 
is a 1026 amino acid protein which is important for maturation and localization of 
maternal mRNAs (St Johnston et al. 1991). It was the first protein to be identified as a 
determinant of cell polarity. It is reported to anchor bicoid mRNA at the anterior of the 
Drosophila oocyte and oskar mRNA to the posterior of the oocyte (Johnston et al. 1989) 
at different development stages. After fertilization, a concentration gradient of bicoid 
protein is produced by the translation of bicoid mRNA at different locations within the 
oocyte; the gradient defines the anterior pattern of the embryo. The staufen gene 
product is found to be involved in the last stage of bicoid RNA localization when the 
RNA moves from the anterior cortex into the cytoplasm in oocytes (Johnston et al. 
1989). After the eggs have been laid, bicoid mRNA is anchored by the staufen product 
to the anterior pole of the egg to determine the anterior position (Johnston et al. (1989); 
Ferrandon et al. (1994)). Bicoid mRNA encodes a homeodomain protein which forms a 
morphogen gradient that specifies the head and thorax (Driever et al. 1990). Posterior 
polarity is defined by accumulation of the product of the oskar gene which define the 
place of formation of the pole plasm that contains a germline and posterior determinant 
encoded by nanos mRNA, important for abdomen development (Ephrussi et al. (1991); 
Kim-Ha et al. (1991)). Also, staufen plays an important role during the asymmetric 
divisions of Drosophila embryonic neuroblasts and their daughter cells, ganglion 
mother cells (GMCs). In these cells, it associates with prospero mRNA but not 
prospero protein. Failure of localization of staufen or of pros RNA results in changes of 
GMC development in embryos (Broadus et al. 1998). Regions of the 3’UTRs of bicoid, 
oskar and prospero form long stem-loop structures with extensive dsRNA regions, that 
are necessary for interact with staufen (Kim-Ha et al. 1993). However, how staufen 
recognizes these transcripts is still unclear. 
 
Staufen protein has four or five conserved dsRNA binding domains (DRBDs) of 
65-70 amino acids depending on the species, and folds into an αβββα structure 
(Bycroft et al. 1995). For Drosophila staufen, DRBD1, 3 and 4 have been shown to bind 
to dsRNA in vitro (St Johnston et al. (1992); Micklem et al. (2000)).  Due to the 
presence of a conserved proline-rich insertion that separates DRBD2 into half, DRBD2 
does not show dsRNA binding activity. DRBD2 dsRNA binding activity is shown to be 
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recovered by removing this insertion (Micklem et al. 2000). DRDB5 is less conserved 
and no dsRNA binding activity is reported. Although DRBD2 and DRBD5 are not 
involved with dsRNA binding, DRBD2 and DRBD5 are required for localization and 
interaction with oskar, bicoid and prospero mRNAs (Micklem et al. 2000). Previous 
researches have shown that DRBDs bind to dsRNA, but not to single-stranded RNA or 
DNA, dsDNA (St Johnston et al. (1992); Bass et al. (1994); Clarke and Mathews (1995); 
Bevilacqua and Cech (1996)). It is interesting that DRBDs do not recognize nucleotide 
sequences and do not contact bases directly, but instead contact through 2’-OH groups 
in the ribose sugars and the phosphate backbone of RNA. The optimal binding is found 
with dsRNA stem loops of 12 uninterrupted base pairs or longer (Ramos et al. 2000). 
Introduction of unpaired bases in the helical structure of dsRNA reduces the binding 
with DRBD3(Ramos et al. 2000). DRBDs specifically bind the A-form double helix of 
dsRNA in which the minor groove is less deep and wider than the minor groove in the 
B-form double stranded nucleic acid structure adopted by DNA. Ramos et al. identified 
three regions of the DRBD3 from Drosophila staufen that are important for dsRNA 
binding, which are helix α1, loop 2 and loop 4. Mutations of amino acids in each of 
these regions either abolish or reduce RNA binding activity, whereas dsRNA binding 
activity was not affected by the mutation of surface residues in other regions. The 
amino acid sequences in these regions which were identified as necessary for dsRNA 
binding are strongly conserved from Drosophila staufen to staufen in humans (Ramos 
et al. 2000). DRBD3 plays a further role in RNA binding, in that helix α1 of DRBD3 is 
found to interact with the single-stranded loop in a stem-loop RNA structure. 
 
In this chapter, recombinant fusion proteins containing DRBD3, Trx/RBD3 and 
Trx/RBD3/GNA were constructed and expressed in E. coli using a pET32 expression 
vector. RBD3 and RBD3/GNA were also expressed in P. pastoris. Transport of 
Trx/RBD3 and RBD3/GNA across the insect gut was demonstrated by western blotting.  
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4.2 Results 
 
4.2.1 Expression of recombinant RNA binding proteins using E. coli as 
expression host 
 
4.2.1.1 Preparation of expression constructs 
Sequences encoding the RNA binding domains RBD1 and RBD3 from the Drosophila 
melanogaster staufen gene (Figure 4-1), containing codon optimisation for expression 
in yeast, were synthesised by a commercial supplier Shinegene (sequences shown in 
Figure 4-2). The sequences were transferred into the expression vector pET32, so that 
the resulting construct directed expression of a fusion protein containing thioredoxin 
(Trx), fused N-terminally to the RNA binding domain, with a (His)6 tag fused C-
terminally to the RBD,  The amino acid sequences are shown in Figure 4-3. These 
proteins were designated Trx/RBD1 and Trx/RBD3. 
 Further constructs were also prepared which contained the coding sequence for 
snowdrop lectin, GNA, fused C-terminally to the RBD1 or RBD3 RNA-binding domain. 
These constructs also contained a C-terminal (His)6 tag. The predicted sizes of the 
Trx/RBD and Trx/RBD/GNA fusion proteins are 24 and 35kDa, respectively. A typical 
construct is illustrated (Figure 4-4), and the predicted sequences of the coding regions 
of the constructs are shown in Figure 4-5. These proteins were designated 
Trx/RBD1/GNA and Trx/RBD3/GNA. 
 Recombinant DNA cloning was carried out in an E. coli cloning host. All 
constructs were verified by DNA sequencing.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
104 
 
Dmstau 
MQHNVHAARPAPHIRAAHHHSHSHAHMHLHPGMEQHLGPSLQQQQQPPPPPQQPPHRDLHARLNHHHLHAQQQQQQQTSSNQAGAVAA
AGAAYHHGNINSNSGSNISSNSNQMQKIRQQHQHLSSSNGLLGNQPPGPPPQAFNPLAGNPAALAYNQLPPHPPHHMAAHLGSYAAPP
PHYYMSQAKPAKYNHYGSNANSNSGSNNSNSNYAPKAILQNTYRNQKVVVPPVVQEVTPVPEPPVTTNNATTNSTSNSTVIASEPVTQ
EDTSQKPETRQEPASADDHVSTGNIDATGALSNEDTSSSGRGGKDKTPMCLVNELARYNKITHQYRLTEERGPAHCKTFTVTLMLGDE
EYSADGFKIKKAQHLAASKAIEETMYKHPPPKIRRSEEGGPMRTHITPTVELNALAMKLGQRTFYLLDPTQIPPTDSIVPPEFAGGHL
LTAPGPGMPQPPPPPAYALRQRLGNGFVPIPSQPMHPHFFHGPGQRPFPPKFPSRFALPPPLGAHVHHGPNGPFPSVPTPPSKITLFV
GKQKFVGIGRTLQQAKHDAAARALQVLKTQAISASEEALEDSMDEGDKKSPISQVHEIGIKRNMTVHFKVLREEGPAHMKNFITACIV
GSIVTEGEGNGKKVSKKRAAEKMLVELQKLPPLTPTKQTPLKRIKVKTPGKSGAAAREGSVVSGTDGPTQTGKPERRKRLNPPKDKLI
DMDDADNPITKLIQLQQTRKEKEPIFELIAKNGNETARRREFVMEVSASGSTARGTGNSKKLAKRNAAQALFELLEAVQVTPTNETQS
SEECSTSATMSAVTAPAVEATAEGKVPMVATPVGPMPGILILRQNKKPAKKRDQIVIVKSNVESKEEEANKEVAVAAEENSNNSANSG
DSSNSSSGDSQATEAASESALNTSTGSNTSGVSSNSSNVGANTDGNNHAESKNNTESSSNSTSNTQSAGVHMKEQLLYLSKLLDFEVN
FSDYPKGNHNEFLTIVTLSTHPPQICHGVGKSSEESQNDAASNALKILSKLGLNNAMK 
 
Figure 4-1 Schematic diagram and amino acid sequence of the product of the 
Drosophila melanogaster staufen gene showing the 5 RNA-binding domains 
(coloured regions). The staufen gene from Drosophila melanogaster encodes a 
protein which is involved in polarity determination during embryo development. It 
contains five similar copies of a domain which potentially binds dsRNA. RNA binding is 
specific for dsRNA, but is not sequence-specific. 
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RBD1 (73 residues, 219bp) 
 
K   D   K   T   P   M   C   L   V   N   E   L   A   R      
AAG GAT AAG ACT CCA ATG TGT TTG GTT AAC GAA TTG GCT AGA  
 Y   N   K   I   T   H   Q   Y   R   L   T   E   E   R    
TAC AAC AAG ATT ACT CAT CAA TAC AGA TTG ACT GAA GAA AGA 
 G   P   A   H   C   K   T   F   T   V   T   L   M   L    
GGT CCA GCT CAT TGT AAG ACT TTT ACT GTT ACT TTG ATG TTG  
 G   D   E   E   Y   S   A   D   G   F   K   I   K   K    
GGT GAT GAA GAA TAC TCT GCT GAT GGT TTT AAG ATT AAG AAG  
 A   Q   H   L   A   A   S   K   A   I   E   E   T   M    
GCT CAA CAT TTG GCT GCT TCT AAG GCT ATT GAA GAA ACT ATG 
 Y   K   H 
TAC AAG CAT 
 
RBD3 (73 residues, 219bp) 
 
D   K   K   S   P   I   S   Q   V   H   E   I   G   I    
GAT AAG AAG TCT CCA ATT TCT CAA GTT CAT GAA ATT GGT ATT 
 K   R   Q   M   T   V   H   F   K   V   L   R   E   E    
AAG AGA CAA ATG ACT GTT CAT TTT AAG GTT TTG AGA GAA GAA 
 G   P   A   H   M   K   N   F   I   T   A   C   I   V    
GGT CCA GCT CAT ATG AAG AAG TTT ATT ACT GCT TGT ATT GTT 
 G   S   I   V   T   E   G   E   G   N   G   K   K   V    
GGT TCT ATT GTT ACT GAA GGT GAA GGT AAG GGT AAG AAG GTT 
 S   K   K   R   A   A   E   K   M   L   V   E   L   Q  
TCT AAG AAG AGA GCT GCT GAA AAG ATG TTG GTT GAA TTG CAA 
 K   L   P 
AAG TTG CCA 
 
Figure 4-2 Nucleotide and derived amino acid sequences of synthetic RBD1 and 
RBD3. Highlighting indicates modification of original AAC (N) to CAA(Q) (highlighted in 
blue) to remove a potential N-linked glycosylation site for RBD3. 
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MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAK
LNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKAMADIGSKDKT
PMCLVNELARYNKITHQYRLTEERGPAHCKTFTVTLMLGDEEYSADGFKIKKAQHLA
ASKAIEETMYKHKLAAALEHHHHHH 
Thioredoxin  Enterokinase site RNA Binding Domain 1 His(6) tag 
(A)Amino acid sequence for expression construct for Trx/RBD1 in E.coli BL21(DE3) 
 
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAK
LNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKAMADIGSDKKS
PISQVHEIGIKRQMTVHFKVLREEGPAHMKNFITACIVGSIVTEGEGNGKKVSKKRAA
EKMLVELQKLPKLAAALEHHHHHH 
Thioredoxin  Enterokinase site RNA Binding Domain 3  His(6) tag 
(B)Amino acid sequence for expression construct for Trx/RBD3 in E. coli BL21(DE3) 
 
Figure 4-3 Amino acid sequences for predicted products of Trx/RBD expression 
constructs 
 
 
 
 
 
Figure 4-4 Schematic diagram of an expression construct for a typical fusion 
protein, Trx/RBD3/GNA in pET32.  
The RBD1 coding sequence was cloned C-terminal to the thioredoxin sequence, (His)6 
tag and enterokinase cleavage site, between BamHI and NotI restriction sites. The 
GNA coding sequence was inserted between Not I and Xho I sites, C-terminal to the 
RBD1 coding sequence. A further (His)6 tag is present C-terminal to the GNA sequence. 
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MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAK
LNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKAMADIGSKDKT
PMCLVNELARYNKITHQYRLTEERGPAHCKTFTVTLMLGDEEYSADGFKIKKAQHLA
ASKAIEETMYKHKLAAADNILYSGETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIW
ATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY
GTDRWATGLEHHHHHH 
Thioredoxin Enterokinase site RNA Binding Domain 1 GNA His(6) tag 
(A) Amino acid sequence for expression construct for Trx/RBD1/GNA in E.coli 
BL21(DE3) 
 
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAK
LNIDQNPGTAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
MHHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKAMADIGSDKKS
PISQVHEIGIKRQMTVHFKVLREEGPAHMKNFITACIVGSIVTEGEGKGKKVSKKRAA
EKMLVELQKLPKLAAADNILYSGETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIW
ATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY
GTDRWATGLEHHHHHH 
(B) Amino acid sequence for expression construct for Trx/RBD3/GNA in E.coli 
BL21(DE3) 
Thioredoxin  Enterokinase site RNA Binding Domain 3 GNA His(6) tag 
 
Figure 4-5 Amino acid sequence for expression construct for Trx/RBD/GNA in E. 
coli BL21 (DE3). 
Coding sequences for RNA binding domain 1 and 3 containing 73 amino acid residues 
are inserted into the MCS of the expression vector pET32a, between BamHI and NotI 
restriction enzyme sites. GNA is introduced by restriction enzyme NotI and Xhol C-
terminal to the RBD coding sequences. Trx, the fusion protein tag containing 109 
amino acid residues precedes RBD with six His residues in between the fusion for 
detection of fusion protein and purification using metal affinity chromatography. 
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4.2.1.2 Expression of RNA binding proteins in PET32 vector in E. coli  
Selected clones of expression constructs for RNA binding proteins were transferred to 
E. coli BL21 DE3 as expression host. Bacterial clones were grown to late logarithmic 
phase and expression was induced by adding IPTG. Soluble and insoluble protein 
fractions from uninduced and induced cultures were analysed by SDS-PAGE, the 
uninduced samples being used as controls (Figure 4-6. A). Bands of the predicted size 
for Trx/RBD1 and Trx/RBD/GNA fusion proteins (27kDa and 35kDa, respectively) were 
produced as the major components of the insoluble protein fractions from induced 
bacteria, but were not present in uninduced bacteria. Although the soluble protein 
fractions from induced bacteria contained more protein than those from uninduced 
bacteria, there were no apparent difference in the band patterns, suggesting that little, 
if any, of the recombinant protein produced as a result of induction was soluble. These 
initial experiments suggested that most, or all of the recombinant proteins produced in 
this expression system were insoluble, although proteins were being produced in large 
amounts, estimated as 100-150 mg/l of E. coli culture. Analysis of protein fractions by 
western blotting using anti-(His)6 tag antibodies confirmed the identity of the bands 
identified as representing Trx/RBD and Trx/RBD/GNA fusion proteins; representative 
results are shown in Figure 4-6 (B) for Trx/RBD1. The band detected by the antibodies 
is of the correct predicted size. This blot shows that small amounts of insoluble protein 
are produced in uninduced cultures (presumably as a result of "leaky" expression from 
the tac promoter in pET32a) and that after induction some soluble fusion protein is 
actually present, even though it is not visible on a stained gel. However, it confirms that 
most of the recombinant protein is produced as an insoluble fraction after induction. 
 
In order to determine whether soluble recombinant protein could be produced in the E. 
coli expression system, conditions for induction of expression were manipulated to 
attempt to enhance protein folding. Initial experiments showed no benefit from 
expression at lower temperature, 25°C compared to 30°C, for either Trx/RBD or 
Trx/RBD/GNA proteins (Figure 4-7 and Figure 4-8). Most, if not all the recombinant 
proteins were still present in the insoluble protein fractions after induction. Using 
different concentrations of IPTG in the inducing medium also had little effect on the 
solubility of the resulting proteins (Figure 4-9), with no increase in recombinant protein 
in the soluble fraction being observed.  
 
Decreasing the temperature for inducing expression of the recombinant proteins to 
15°C proved successful in enabling expression of soluble or partially soluble fusion 
proteins. Results for Trx/RBD3 fusion protein are shown in Figure 4-10. When induced 
at 15°C, this recombinant protein is wholly present in the soluble protein fraction. The 
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expression levels of soluble fusion proteins from Trx/RBD1, Trx/RBD1/GNA and 
Trx/RBD3/GNA cultures induced at 15°C were approximately 25mg/L. 
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(A) 
Figure 4-6 (A) Expression of recombinant thioredoxin-RNA binding domain fusion 
proteins in E. coli BL21 (DE3) at 15°C. SDS-PAGE gel stained with Coomassie 
Blue. 
Lanes 1 and 2 show Trx/RBD1 uninduced soluble (S) and insoluble fractions (IS). 
Lanes 3 and 4 show Trx/RBD1 induced soluble (IS) and insoluble fractions (II). 
Trx/RBD1 shows a fusion protein of approx. 27kDa. Lanes 5 and 6 show 
Trx/RBD1/GNA uninduced soluble and insoluble fractions.  Lanes 7 and 8 show 
Trx/RBD1/GNA induced soluble and insoluble fractions. Trx/RBD1/GNA shows a fusion 
protein of approx. 35kDa. Lanes 9 and 10 show Trx/RBD3/GNA uninduced soluble and 
insoluble fractions. Lanes 11 and 12 show Trx/RBD3/GNA induced soluble and 
insoluble fractions. Trx/RBD3/GNA shows a fusion protein of approx. 35kDa. Lane 13 
shows a 12kDa band of GNA (1µg; as a standard). Lane M represents a molecular 
weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 kDa. 1µl from each fraction 
was loaded on SDS-PAGE. 
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  (B) 
Figure 4-6 (B) Confirmation of Trx/RBD1 recombinant protein expression by 
western blotting. 
Western blotting result shows Uninduced soluble fraction (US) of Trx/RBD1 in lane 1, 
Lane 2 shows Uninduced insoluble fraction (UI), lane 3 shows Induced soluble fraction 
(IS) and Lane 4 shows Induced insoluble fraction (II). Lane M represents a molecular 
weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 kDa. 
  
 
 
Figure 4-7 Expression of induced recombinant Trx-RBD1 fusion protein at 25°C 
and 30°C. SDS-PAGE gel stained with Coomassie Blue 
Lane 1 shows 3µl Trx/RBD1 from uninduced soluble fractions. Lane 2 and 3 shows 2µl 
and 4µl Trx/RBD1 induced soluble fractions at 25°C. 2µl and 4µl Trx/RBD1 (27kDa) 
induced insoluble fractions at 25°C are shown in lanes 4 and 5. Lanes 6 and 7 shows 
2µg and 4µg 12kDa band of GNA as standards. Lanes 8 and 9 shows 2µl and 4µl 
Trx/RBD1 induced soluble fractions at 30°C whereas 2µl and 4µl Trx/RBD1 from 
induced insoluble fractions at 30°C are shown in lanes 10 and 11. Lane M represents a 
molecular weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 kDa. 
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Figure 4-8 Expression of induced recombinant Trx/RBD/GNA fusion protein at 
25°C. SDS-PAGE gel stained with Coomassie Blue. 
Induced soluble and insoluble fractions of Trx/RBD1/GNA are shown in lane 1 and 2. 
Trx/RBD3/GNA induced soluble and insoluble fractions are shown in lane 3 and 4.   
Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are shown in lane 5, 6 
and 7. One microliter from each fractions were loaded on SDS-PAGE. Lane M 
represents a molecular weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 kDa. 
 
 
 
Figure 4-9 Analysis of expression of recombinant Trx/RBD3/GNA protein in E. coli 
induced by 1mM, 2mM and 2.5mM IPTG by SDS-PAGE. 
Soluble and insoluble fractions from uninduced Trx/RBD3/GNA cell culture are shown 
in lane 1 and 2. Soluble and insoluble fractions from Trx/RBD3/GNA cell cultures 
induced at final concentrations of IPTG at 1mM, 2mM and 2.5mM are shown in lanes 
Lanes 3,4; 5,6; 7,8: Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are 
shown in lane 9-11. One microliter from each fraction was loaded on SDS-PAGE. Lane 
M represents a molecular weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 
kDa. 
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Figure 4-10 Analysis of expression of Trx/RBD3 protein in E. coli at 15°C by SDS-
PAGE 
Soluble and insoluble fractions from uninduced Trx/RBD3 cell cultures are shown in 
lanes 1 and 2. Soluble and insoluble fractions from induced Trx/RBD3 cell cultures are 
shown in lane 3 and 4. Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) 
are shown in lane 5-7. The band identified as Trx/RBD3 protein (approx. 27kDa) is 
indicated by an arrow. One microliter from each fraction was loaded on SDS-PAGE. 
Lane M represents a molecular weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 
14.4 kDa.  
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4.2.2 Purification of Trx/RBD and Trx/RBD/GNA fusion proteins expressed in E. 
coli 
The purification of recombinant proteins exploited the (His)6 tag incorporated into the 
pET32 vector-encoded sequence, and the C-terminal (His)6 tag added to the fusion 
proteins containing GNA. Conditions for elution of the proteins were checked using 
"empty" vector which expressed the tagged Trx protein only. Cells were pelleted after 
induction of the protein, and a soluble protein fraction was prepared and subjected to 
metal affinity chromatography. Results are shown in Figure 4-11. The Trx recombinant 
protein bound tightly to a nickel affinity column, and could be eluted by including with 
200mM imidazole in the column buffer, with only small additional amounts eluting at 
400mM imidazole. Very little recombinant protein eluted at 25mM imidazole, which 
therefore made a good wash solution to remove non-specifically bound E. coli proteins. 
Approximately 7mg thioredoxin was purified from a 50ml induced cell culture, and the 
eluted protein can be estimated as at least 90% pure, based on staining of the 20kDa 
thioredoxin band compared to other bands in the fraction eluted at 200mM imidazole. 
These conditions were used as a basis for purifying recombinant fusion proteins. 
 
Purification of Trx/RBD3 from the soluble protein fraction of an E. coli culture containing 
the appropriate expression construct is shown in Figure 4-12. The culture was induced 
at 15°C overnight. Soluble proteins extracted from the cell pellet were loaded onto a 
nickel affinity column, which was washed successively with binding buffer, and buffer 
containing 25mM, 200mM and 400mM imidazole. Trx/RBD3 bound more tightly to the 
column than Trx alone, and was not eluted in 200mM imidazole (tracks 3 and 4); 
washing with 400mM imidazole was necessary to elute the fusion protein. The eluted 
Trx/RBD3 gave a major band of  30kDa on SDS-PAGE (tracks 5 and 6) with minimal 
amounts of contaminating proteins indicated by minor bands on the gel. Approximately 
3.5mg Trx/RBD3 fusion protein was purified from 50ml cell culture pellet. 
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Figure 4-11 Expression and purification of thioredoxin from transformed empty 
pET32 vector. 
Binding buffer wash fraction (10µl) is shown in lane 1. Thioredoxin washed fraction and 
peak drop in volume of 10µl with 25mM imidazole in 1XBB are shown in lane 2 and 4, 
whereas 10µl eluted fraction and peak drop with 200mM imidazole in 1XBB are shown 
in lane 6 and 7. Lane 8 shows 1µl induced insoluble thioredoxin fraction. Twelve-
kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are shown from lane 9-11. 
Induced soluble thioredoxin (5µl) shows protein at 20kDa as indicated by arrow in lane 
12. Lane M represents a molecular weight marker (SDS7)  = 116, 66.2, 45, 35, 25, 
18.4, 14.4 kDa. 
                                                   
 
 
Figure 4-12 Purification of Trx/RBD3 from soluble protein fraction of E. coli cell 
cultures. 
Wash fraction and peak drop eluted with 25mM imidazole are shown in lane 1 and 2.  
Elution fraction and peak drop from elution with 200mM imidazole are shown in lane 3 
and 4, elution with 400mM imidazole are shown in lane 5 and 6. Eluted Trx/RBD3 
shows protein at 27kDa as indicated by arrow in lane 5 and 6. Ten microliter from all 
fractions was loaded on SDS-PAGE. Lane M represents a molecular weight marker 
(SDS7)  = 116, 66.2, 45, 35, 25, 18.4, 14.4 kDa. 
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Purification of the Trx/RBD/GNA fusion proteins from soluble protein fractions from E. 
coli cells containing appropriate expression constructs induced at 15°C overnight did 
not yield similarly successful results. Although some fusion protein was recovered, 
the eluted proteins were obtained in poor yield and with much lower levels of purity. 
Results are summarised in Figure 4-13 (A), which shows an analysis of fractions from 
the purifications of Trx/RBD/GNA proteins by SDS-PAGE.  
The Trx/RBD/GNA fusion proteins appeared to bind relatively poorly to the nickel 
affinity column, as shown by the presence of a band of approx. 35kDa in the 10mM 
imidazole wash fractions (lanes 2, 3, 7, 8). When bound proteins were subsequently 
eluted in buffer containing 400mM imidazole, a band corresponding to 
Trx/RBD1/GNA was only present in low amount as a minor component in the eluted 
fraction and peak drop (lanes 4, 5). A band corresponding to Trx/RBD3/GNA was the 
major component in the eluted fraction and peak drop (lanes 9, 10) but was still only 
obtained in low yield. Analysis of the fractions by western blotting (Figure 4-13 B) 
showed that the fusion protein was eluted in 400mM imidazole, and that no 
immunoreactivity was observed in fractions from the 10mM imidazole wash, 
suggesting that the 35kDa band observed at lower imidazole concentrations 
represents a contaminating E. coli protein. 
Attempts to purify fusion proteins by exploiting denaturing conditions are discussed in 
a later section (4.2.10).  
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(A) 
  (B) 
Figure 4-13 Purification of induced soluble recombinant Trx/RBD1/GNA and 
Trx/RBD3/GNA fusion protein in E. coli BL21 (DE3). SDS-PAGE gel stained with 
Coomassie Blue. 
(A): Induced soluble fractions of Trx/RBD1/GNA and Trx/RBD3/GNA culture 
supernatant are shown in lanes 1 and 6, respectively. Trx/RBD1/GNA and 
Trx/RBD3/GNA fractions washed with 10mM Imidazole are shown in lanes 2 and 7, 
and peak drops are shown in lanes 3 and 8. Lanes 4 and 9 shows Trx/RBD1/GNA and 
Trx/RBD3/GNA eluted fractions with 400mM Imidazole, and peak drops are in lanes 5 
and 10. The Trx/RBD/GNA fusion protein band at approx. 35kDa is indicated by an 
arrow. Ten microliter of all fractions were loaded. Lane M represents a molecular 
weight marker (SDS7). 
(B): Identification of recombinant fusion proteins by Western blotting 
Fractions from the purification of Trx/RBD3/GNA were probed with anti-(His)6 
antibodies. Ten microlitre samples were loaded. Lane 1 shows flow-through fraction 
from metal affinity column. Lane 2 shows fraction washed with 1XBB. Lanes 3 and 4 
shows wash fraction containing 10mM imidazole. Lanes 5 and 6 show eluted fraction 
and peak drop containing 400mM imidazole. Soluble protein fraction from E. coli 
expressing Trx/RBD3/GNA after induction is shown in lane 7.  
 
Trx/RBD1/GNA Trx/RBD3/GNA 
116 
66.5 
45 
35 
25 
18.4 
14.4 
Mr, kDa 
M 1 2 3 4 10 5 6 7 8 9 
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4.2.3 Downstream processing of purified recombinant proteins 
The purified recombinant proteins were eluted from the metal affinity column in buffer 
containing 200mM-400mM imidazole, which must be removed as it is toxic to insects 
and would interfere with use of the fusion proteins in making protein-RNA complexes. 
 
In an initial experiment, the peak of Trx/RBD3/GNA protein eluted in 400mM imidazole 
was dialysed againt sodium phosphate buffer containing 10% glycerol and 0.15M NaCl. 
A precipitate was formed on dialysis, and after several changes of buffer, the 
supernatant and pellet were seperated by centrifugation and analysed by SDS-PAGE. 
Results are shown in Figure 4-14. No Trx/RBD3/GNA fusion protein remained in the 
supernatant (lane 4), indicating that all the fusion protein had precipitated out on 
removal of imidazole. The insoluble protein cannot show biological activity and is 
useless for further applications. 
 
To investigate conditions for downstream processing which could retain biological 
activity in the fusion proteins, thioredoxin expressed from "empty" pET32a vector was 
again used as a model system. This protein was processed by passage through a PD-
10 desalting column that had been pre-equilibrated in deionised water; results are 
shown in Figure 4-15. The eluted peak of protein remained soluble (lanes 1-5). It was 
collected, flash-frozen and lyophilised; the resulting protein powder was fully soluble in 
a non-denaturing buffer (phosphate-buffered saline), with no evidence for any 
remaining insoluble material being observed. 
 
A similar process was used to treat the Trx/RBD3 and Trx/RBD3/GNA fusion proteins 
eluted from the metal affinity chromatography column. The proteins remained soluble 
after desalting into deionised water using a PD-10 column (Figure 4-16). Protein-
containing fractions were flash-frozen and lyophilised. The freeze dried proteins (with 
thioredoxin as a comparison) were resuspended in 1XPBS and soluble and insoluble 
fractions were separated by centrifugation, and analysed by SDS-PAGE. Results are 
shown in Figure 4-17. This experiment confirmed that recombinant thioredoxin showed 
100% solubility in1XPBS after lyophilisation. The Trx/RBD3 fusion protein showed 
approx. 70% solubility, although some Trx/RBD3 could be detected in the insoluble 
fraction (lanes 2 and 7). In contrast, little of the Trx/RBD3/GNA fusion protein was 
soluble after lyophilisation, and only the insoluble fraction contained a prominent 35kDa 
fusion protein band (lanes 3 and 8). 
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Figure 4-14 Downstream processing of Trx/RBD3/GNA after purification. 
Purified Trx/RBD3/GNA was dialysed against sodium phosphate buffer containing 10% 
glycerol and 0.15M NaCl. Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) 
are shown from lanes 1-3. Lane 4 shows soluble fraction after dialysis and lane 5 
shows insoluble fraction after dialysis. Trx/RBD3/GNA fusion protein is represented by 
the 35kDa band in the insoluble fraction as indicated by arrow. Lane M represents a 
molecular weight marker (SDS7).  
 
 
Figure 4-15 Downstream processing of recombinant thioredoxin. 
Purified thioredoxin was desalted into deionised water on a PD-10 column. Ten 
microlitre of eluted protein fractions are shown from lanes 1-5. After desalting, 
Thioredoxin was freeze dried and re-suspended in 1XPBS. Lane 8 shows desalted 
thioredoxin after lyophilisation and dissolving in phosphate-buffered saline. Lane 9 
shows 5µl of eluted thioredoxin fractions from desalting PD-10 column. Twelve-
kilodalton band of GNA (2µg, 4µg as a standard) are shown in lane 6 and 7. Lanes 10-
12 shows 4µg, 2µg and 1µg GNA standard. Lane M represents a molecular weight 
marker (SDS7). 
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Figure 4-16 Desalting Trx/RBD3 and Trx/RBD3GNA fusion proteins on a PD-10 
column  
Lanes 1-4 shows 5µl of eluted Trx/RBD3 fractions from PD-10 column. The band at 
27kDa represents Trx/RBD3 as indicated by arrow. Twelve-kilodalton band of GNA 
(1µg, 2µg, 4µg as a standard) are shown in lanes 5-7. Lanes 8-10 shows 5µl of eluted 
Trx/RBD3/GNA fractions from PD-10 column. The band at 35kDa represents 
Trx/RBD3/GNA. Lane M represents a molecular weight marker (SDS7).  
 
 
 
Figure 4-17 Solubility of Trx, and Trx/RBD3 and Trx/RBD3/GNA fusion proteins in 
PBS after lyophilisation 
Lane 1-3 represents 10µg soluble fraction of thioredoxin, 5µg soluble fraction of 
Trx/RBD3 (27kDa) and soluble fraction of Trx/RBD3/GNA (35kDa), respectively. 
Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are shown in lanes 4-6. 
Lanes 7 and 8 show insoluble fraction of Trx/RBD3 and Trx/RBD3/GNA, respectively. 
Lane M represents a molecular weight marker (SDS7).  
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4.2.4 Expression of RBD3/GNA in the periplasm of E. coli 
Secretion of recombinant protein into the periplasmic space was attempted in order to 
produce soluble RBD3/GNA protein in E. coli system. The vector pET22, containing the 
E. coli periplasmic secretion signal sequence from pelB was used to produce an 
expression construct for recombinant protein production. The schematic diagram and 
sequences of PelB/RBD3/GNA is shown in Figure 4-18; the pelB leader sequence was 
introduced N-terminal to the RBD3 coding sequence, and a (His)6 tag was arranged C-
terminal to the GNA coding sequence (Figure 4-19). The predicted size of the 
PelB/RBD3/GNA fusion protein is 24.5 kDa. After introduction into the BL21(DE3) 
expression strain, fusion protein production was induced by addition of IPTG. After 
induction, fractions corresponding to periplasmic proteins, soluble cytoplasmic proteins 
and insoluble proteins were purified from E. coli cells, and analysed by SDS-PAGE and 
western blotting. Results are summarised in Figure 4-20. The stained SDS-PAGE gel 
shows evidence of PelB/RBD3/GNA production, but only in the insoluble protein 
fraction (panel A, lane 6); the prominnent band at approx. 25kDa could be 
pelB/RBD3/GNA whereas the lower band around 24kDa could be RBD3/GNA without 
pelB leader sequence. The Western blot has overloaded in the corresponding track, 
but confirms that immunoreactivity is strongly present in the insoluble fraction. Very 
little potential pelB/RBD3/GNA can be detected in periplasmic fraction (Figure 4-20 A 
and B, lane 2; a possible trace of soluble fusion protein is indicated by an arrow in 
panel B). This method was not successful in producing soluble recombinant protein. 
 
 
 
 
 
Figure 4-18 Schematic diagram of an expression construct for the fusion protein, 
PelB/RBD3/GNA in pET22b+. 
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ATGAAATACCTGCTGCCGACCGCTGCTGCTGGTCTGCTGCTCCTCGCTGCCCAG
CCGGCGATGGCCATGGATATCGGAATTAATTCGGATCCCGATAAGAAGTCTCCA
ATTTCTCAAGTTCATGAAATTGGTATTAAGAGACAAATGACTGTTCATTTTAAGG
TTTTGAGAGAAGAAGGTCCAGCTCATATGAAGAACTTTATTACTGCTTGTATTGT
TGGTTCTATTGTTACTGAAGGTGAAGGTAAGGGTAAGAAGGTTTCTAAGAAGAG
AGCTGCTGAAAAGATGTTGGTTGAATTGCAAAAGTTGCCAAAGCTTGCGGCCGC
CGACAATATTTTGTACTCCGGTGAGACTCTCTCTACAGGGGAATTTCTCAACTAC
GGAAGTTTCGTTTTTATCATGCAAGAGGACTGCAATCTGGTCTTGTACGACGTGG
ACAAGCCAATCTGGGCAACAAACACAGGTGGTCTCTCCCGTAGCTGCTTCCTCA
GCATGCAGACTGATGGGAACCTCGTGGTGTACAACCCATCGAACAAACCGATTT
GGGCAAGCAACACTGGAGGCCAAAATGGGAATTACGTGTGCATCCTACAGAAG
GATAGGAATGTTGTGATCTACGGAACTGATCGTTGGGCCACTGGACTCGAGCAC
CACCACCACCACCACTGA 
 
MKYLLPTAAAGLLLLAAQPAMAMDIGINSDPDKKSPISQVHEIGIKRQMTVHFKVLRE
EGPAHMKNFITACIVGSIVTEGEGKGKKVSKKRAAEKMLVELQKLPKLAAADNILYS
GETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLV
VYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWATGLEHHHHHH. 
 
Figure 4-19 Nucleotide and derived amino acid sequences of synthetic 
RBD3/GNA in PET22b+ vector 
pelB leader sequence, RBD3 coding sequence, GNA coding sequence, His6 tag 
Extra c highlighted in blue is added into sequence to get right frame. 
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(A) (B)																																																																					
Figure 4-20 SDS-PAGE analysis and western blotting confirmation of 
recombinant RBD3/GNA expression in cytoplasm and periplasm. 
Lanes 1 and 2 show periplasmic fractions from uninduced and induced cell culture 
checked on SDS-PAGE (A) and blot (B). Lanes 3 and 4 show cytoplasmic fractions 
from uninduced and induced cell culture on SDS-PAGE (A) and blot (B). Lanes 5 and 6 
show Insoluble fractions from uninduced and induced cell culture on SDS-PAGE (A) 
and blot (B).  Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are shown 
in lanes 7-9. pelB/RBD3/GNA was predicted as 24kDa as indicated by arrow.   
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4.2.5 Expression of recombinant proteins containing RBD domains in the yeast 
Pichia pastoris 
The difficulties experienced in trying to produce soluble recombinant Trx/RBD/GNA 
fusion proteins in E. coli as an expression host reflect previous work, in which GNA 
itself has been expressed in bacterial hosts. The recombinant GNA was found to be 
insoluble after expression in E. coli, and although purification by denaturation-
renaturation can be made to work, recovery of soluble protein was poor and non-
reproducible (Longstaff et al. 1998). In contrast, GNA can be produced in the 
eukaryotic microorganism Pichia pastoris as a functional, soluble protein secreted into 
culture medium in high yield (Baumgartner et al. 2003). Expression of RBD/GNA fusion 
proteins was thus attempted in this host with the aim of generating soluble, functional 
products. 
 Constructs encoding RBD3 fused C-terminally to the yeast α-mating factor 
prepropeptide, and N-terminally to myc and (His)6 tags, and RBD3 fused C-terminally 
to the yeast mating factor prepropeptide, and N-terminally to a GNA coding sequence 
with C-terminal myc and (His)6 tags were assembled in the vector pGAPZα. This 
shuttle vector is propagated and manipulated in E. coli, and can be linearised and 
transfromed into P. pastoris, where it integrates into the genome by homologous 
recombination. Yeast transformants thus contain an integrated genomic copy of the 
expression construct, whose promoter directs constitutive expression of the 
recombinant protein. The yeast α-mating factor sequence directs the recombinant 
protein into the yeast secretory pathway, and consequently it can be purified from the 
culture supernatant. The constructs are described by block diagrams and predicted 
sequences of their products in Figure 4-21. The predicted molecular weights of the 
recombinant proteins after removal of the α-mating factor prepropeptide are 9.21 kDa 
for RBD3, and 21.18 kDa for RBD3/GNA. 
 Construct assembly was carried out by restriction-ligation after PCR of 
appropriate fragments, and resulting plasmids were checked by sequencing prior to 
transformation of Pichia pastoris strain (SMD1168). Recombinant yeast were selected 
on plates containing zeocin, the selectable marker included on the vector pGAPZα.  
 Screening recombinant RBD3 yeast clones by analysis of culture supernatants 
by Western blotting detected clones showing low levels of expression of a polypeptide 
of approx. 10kDa, assumed to correspond to RBD3. The best expressing clone was 
selected. A similar screening analysis of recombinant RBD3/GNA yeast clones allowed 
selection of several clones which were expressing a polypeptide of approx. 20kDa, 
close to the size predicted for RBD3/GNA. The best expressing clone was again 
selected. 
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(A) 
 
ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGC
TGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAG
CTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATT
TTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATT
GCTGCTAAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGC
AGATAAGAAGTCTCCAATTTCTCAAGTTCATGAAATTGGTATTAAGAGACAAATG
ACTGTTCATTTTAAGGTTTTGAGAGAAGAAGGTCCAGCTCATATGAAGAACTTTA
TTACTGCTTGTATTGTTGGTTCTATTGTTACTGAAGGTGAAGGTAAGGGTAAGAA
GGTTTCTAAGAAGAGAGCTGCTGAAAAGATGTTGGTTGAATTGCAAAAGTTGCC
AGTCGACCATCATCATCATCATCATTGA 
 
MRFPSIFTAVLFAASSALAAPVNTTTEDETAQIPAEAVIGYSDLEGDFDVAVLPFSNS
TNNGLLFINTTIASIAAKEEGVSLEKREAEAAADKKSPISQVHEIGIKRQMTVHFKVLR
EEGPAHMKNFITACIVGSIVTEGEGKGKKVSKKRAAEKMLVEQKLPVDHHHHHH. 
 
α-factor signal sequence, RBD3 coding sequence, His6 tag 
 
(A) Schematic diagram and amino acid sequence of an expression construct for RBD3 
in pGAPZαB 
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(B) 
 
 
  
ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGC
TGCTCCAGTCAACACTACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAG
CTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATT
TTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATT
GCTGCTAAAGAAGAAGGGGTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCAGC
AGATAAGAAGTCTCCAATTTCTCAAGTTCATGAAATTGGTATTAAGAGACAAATG
ACTGTTCATTTTAAGGTTTTGAGAGAAGAAGGTCCAGCTCATATGAAGAACTTTA
TTACTGCTTGTATTGTTGGTTCTATTGTTACTGAAGGTGAAGGTAAGGGTAAGAA
GGTTTCTAAGAAGAGAGCTGCTGAAAAGATGTTGGTTGAATTGCAAAAGTTGCC
AGCGGCCGCCGATAACATTTTGTACTCTGGTGAAACTTTGTCTACTGGTGAATTT
TTGAACTACGGTTCTTTTGTTTTTATTATGCAAGAAGATTGTAACTTGGTTTTGTA
CGATGTTGATAAGCCAATTTGGGCTACTAACACTGGTGGTTTGTCCAGATCTTGT
TTTTTGTCTATGCAAACTGATGGTAACTTGGTTGTTTACAACCCATCTAACAAGC
CAATTTGGGCTTCTAACACTGGTGGTCAAAACGGTAACTACGTTTGTATTTTGCA
AAAGGATAGAAACGTTGTTATTTACGGTACTGATAGATGGGCTACTGGTGTCGA
CCATCATCATCATCATCATTGA 
 
MRFPSIFTAVLFAASSALAAPVNTTTEDETAQIPAEAVIGYSDLEGDFDVAVLPFSNS
TNNGLLFINTTIASIAAKEEGVSLEKREAEAAADKKSPISQVHEIGIKRQMTVHFKVLR
EEGPAHMKNFITACIVGSIVTEGEGKGKKVSKKRAAEKMLVELQKLPAAADNILYSG
ETLSTGEFLNYGSFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVV
YNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTDRWATGVDHHHHHH. 
 
 α-factor signal sequence, RBD3 coding sequence, GNA coding sequence, His6 
tag 
 
(B) Schematic diagram and amino acid sequence of an expression construct for 
RBD3/GNA in pGAPZαB 
 
Figure 4-21 Schematic diagrams and amino acid sequences of expression constructs 
for RBD3 and RBD3/GNA in pGAPZαB 
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4.2.6 Purification of recombinant proteins containing RBD3 from P. pastoris 
culture supernatant 
 
4.2.6.1 Purification of RBD3 
RBD3 was purified from yeast culture supernatant by metal affinity chromatography as 
described for purification of Trx/RBD3 from E. coli. Yeast culture supernantant after 
fermentation was diluted x4 with binding buffer, and was loaded directly onto a nickel-
NTA-agarose column. After washing, the column was eluted with binding buffer 
containing 400mM imidazole. results are shown in Figure 4-22. The protein fraction 
eluted from the affinity column at 400mM imidazole contained a polypeptide of approx. 
10 kDa mol. wt. which was assumed to be RBD3; however, this material was 
contaminted by a yeast protein of approx. 55 kDa (Figure 4-22, panel A, lanes 3-5). 
 The eluted protein was concentrated by centrifugal concentrator and dialysed 
into RNA binding buffer. A small amount of protein precipitated out under these 
conditions (Figure 4-22, panel B, lanes 16 and 17), but most remained soluble (lanes 
14-15).  
 The results showed that purification of recombinant RBD3 from yeast culture 
supernatant was feasible, but yileds were very low, and the final product was inferior in 
purity to the soluble recombinant protein produced in E. coli. This method for producing 
recombinant RBD3 was not taken further. 
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(A) (B)	
Figure 4-22 SDS-PAGE analysis of fractions from purification of RBD3 from P. 
pastoris culture supernatant. 
Panel A: Lanes 1 and 2 show 20µl of RBD3 culture supernatant and 20µl of peak drop 
from 10mM imidazole wash, respectively. Lanes 3 and 5 show 10µl of fraction eluted 
by 400mM imidazole. Lane 4 shows 20µl of peak drop from 400mM imidazole elution. 
Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are shown in lanes 6-8. 
Panel B: Lanes 14 and15 shows 2µg and 5µg RBD3 soluble protein after concentration. 
Insoluble RBD3 protein after concentration  are show in lane. 16 and 17. Lane M 
represents a molecular weight marker (SDS7). 
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4.2.7 Purification of RBD3/GNA by metal affinity chromatography under different 
pH conditions 
The selected P. pastoris clone expressing RBD3/GNA was grown on a larger scale in a 
5 L laboratory fermentation system. After 4 days fermentation at 30°C, 2.5 L of culture 
supernatant were harvested and filtered by 2.7µM and 0.7µM filter before purification. 
RBD3/GNA was purified from culture supernatant by metal affinity chromatography on 
a column of immobilised nickel. To achieve better protein recovery efficiency, several 
purification methods were applied.  
 
First, purification of RBD3/GNA under native conditions was performed by diluting 
yeast supernatant with 4XBB pH 7.4. The pH of diluted yeast supernatant was around 
4 before loading. As the stained SDS-PAGE result shown in Figure 4-23, Purification of 
RBD3/GNA from the yeast culture supernatant gave a product of the expected size 
visible as a band on SDS-PAGE (see Figure 4-23, panel B, lanes 5 and 6; arrowed 
band), although this was present in small amount, and other polypeptides were also 
present in the eluted fraction. However, analysis of the culture supernatant by SDS-
PAGE followed by Western blotting probed with anti-GNA antibodies showed bands at 
the expected size for the RBD3/GNA fusion protein and a GNA cleavage product 
(Figure 4-23, panel C, lanes 1,2). These bands were also present in the fraction eluted 
from the column in 200mM imidazole, and thus are likely to represent the RBD3/GNA 
fusion protein, which has been produced in soluble form in P. pastoris. The RBD3/GNA 
band is indicated by an arrow in the Figure 4-23 panel C. RBD3/GNA is also in the 
fraction eluted by 0.4M imidazole (Figure 4-23 panel c lane 5) suggest that some of the 
RBD3/GNA bounds to column tightly and most of cleaved GNA can be eluted in 0.4M 
imidazole fraction. The solubility of RBD3/GNA is maintained after dialysis against both 
distilled water and 0.02M sodium phosphate buffer (Figure 4-23 panel C lane 7 and 
lane 9). RBD3/GNA shows more solubility in 0.02M sodium phosphate buffer than 
distilled water. The yield of fermented RBD3/GNA was approx.10mg/L and about 0.8 
mg RBD3/GNA was recovered from 300ml supernatant that contained approx. 3mg 
fusion protein. 
  
Secondly, the purification of RBD3/GNA was also carried out at pH 5.5 by adding 4XBB 
pH 9.0. The nickel-NTA column was washed with 0.01M imidazole to remove unbound 
protein and RBD3/GNA was eluted in 0.2M imidazole. Western blotting of fractions 
from the purification using anti-GNA antibody is shown in Figure 4-24. RBD3/GNA was 
detected in the fraction eluted with 0.2M imidazole. After dialysis against 0.02M sodium 
phosphate buffer followed by centrifugation, RBD3/GNA was found in soluble 
supernatant (Figure 4-24.B lane 2) with no protein detected in insoluble fraction (Figure 
  
  
130 
4-24.B lane 1). However, there is no obvious improvement of RBD3/GNA protein 
recovery efficiency compared to purification at pH 4. 
 
Finally, the purification of RBD3/GNA was performed from freeze dried culture 
supernatant powder that was re-suspended in 1XBB at pH 7.4.  Washing and elution 
were carried out with 0.01M imidazole and 0.2M imidazole as mentioned above; results 
are shown in fig.4.25. Whereas higher mol. wt. polypeptides did not bind to the column, 
major protein components of culture supernatant with polypeptides approx. 25 and 
50kDa were washed off in binding buffer containing 10mM imidazole. RBD3/GNA were 
eluted in 0.2M imidazole fraction. Pooled 0.2M imidazole fractions were dialysed 
against distilled water overnight at 4°C followed by freeze drying. Pooled 0.01M 
washed fractions were dialysed against 0.02M sodium phosphate buffer followed by 
concentration by a centrifugal filtration system. Analysis of fractions by SDS-PAGE 
showed that detectable RBD3/GNA was washed out from column by 0.01M imidazole 
(Figure 4-25 panel B, lane 4), but that RBD3/GNA protein was purified in reasonable 
yield by elution with 0.2M imidazole (Figure 4-25 panel A, lanes 3, 4 and 7, 8).  Approx. 
1.3mg RBD3/GNA was recovered from 300ml yeast supernatant.  
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(A) (B)	
Figure 4-23 Purification of RBD3/GNA from culture supernatant of P. pastoris by 
nickel affinity chromatography at pH 4 
(A, B) Analysis of fractions by SDS-PAGE; results from 2 separate column purifications 
RBD3/GNA supernatant is shown in lanes 1 and 2 (A) and RBD3/GNA supernatant 
diluted in in 1Xbinding buffer (pH 4) is shown in lane 3 (A). Lane 4 (A) shows flow-
through protein fraction. Lanes 5 and 6 (A) and B4 showsfraction and peak drop from 
10mM imidazole wash. Lanes 7 and 8 (A) and 5 and 6 (B) show fraction and peak drop 
from elution with 200mM imidazole. Lanes 7 and 8 (B) shows fraction and peak drop 
from elution with 400mM imidazole. Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as 
a standard) are shown in lanes 9-11 (A) and 1-3 (B).  
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                                                  (C) 
(C) Analysis of fractions from purification of RBD3/GNA produced by P. pastoris 
by Western blotting, probed with anti-GNA antibodies 
Lanes 1 and 2 show culture supernatant of P. pastoris clone expressing RBD3/GNA.  
Lane 3, 4 and 5 show 10mM imidazole wash fraction, 200mM imidazole elution 
fraction, and 400mM imidazole elution fraction from nickel affinity chromatography, 
respectively.  Lane 7 and 8 show soluble  and insoluble fractions after dialysis of 
purified RBD3/GNA against water, respectively. Lane 9 and 10 show soluble and 
insoluble fraction after dialysis of purified RBD3/GNA against 20mM sodium phosphate 
buffer, respectively. Twelve-kilodalton band of GNA (1µg, 2µg, 4µg as a standard) are 
shown in lanes 11-13. Band of expected size for RBD3/GNA fusion protein is indicated 
by arrow.  
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                                                (A)                                                           (B) 
Figure 4-24 Purification of RBD3/GNA from culture supernatant of P. pastoris by 
nickel affinity chromatography at pH 5.5 
Panel A: Lane 1 and 2 show RBD3/GNA neat supernatant and the supernatant diluted 
in 1Xbinding buffer (pH 5.5). Lane 3 shows flow-through fraction from nickel column. 
Lanes 4 and 5 show fraction from 10mM imidazole wash and elution with 200mM 
imidazole. Twelve-kilodalton band of GNA (30ng, 50ng, 100ng as a standard) are 
shown in lanes 6-8. After dialysis against 0.02M sodium phosphate buffer, RBD3/GNA 
can be detected in soluble fraction (lane 2, B) whereas no fusion protein was found in 
insoluble fraction (lane 1, B). 
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 (A) 
 (B) 
                      
Figure 4-25 Purification of RBD3/GNA from dialysed freeze dry supernatant 
powder pH 7.4 
A: Analysis of fractions by SDS-PAGE; results from 3 separate purifications. Flow-
throughs are shown in lanes 1, 5 and 9 and eluted peak drop from 10mM imidazole 
washes are shown in lanes 2, 6 and 10.  Elution fractions and peak drops with 200mM 
imidazole are shown in lanes 3, 7, 11 and lanes 4, 8 and 12, respectively. Twelve-
kilodalton band of 2µg GNA as a standard is shown in lane 13.  
B: Western blotting of purification of RBD3/GNA from freeze dried supernatant powder 
pH 7.4 by GNA antibody. Lane 1 shows RBD3/GNA supernatant. Lane 2 shows fraction 
from 0.01M imidazole wash. After concentration, fraction was check in lane 4. Lane 3 
and 5 shows fraction eluted in 0.2M imidazole (RBD3/GNA indicated by arrow) and 
RBD3/GNA after lypophilisation, respectively.  Twelve-kilodalton band of GNA (30, 50, 
and 100ng as a standard) are shown in lanes 6-8.  
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4.2.8 Purification of RBD3/GNA by gel filtration chromatography 
Freeze dried RBD3/GNA supernatant powder was re-suspended in 0.02M sodium 
phosphate buffer and loaded onto a Sephacryl S-200 gel filtration column which was 
equilibrated in 0.02M sodium phosphate buffer. As the result shown in Figure 4-26, 
gel filtration failed to separate yeast proteins in the culture supernatant from 
RBD3/GNA. Large amounts of proteins above 35kDa were still presented in all 
fractions analysed. 
 
4.2.9 Purification of RBD3/GNA under denaturing conditions at pH 6 
As the His tag will be exposed to nickel column and thus increase the chance of 
binding when protein was unfolded, purification of RBD3/GNA was performed under 
denaturing conditions by metal affinity chromatography in the presence of 6M urea. 
Results are shown in Figure 4-27. 
Analysis by western blotting using anti-GNA antibodies (Figure 4-27) confirmed that 
RBD3/GNA was successfully purified by elution with 0.2M imidazole, and that no 
residual fusion protein was observed in wash fraction. However, purified RBD3/GNA 
failed to refolded after dialysis against 0.02M sodium phosphate buffer with a gradient 
dilution of urea (see Figure 4-27 lane 5), and only insoluble protein was present. 
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Figure 4-26 Purification of RBD3/GNA by gel filtration chromatography 
Fractions eluted from the column containing protein (lanes 1-12; fractions 21-44) were 
analysed by SDS-PAGE. Twelve-kilodalton band of 2µg GNA as a standard is shown in 
lane 13.  
 
 
 
Figure 4-27 Western Blot of purification of RBD3/GNA under denaturing 
conditions probed with anti-GNA antibody 
Lanes 1 and 3 show fraction washed with 1XBB containing 6M urea and 10mM 
imidazole containing 6M urea. Lane 2 shows Flow-through. Eluted RBD3/GNA in 0.2M 
imidazole is shown in lane 4. Dialysised insoluble and soluble fractions of RBD3/GNA 
are shown in lanes 5 and 6, respectively. Twelve-kilodalton band of GNA (30, 50 and 
100ng as a standard) are shown in lanes 7-9. Five-microlire from each samples were 
used for western blotting. 
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4.2.10 Processing of recombinant proteins by denaturation-renaturation 
The insoluble protein fractions from E. coli strains expressing Trx/RBD1 and 
Trx/RBD/GNA fusion proteins showed clean single bands on SDS-PAGE, in high 
yield, and thus offer a source to recover recombinant proteins without further 
purification. These insoluble fractions were dissolved in 6M urea to provide material 
for experiments to determine whether renaturation could produce functional proteins. 
 Insoluble Trx/RBD1 and Trx/RBD/GNA fractions solubilised in 6M urea were 
dialysed against a gradient dilution of urea to 0.5M, and were stored at 0.5M urea 
and 0.5mM DTT. This process was successful in maintaining protein solubility, in that 
no precipitation was observed. However, when the refolded Trx/RBD1 was tested in a 
RESMA assay no dsRNA binding activity was observed, as no dsRNA mobility shift 
was detected. Refolded Trx/RBD3/GNA was also checked for biological activity of the 
GNA by aggutination assay  (shown in Figure 4-29, row 6). The result indicated that 
GNA had lost any activity. Therefore, the refolding of Trx/RBD1 AND Trx/RBD3/GNA 
against urea and DTT was unsuccessful in allowing biological activity to be restored. 
 When the insoluble Trx/RBD and Trx/RBD/GNA fractions after refolding in 
0.5M urea were dialysed against 20mM sodium phosphate solutions without urea, but 
containing decreasing concentrations of DTT to zero, extensive precipitation of 
proteins was observed, with little material remaining in the soluble fraction after 
separation by centrifugation, result shown in Figure 4-28. These samples were tested 
for REMSA (results shown in Figure 4-34 lane 7 and 8). No dsRNA mobility shift 
deteced suggesting that the Trx/RBD/GNA fusion protein had failed to renature. 
 
4.2.11 Confirmation of protein activity by agglutination assays 
The biological activity of the GNA part of recombinant fusion proteins was tested by 
an agglutination assay using rabbit erythrocytes. Results are shown in Figure 4-28. A 
positive agglutination reaction results in erthrocytes forming a layer over the bottom 
of the well (e.g. GNA positive control, row1 wells A-E; lowest agglutination 
concentration = 6 µg ml-1). In a negative reaction, shown in row 2, no agglutination 
allows the erythrocytes to settle into the bottom of the well to form a "pellet" (e.g. row 
2, wells A-J). Soluble RBD3/GNA from P. pastoris which had been purified under 
native conditions at pH 7.4 showed agglutination activity (lowest agglutination 
concentration = 31 µg ml-1) showing that the GNA part of the fusion was functional. 
However, none of the GNA-containing fusion proteins which had been purified via 
processes involving denaturation and refolding showed any agglutination activity. 
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Figure 4-28 Attempted refolding of Trx/RBD and Trx/RBD/GNA fusion proteins. 
Recombinant proteins were dissolved in 6M urea and dialysed against sodium 
phosphate buffer containing DTT to a final concentration of 0.5M urea.  Soluble and 
insoluble fractions were separated by centrifugation. Lanes 1, 2 and 3 show soluble 
Trx/RBD3/GNA, Trx/RBD1/GNA and Trx/RBD1, respectively. Twelve-kilodalton band of 
GNA (1µg, 2µg, 4µg as a standard) are shown in lanes 4, 5 and 6.  
 
 
 
Figure 4-29 GNA agglutination assay by agglutination  
Each row of wells contains a serial dilution (left to right) of the protein from 1µg µl-1, and 
the same amount of rabbit erythrocyte suspension. GNA (starting concentration 
100ng/µl) as positive control is shown in row 1 and negative control was performed by 
using 1XPBS (row 2). RBD3/GNA soluble and refolded RBD3/GNA proteins produced 
in P. pastoris are shown in rows 3 and 4, respectively. Refolded pelB/GNA/RBD3 and 
Trx/RBD3/GNA produced in E.  coli are shown in rows 5 and 6.  
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4.2.12 Production of Labelled RNAs and Assays of RNA-Binding Activity of 
Recombinant Proteins 
 
4.2.12.1 Production of synthetic ss and dsRNAs 
Synthetic single stranded (ss) RNAs were produced by in vitro transcription of 
linearized plasmid templates, using T7 RNA polymerase. RNAs were purified by 
treatment with DNase followed by precipitation, and RNA was quantified by UV 
absorbance at 260nm. The yield of ssRNA from 1µg of DNA template was routinely 
around 100µg. dsRNAs were prepared by annealing similar amounts of synthetic 
sense and antisense strands. All synthetic RNA products were analysed by agarose 
gel electrophoresis to check for integrity, and to provide a semiquantitative estimate of 
RNA amount. Typical results are shown in Figure 4-30. 
 
4.2.12.2 Detection of Biotin-labelled RNAs on dot blot and after gel 
electrophoresis 
Single-stranded (ss) RNAs were 3’-end labelled with biotin using biotinylated cytidine 
bisphosphate and T4 RNA ligase, and purified by chloroform:isomyl alcohol extraction, 
and precipitation. Biotin-labelled dsRNAs were prepared by annealing separately 
labelled strands together. To test the senstivity of the detection method, 2µl "dots" of 
different concentrations of biotin-labelled RNAs were pipetted onto a positively charged 
nylon membrane and detected using stabilized streptavidin-horseradish peroxidase as 
shown in Figure 4-31. Dot blots showed that amounts <3x10-17 moles of a labelled 
control ssRNA (biotinylated iron responsive elements (IRE) RNA) supplied with the 
labelling kit could be readily detected. RNAs labelled using the kit gave less strong 
signals at similar amounts, but amounts of the order of 4x10-16 moles (7 x 10-11 g) of 
both single and double stranded labelled RNAs were readily detectable, with no 
apparent difference in sensitivity between ssRNA and dsRNA. Sensitivity of detection 
of labelled dsRNAs after separation by 6% polyacrylamide gel electrophoresis was 
tested. In this case the separated bands were blotted onto nylon membrane and 
detected as for dot-blots. As shown in Figure 4-32.B, a minimum of 10 ng labelled 
dsRNA could be visualised as a single band after gel electrophoresis. The markedly 
lower sensitivity of the gel method may reflect inefficient transfer from the gel. 
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Figure 4-30 In vitro transcription of RNAs  
Lanes 2, 3 show single stranded RNAs (TcVTE sense and antisense strand 
respectively; 277 bases) and  double stranded RNA produced by annealing ssRNAs 
shown in lane 1. M: DNA ladder.  
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Figure 4-31 Biotin-lablled ssRNA and dsRNA 
(A) Dot blot of biotinylated ssRNAs and dsRNAs. A1-A5 show 1, 0,75, 0.5, 0.25 and 
0nM Labeled IRE control RNA provided from Kit. B1-G1 show 1, 0.5, 0.25, 0.125, 
0.0625 and 0.0312nM Labeled IRE control RNA. B2-G2, B3-G3, B4-G4, B5-G5, B6-G6 
and B7-G7 show 66.8, 33.4, 16.7, 8.35, 4.17, 2.08nM MdVTE  (Sense) ssRNA, MdVTE 
(Antisense)ssRNA, MbVTE (Sense) ssRNA, MbVTE (Antisense) ssRNA, MdVTE 
dsRNA and MbVTE dsRNA, respectively. (B) Detection of labelled MbVTE dsRNA on 
6%TBE  polyacrylamide gel. The amoutn of 10ng, 20ng, 50ng, 200ng, 500ng labelled 
MbVTE dsRNA are shown in lanes 1-5.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
142 
4.2.13 RNA Binding Assays using Blotted Proteins 
Following a procedure used to show the RNA-binding activity of staufen RBD domains 
(Micklem et al. 2000), protein samples were separated on normal SDS-PAGE and 
blotted onto nitrocellulose membrane. The membrane was then probed with biotin-
labelled dsRNA (a 277 bp fragment from the D. radicum V-type ATPase gene was 
used), and RNA binding was detected using a streptavidin-HRP conjugate. The assays 
were carried out under conditions where proteins on the membrane were probed 
directly after blotting, or were subjected to denaturation in 6M urea followed by 
renaturation in a series of washes of lower urea concentrations, with similar results. 
This method for detecting RNA-binding activity proved non-viable when biotin-labelled 
dsRNA was used as a probe on cell extracts or culture supernatants, due to the 
presence of small amounts of biotin-containing contaminating proteins in all the 
samples analysed. These contaminants were detected by the streptavidin-HRP 
conjugate as bands present in negative controls. Representative results are shown in 
Figure 4-32. E. coli cell extracts (Lanes 2, 3 and 5) gave bands in the region 14-25 kDa, 
which were present in the negative "empty vector" control (lane 2) even when no 
labelled RNA probe was used (panel D). Proteins purified from E. coli could contain 
small amounts of a contaminating biotin-containing band at approx. 22 kDa (lane 2). In 
highly purified samples, this band was absent (lanes 4, 6), but in these samples, no 
RNA binding was observed (panels B and C). Culture supernatants from P. pastoris, 
whether expressing RBD-domain containing proteins or not, contained a high 
molecular weight contaminants which contained biotin, as shown by reaction with 
streptavidin-HRP conjugate (panel D, lanes 7-11), and variable amounts of a band at 
approx. 25 kDa which also reacted with streptavidin. No evidence for specific RNA-
binding proteins was observed in any of these blot assays. 
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Figure 4-32 Probing protein blots with biotin-labelled RNA cannot be used to 
demonstrate RNA binding. 
Stained SDS-PAGE gel of protein samples is shown in panel A and blot probed with 
labelled dsRNA and single-stranded RNA are shown in panel B and C, respectively. 
Blot treated with streptavidin-HRP conbjugate without probing with labelled RNA 
(negative control) is shown in panel D. Each panel contains the following lanes: lane 1 
shows purified RBD1/Trx fusion protein. Lanes 2, 3 and 5 show soluble protein fraction 
from E. coli expressing Trx protein (negtive control), RBD1/GNA and Trx/RBD3/GNA, 
respectively. Purified fraction of Trx/RBD1/GNA and Trx/RBD3/GNA fusion protein is 
shown in lanes 4 and 6. Culture supernatant from SMD yeast ( negive control), RBD1, 
RBD1/GNA, RBD3 and RBD3/GNA in  P. pastoris are shown in lanes 7-11. 
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4.2.14 RNA Electrophoretic Mobility Shift Assays (REMSA) using biotin labelled 
dsRNA 
The failure to detect RNA-binding activity in recombinant fusion proteins containing 
RBD domains after SDS-PAGE suggested that an assay which could be carried out 
using non-denatured protein would be necessary to show biological activity. An RNA 
electrophoretic mobility shift assay (REMSA) to demonstrate the formation of protein-
RNA complexes was selected as a suitable method. The technique was evaluated 
using the positive control reaction provided in the Pierce biotin labelling kit, which 
involves interaction of an IRE-element binding protein in a liver extract with its target 
RNA. Results are shown in Figure 4-33. The interaction results in the formation of a 
complex with reduced mobility on gel electrophoresis, which is clearly visualised after 
blotting and detection of biotin-labelled RNA. Further experiments (data not presented) 
showed that no interaction was observed when labelled insect RNAs were tested. 
 
When similar assays were carried out to show interactions of purified recombinant 
proteins containing RBD domains with dsRNAs, results were less clear-cut. Typical 
results are shown in Figure 4-34. Proteins produced in Pichia could not be assayed 
using this method due to the presence of contaminants which gave high levels of 
background reactivity in the biotin detection reaction; this resulted in tracks containing 
smears (see lane 3, Figure 4-34), which could not be interpreted as unambiguous 
evidence for the formation of protein-RNA complexes. In addition, all recombinant 
proteins produced in E. coli which had been subjected to denaturation-renaturation 
procedures during purification failed to show evidence for complex formation with 
labelled dsRNA, which was shown by the labelled RNA control running to the same 
position on the gel as the labelled RNA mixed with recombinant protein, or by dsRNA 
degradation. Since Trx/RBD1 and Trx/RBD1/GNA could not be produced as soluble 
proteins in E. coli, the binding activity of the RBD1 domain could not be demonstrated 
in recombinant proteins. 
 
The data shown in Figure 4-34 suggests evidence for complex formation between the 
recombinant protein and dsRNA for Trx/RBD3/GNA produced in E. coli, which had 
been produced and purified as a soluble protein. Further work was carried out to 
demonstrate that the RBD3 domain produced as a soluble protein in E. coli was 
biologically active. 
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Figure 4-33 Electrophoretic Mobility Shift Assays (REMSA); Control for Binding 
Control biotin IRE-RNA (16.25nM) is shown in lane 1 and control biotin IRE-RNA with 
added liver extract protein the formation of a protein-RNA complex is indicated by the 
arrow which is shown in lane 2.  
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Figure 4-34 RNA Electrophoretic mobility shift assay (REMSA) of recombinant 
proteins containing RBD domains.  
Negtive controls used for this assay were 10ng biotin-MbVTE dsRNA (lane 1) and the 
reaction of 10ng biotin-MbVTE dsRNA incubated with 2µg GNA (lane 2). Smearing and 
background is detected after inucating 10ng biotin-dsRNA incubated with RBD3/GNA 
produced in P. pastoris (lane 3). Additional negative control is soluble fraction of 
induced ‘empty’ pET32 vector expressing Trx (lane 4). Lanes 5 and 6 show 10ng biotin-
dsRNA incubated with 2µg purified Trx/RBD1/GNA and Trx/RBD3/GNA (peak drops 
from nickel affinity column) whereas lanes 7, 8 show 10ng biotin-dsRNA incubated with 
2µg Trx/RBD1/GNA and Trx/RBD3/GNA purified under denaturing conditions. Lane 9 
shows 10ng biotin-dsRNA incubated with 2µg Trx/RBD1 purified under denaturing 
conditions.  
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4.2.15 RNA-binding activity of RBD3-containing recombinant proteins 
Trx/RBD3 fusion protein purified from soluble E.coli cell fractions showed dsRNA 
binding activity, assayed by REMSA (Figure 4-35). Incubation of 2.5µg of recombinant 
protein with 10ng biotin-labelled dsRNA caused a clear mobility shift, whereas 
incubation of lower amounts of recombinant protein (0.5µg and 1µg) gave no clear 
mobility shift. Thioredoxin and GNA protein were incubated with labelled dsRNA as 
negative controls; no shift was observed with 2.5µg of either protein, showing that the 
mobility shift observed in lane 9 of Figure 4-35 must be due to the RBD3 domain. 
Although this result demonstrates binding activity, the recombinant protein is present in 
large excess over the dsRNA target when binding is observed (approx. 2000-fold, on a 
molar basis) which suggests that the protein is either only partially biologically active, or 
that the binding constant for the interaction is relatively high.  
Similar results were obtained with the Trx/RBD3/GNA fusion protein produced as a 
soluble protein in E. coli. This protein became insoluble after lyophilisation following 
purification by metal affinity chromatography, and thus in order to carry out a REMSA 
assay, the eluted peak fraction of Trx/RBD3/GNA from the nickel column was used 
directly for the binding assay. Ten nanograms biotin dsRNA was incubated with varying 
amounts of Trx/RBD3/GNA fusion protein, from 50ng to 2µg; results are shown in 
Figure 4-36.A mobility shift in the dsRNA band was observed consistently when 
≥750ng of recombinant fusion protein was added to the labelled RNA (panel A, lanes 4-
8; panel B, lane 5). Again, although these results suggest that recombinant RNA 
binding domain RBD3 has dsRNA binding activity, whereas GNA and thioredoxin 
controls do not, the amount of protein required to show a mobility shift is in large 
excess over the dsRNA.  
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Figure 4-35 RNA-binding activity of Trx/RBD3 shown by REMSA 
Negtive control is shown in lane 1 represent 10ng biotinylated dsRNA.  Negtive 
controls were used as 2.5µg protein (i.e. without incubating with dsRNA) that are 
Thioredoxin (lane 3), GNA (lane 5) and Trx/RBD3 (lane 6). Lanes 2, 4 show 10ng 
biotinylated dsRNA incubated with 2.5µgThioredoxin and GNA, respectively. Lanes 7-9 
show 0.5µg, 1µg and 2.4µg Trx/RBD3 incubated with 10ng biotinylated dsRNA. 
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Figure 4-36 RNA-binding activity of Trx/RBD3/GNA shown by REMSA 
Panel A and B show independent replicates. 
A: Lane 1 shows 10ng biotinylated dsRNA (i.e. without incubating with protein) as 
negative control. Additional negive control is 2µg Trx/RBD3/GNA (lane 8). Lanes 2-7 
show 300ng, 500ng, 750ng, 1ug, 1.5µg and 2µg Trx/RBD3/GNA incubated with 10ng 
biotinylated dsRNA.  
B: Lanes 1-5 show 50ng, 100ng, 250ng, 500ng and 1µg Trx/RBD3/GNA fusion protein 
incubated with 10ng biotinylated dsRNA. 
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4.2.16 REMSA assays with FITC-labelled dsRNA 
To investigate the possibility that biotin-labelling dsRNA was interfering with RBD3 
binding, an alternative labelling system was used. 
 
When carrying out in vitro transcription to produce RNA, T7 RNA polymerase can 
incorporate modified 5’-initiating nucleosides based on guanosine. These modified 
nucleotides can incorporate chemical functionality which introduces reactive groups for 
bioconjugation. One of the 5’-deoxyguanosine derivatives, 5’-deoxy-5’-
hydrazinylguanosine (see Figure 4-37; 1) is used to enable the RNA transcripts to be 
labelled with a fluorophore such as FITC, giving the conjugate shown in Figure 4-37 
(2). 5’-deoxy-5’-hydrazinylguanosine 1 was introduced during in vitro transcription of a 
200bp RNA fragment derived from the T. castaneum V-type ATPase encoding 
sequence; FITC was added after the initial initiation and transcription completed.  The 
labelling reaction was initiated and quenched by pH adjustment. Unincorporated 5’-
deoxy-5’-hydrazinylguanosine 1 and FITC were removed by gel filtration using spin 
columns. 
 
Analyses of the FITC labelled dsRNA by gel electrophoresis on 6% native TBE 
polyacrylamide gels are shown in Figure 4-38. Imaging 2ng, 5ng and 10ng FITC-
dsRNA showed that the lowest amount could be detected as a band of the expected 
indicated size (panel A). FITC-dsRNA also shows single band on a similar gel stained 
by ethidium bromide at final concentration of 0.5mg/ml in 200ml 0.5X TBE buffer. 
(panel B).  
 
The results of FITC-dsRNA mobility shift assays using purified Trx/GNA produced as a 
soluble recombinant protein in E. coli are shown in Figure 4-39. The labelled FITC-
dsRNAs are detected in by inherent fluorescence using a phosphorimager (panel A) or 
by staining with ethidium bromide (panel B). Labelled dsRNA is detected as a band 
towards the bottom of the gel (lane 1), and no evidence of complex formation with 
thioredoxin or GNA is observed (lanes 7 and 8). In this assay, the formation of a 
dsRNA-Trx/RBD3 complex shifts the dsRNA band to the top of the gel over the entire 
range of amounts of fusion protein used (1-8ng; lanes 2-5). The results show that 
Trx/RBD3 has binding activity towards FITC-labelled dsRNA. The assays shown in 
Figure 4-39, when compared to those of Figure 4-35 and Figure 4-36, suggest much 
stronger binding of Trx/RBD3, shown by the almost complete absence of mobility of the 
complex on gel electrophoresis. Even when a higher amount of dsRNA is used in the 
assay (Figure 4-39, panel B) no evidence for the presence of uncomplexed dsRNA is 
seen. 
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Figure 4-37 Modification of the 5’-hydrazinyl functional group of 5’-deoxy-5’-
hydrazinylguanosine with FITC. (M. Skipsey et al. 2013) 
 
 
 
Figure 4-38 Visualisation of FITC-labelled dsRNA by inherent fluorescence and by 
staining. 
A: Lanes 1-3 show 2ng, 5ng and 10ng FITC-TcVTE dsRNA on 6% TBE polyacrylamide 
gel visualised by endogenous fluorescence using a Typhoon phosphorimager.  
B: Lane 1 shows 100ng FITC-TcVTE dsRNA on 6% TBE polyacrylamide gel stained 
with ethidium bromide. M: dsRNA marker 
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(A) (B)	
 
Figure 4-39 Trx/RBD3 fusion protein binds to FITC-dsRNA demonstrated by RNA 
Electrophoresis Mobility shift assays. 
(A) 6%TBE polyacrylamide gel of FITC-dsRNA mobility shift assay visualised by 
Typhoon phosphorimager. 
Negtive controls are 5ng FITC-dsRNA (lane 1) and 8µg Trx/RBD3 fusion protein (lane 
6). Lanes 2-5 show 5ng FITC-dsRNA incubated with 1µg, 2µg, 4µg and 8µg Trx/RBD3 
fusion protein. Lanes 7 and 8 show 5ng FITC-dsRNA incubated with 8µg thioredoxin 
and GNA proteins respectively.  
(B) 6% TBE polyacrylamide gel of FITC-dsRNA mobility shift assay stained with 
ethidium bromide 
Negtive controls are 20ng FITC-dsRNA (lane 1) and 8µg Trx/RBD3 fusion protein (lane 
6). Lanes 2-5 show 20ng FITC-dsRNA incubated with 1µg, 2µg, 4µg and 8µg Trx/RBD3 
fusion protein Lanes 7 and 8 show 20ng FITC-dsRNA incubated with 8µg thioredoxin 
and GNA proteins respectively.  
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4.2.17 REMSA assays with unlabelled dsRNA 
The results in Figure 4-39 show that when assays are carried out in vitro, with amounts 
of RNA that can be visualised by ethidium bromide staining, it is not necessary to label 
dsRNA to show mobility shifts due to protein binding. This is advantageous in that any 
interference with the protein-RNA interaction caused by labelling the RNA can be 
avoided. Further assays were thus carried out with unlabelled dsRNA. 
 
A REMSA assay using a constant amount of dsRNA incubated with varying amounts of 
Trx/RBD3 from 2ng to 2µg was carried out, and visualised using polyacrylamide gel 
electrophoresis and ethidium bromide staining. Results are shown in Figure 4-40. 50ng 
T. castaneum APIN dsRNA (300 bp) was used in each binding reaction; the molar 
equivalent of Trx/RBD3 GNA is approx. 7ng. In the assay, no mobility shift of dsRNA is 
apparent when incubating Trx/RBD3 fusion protein with 2, 5 or 10ng of protein (Figure 
4-40, lanes 2-4). When 40ng Trx/RBD3 protein is used, the band of uncomplexed RNA 
is decreased significantly, and evidence for protein-RNA complexes is seen in the form 
of a smear up the gel. Because RBD3 is a non-specific dsRNA binding protein, and 
binds at multiple sites on the RNA molecule, distinct complexes are not visualised 
(Figure 4-40, lane 5). Uncomplexed dsRNA is still present when 80ng of Trx/RBD3 is 
added, but not when 300ng or greater is added Figure 4-40, lanes 5-6). When dsRNA 
is incubated with 300ng-1µg Trx/RBD3 fusion protein, all the dsRNA is complexed, and 
the complexes become of higher mol. wt., as shown by a shift of the smear up the gel; 
finally, when 2 µg protein is added to 50ng dsRNA, all the RNA is present in the form of 
a high mol. wt. complex that hardly enters the gel (Figure 4-40 lanes 7-9). The binding 
constant, Kd, of Trx/RBD3 with dsRNA can be estimated from the amount necessary to 
convert approx. 50% of uncomplexed RNA to complexed RNA; the value is approx. 
8x10-8M. Recombinant thioredoxin was used as a control to show that addition of 
protein alone has no effect an dsRNA mobility (Figure 4-40 lane 11). 
 
A similar REMSA assay was carried out using the same dsRNA with varying amounts 
of purified recombinant RBD3/GNA fusion protein produced in P. pastoris. The result is 
shown in Figure 4-41. GNA, used as a negative control, shows that protein alone has 
no effect on RNA mobility (Figure 4-41 lane 11). However, all amounts of RBD3/GNA 
used affect dsRNA mobility; amounts of dsRNA from 1-50ng RBD3/GNA increase the 
mobility of the dsRNA (Figure 4-41, lanes 2-6), whereas amounts >50ng result in the 
formation of high mol. wt. complexes (Figure 4-41, lanes 7-9). Addition of 800ng 
RBD3/GNA results in a high. mol. wt. complex.   
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Figure 4-40 RESMA assay by using increasing amount of Trx/RBD3 fusion protein 
incubated with 50ng dsRNA. (TBE gel stained with ethidium bromide) 
Negative controls are 50ng TcAPIN dsRNA (i.e. without incubating with protein) shown 
in lane 1, and 2µg thioredoxin and Trx/RBD3 (i.e. without incubating with dsRNA) 
shown in lanes 12 and 13 respectively. Additional negtive control is applied by using 
50ng dsRNA incubated with 2µg Thioredoxin (lane 11). Lanes 2-10 show 50ng dsRNA 
incubated with 2ng, 5ng, 10ng, 40ng, 80ng, 300ng, 700ng, 1µg and 2µg Trx/RBD3 
fusion protein. 
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Figure 4-41 RESMA assay by using increasing amount of RBD3/GNA fusion 
protein incubated with 50ng dsRNA. (TBE gel stained with ethidium bromide) 
Negtive controls are 50ng TcAPIN dsRNA (lane 1, i.e. without protein) and 800ng 
RBD3/GNA fusion protein (lane 10, i.e. without dsRNA). Additional negative control is 
using 50ng dsRNA incubated with 800ng GNA (lane 11). Lanes 2-9 show 50ng TcAPIN 
dsRNA incubated with 1ng, 5ng, 10ng, 50ng, 80ng, 150ng, 400ng, 800ng RBD3/GNA 
fusion protein. 
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4.2.18 Detection of Trx/RBD3 and RBD3/GNA in A. pisum by western blotting  
Fusion proteins were fed to aphids as components of the liquid diet. Trx/RBD3 was 
detected in diet and A. pisum gut sample by using an anti-(His)6 antibody (recognises 
tag on recombinant protein), but not in haemolymph or honeydew, demonstrating that 
Trx/RBD3 is not able to transport from A. pisum gut to haemolymph as expected 
(Figure 4-42 A). In terms of detection of RBD3/GNA, GNA as positive control can be 
detected in all different tissues (gut, haemolymph and honeydew) which suggests that 
GNA was able to transport cross the aphid gut epithelium to the circulatory space 
(Figure 4-42 B). However, RBD3/GNA was not visualized in any other samples apart 
from diet. The band reacting with antibodies observed around 10kDa in gut and 
haemolymph lanes is most likely to represent GNA resulting from cleavage of 
RBD3/GNA fusion protein in aphid gut.  
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Figure 4-42 Western blot using anti-His (A) and anti-GNA (B) demonstrating the 
transportation of Trx/RBD3 (A) and RBD3/GNA (B) in A. pisum circulatory system 
after feeding.  
A Trx/RBD3 is detected in aphid diet and gut extract (Gut, arrowed) after feeding for 
48h but not presented in haemolymph or honeydew (Hd). Fifty-nanograms GNA is 
used as positive control for the blot (GNA standard). 
B GNA used as positive control shows that it transports from aphid gut to the 
haemolymph (Hm) It is detectable in honeydew (Hd) as well. However, RBD3/GNA can 
be detected only in diet (Diet), cleaved GNA is found in aphid gut extract (Gut) and 
haemolymph (Hm, arrowed). Ten, 20 and 30ng GNA used as standard and positive 
control for the blot. 
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4.3 Discussion and Conclusion 
In this chapter, constructs for expressing the dsRNA-binding domain RBD3 from 
Drosophila staufen were designed.  Expression of the domain as a fusion protein with 
thioredoxin (Trx) in E. coli, using a pET32 expression vector was successful in giving a 
functional product.  The expression level of Trx/RBD3 was approx. 180mg per litre of 
induced bacterial culture. After purification and desalting from induced soluble fraction, 
approximately 60% soluble Trx/RBD3 could be recovered. Most of the protein was lost 
during extended concentration of protein solutions by filter centrifugation. The most 
concentrated Trx/RBD3 sample achieved was 3mg/ml in 20mM sodium phosphate 
buffer. 
RBD3/GNA was successfully produced as a soluble protein, in yields of approx. 
10mg/L, by P. pastoris. However, purification from culture supernatant proved a 
problem, and the recovery level was low. The best recovery level was achieved by 
purifying from freeze dried supernatant re-suspended in 1XBB at pH 7.4. Overall, small 
amounts of soluble protein were produced by dialysis of eluted fractions after metal 
affinity chromatography, with dialysis into 20mM sodium phosphate buffer, pH 7.2, 
giving the most successful result, as shown in fig. 4.25 panel B, lane 5. This material 
was used in subsequent assays of RNA binding. 
 
 Further research into optimising expression conditions, and improving 
downstream processing, would be necessary before P. pastoris could be considered as 
a viable host for expressing RBD-containing fusion proteins. 
 
Assaying the binding activity of the recombinant protein by RESMA shows that 
Trx/RBD3 binds to dsRNA to cause a mobility shift on a stained TBE polyacrylamide 
gel. The binding constant Kd is estimated at approx. 8x10-8M in this work. In a previous 
study reported by (Ramos et al. 1999), the binding constant of dsRNA binding domains 
was estimated as 10-6M or higher by NMR. This could be due to using short dsRNA 
which is 12bp, whereas the assays reported here used a 277bp double helix designed 
for causing RNAi effect in insects. The RBD3-dsRNA recognition is mediated by loop2 
and loop4 of RBD3 interacting with adjacent minor and major grooves of dsRNA. 
However, the 12bp dsRNA designed by Ramos et al. was capped by an exceptionally 
stable C (UUGG) G tetraloop. Their results revealed that helix α 1 of RBD3 interacts 
with the tetraloop by contacting both the RNA bases and sugars (Ramos et al. 1999). 
The interactions between helix α 1 and capped dsRNA releases extra binding energy, 
but could also provide preference of certain RNA sequences. The failure to include a 
"loop" structure in the dsRNA used in the assays reported here might lead to a weaker 
interaction, but the estimated Kd is lower than that reported by Ramos et al. (1999), 
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which suggests the protein binds better to a longer dsRNA. Another factor in the 
binding activity of RBD3 is the length and exact sequence of the "domain" used for 
assays. Previous studies performed by St Johnston et al. (1992) and Ramos et al. 
(2000) used a staufen RBD3 sequence with an additional 10 residues beyond the end 
of the domain (Figure 4-43). A protein containing just the dsRNA binding domain (65 
amino acids) showed weak binding activity (St Johnston et al. 1992). The recombinant 
RBD3-containing proteins constructed in this work (70 aa) is 6 amino acid less on both 
N-terminal and C-terminal sides compared to the sequences previously used. This 
could affect the binding constant estimated from REMSA, but again, the estimated 
binding constant is actually lower than previous estimates, suggesting stronger binding. 
Therefore, the additional residues omitted from the present constructs compared to 
those used previously do not seem to be important for strong dsRNA binding activity. 
However, it has been proved that deletion of two or three amino acids from N terminal 
of the RNA-binding domain itself result in inactivity in RNA binding.   
In terms of the binding conditions, dsRNA and Trx/RBD3 was incubated in 
1Xbinding buffer containing 50mM Tris-HCL (pH 8), 5mM EDTA, 1mM DTT, 100ug/ml 
BSA and 5% glycerol. The mixture was incubated on ice for 20 minutes which gave the 
conditions used to estimate the binding constant. Ramos et al. (1999) performed the 
binding reaction in 10mM PO4-, 3mM DTT at pH 6.5 and incubated at 27 °C. They 
claimed that neither pH range between 5.5 and 6.8 nor the temperature from 6, 27 and 
34 °C will affect the binding. However, significant decrease in binding was observed 
when 5mM Mg2+ was added in the reaction; this could be due to the aggregation or 
interaction with RNA (Ramos et al. 1999).  
A similar buffer condition used for REMSA was performed by Bass et al. (1994). 
They identified Xenopus proteins containing two dsRNA binding domains and an 
auxiliary domain rich in arginine and glycine (RG domain).  The estimated Kd is 2.7x10-
9M for a synthetic 36bp dsRNA without extra loop. Binding is significantly reduced with 
the amino-terminal domain alone. Compared to staufen RBD3 used in this work. It 
suggests that a fusion protein containing multiple binding RNA-binding domains could 
provide stronger binding activity. Although previous research suggested that the RG 
domain lends cooperativity to the overall nucleic acid binding when associated with the 
RNA recognized motif (RRM) (Cobianchi et al. (1988); Nadler et al. (1991)), there was 
no significant differences in binding efficiency with proteins lacking the RG domain 
(Bass et al. 1994). 
The experiments described here show that dsRNA was successfully bound with 
Trx/RBD3. Despite this success, several improvements could be made to the system to 
achieve stronger binding and better protection. First, use of a stem-loop dsRNA with a 
tetraloop with a well-studied C (UUGG) G sequence could enhance the binding, as this 
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single stranded loop structure will increase additional binding sites with the helix α 1 of 
Trx/RBD3. Secondly, the amino acid sequence region for binding dsRNA used in the 
construct could include the additional 10 residues on either side of 65 amino acid 
RBD3 domain to achieve stronger dsRNA binding activity.  RBD3 is expressed 
successfully as soluble protein in pET32 system, therefore mutation N to Q for 
optimizing the condition of yeast expression in not necessary, although this mutation 
will not affect dsRNA binding. Lastly, a fusion protein with multiple copies of the RBD3 
domain could result in stronger binding, reducing the number of fusion protein 
molecules necessary to bind to cover the dsRNA. This would reduce the molar ratio of 
fusion protein: target RNA necessary to give protection. 
 
 
 
 
 
Figure 4-43 Alignment of RBD3 sequence from staufen homologues of 
Drosophila melanogaster (Dm) and Mus musculus (Mm).   
A: 85 amino acids region containing staufen RBD3 selected by previous studies shows 
strong dsRNA binding activity. Staufen RBD3 of 65 amino acids is highlighted in yellow.  
B: 70 amino acids region containing staufen RBD3 constructed as fusion protein in this 
work. Mutants in RBD3 either reduce or abolish dsRNA binding activity. Q replaces N 
for the convenience of yeast expression. Fortunately, this mutant does not reduce or 
abolish dsRNA binding activity.  
C: RBD3 of 65 amino acids from M. Musculus selected by Kawaguchi et al., (2009). S 
replaces E in M. musculus. Mutation of E in D. melanogaster cause inactive of dsRNA 
binding activity. This sequence different could cause different efficiency of dsRNA 
binding activity.  Adapted from Ramos et al. (1999). 
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Chapter 5 The persistence and stability of dsRNA against 
insect tissues and its improvement by conjugating with 
recombinant protein containing dsRNA-binding domain  
 
5.1 Introduction 
The results in Chapter 3 demonstrate that there are differences in the RNAi efficiencies 
among insect species from different orders. Robust and long-lasting RNAi effect is 
proved in T. castaneum, RNAi-induced gene downregulation was also detected in two 
Dipteran species: M. domestica and D. radicum, but only a weak and transient RNAi 
response was observed in A. pisum. Since dsRNA must be taken up into cells to 
generate siRNA which leads to subsequent degradation of target mRNA, stability of 
dsRNA to degradation in the extracellular environment could be a major factor in 
determining the efficiency of RNAi effects. Degradation of of dsRNA would lead to poor 
uptake, and a less sensitive RNAi response. Data concerning the stability of dsRNA in 
the haemolymph and gut extract of T. castaneum, D. radicum and A. pisum are 
presented in this chapter, and examined to determine whether correlations between 
dsRNA persistence and sensitivity to RNAi effects can be drawn. 
 To address potential problems of dsRNA stability in insect haemolymph and gut 
lumen, protection by forming complexes with the RNA-binding fusion proteins 
Trx/RBD3 and RBD3/GNA was considered. Enhancement of stability of dsRNA 
conjugated with RBD3-containing fusion proteins against the ribonucleases in insect 
haemolymph and gut extract is investigated. 
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5.2 Result 
 
5.2.1 The stability of dsRNA in insect diet 
 
5.2.1.1 The stability of dsRNA in T. castaneum diet 
Stability of dsRNA in the presence of T. castaneum larvae in flour disks were assessed. 
Samples of disks were taken at different time points after exposure to larvae, and 
dsRNA was extracted and analysed by electrophoresis on 1% agarose gel. Results are 
shown in Figure 5-1. Intact dsRNA can be detected in the diet up to 72h after feeding, 
as shown by the prominent band at approx. 380 bp (same as input dsRNA). However, 
the gel also shows multiple bands of lower mobility as a result of mixing dsRNA with 
wheat flour, possibly as a result of the formation of complexes between the dsRNA and 
wheat proteins. At 120h post feeding, the lower mobility bands disappear, and a 
broader smeared dsRNA band is present on the gel, which is indicative of dsRNA 
degradation. Despite the longer-term indications of degradation, the experiment 
establishes that feeding dsRNA as a component of diet in Tribolium spp. is a viable 
procedure. 
 
5.2.1.2 The stability of dsRNA in A. pisum diet  
The stability of dsRNA in aphid diet was investigated by using FITC-labelled dsRNA. 
The aphid liquid diet is a sterile mixture of defined chemicals, and dsRNA is stable over 
at least 5 days when dissolved (results not shown); diet containing dsRNA which was 
not exposed to aphids was used as control treatment. To evaluate dsRNA degradation 
caused by the secreted products of the aphid salivary gland, aphids were allowed to 
feed on diet containing dsRNA; diet samples were examined at two different time 
points, 5h and 72h. Samples from different treatments were then extracted and loaded 
on 6% TBE gel followed by visualization. Results are shown in Figure 5-2. After 5h 
feeding, the dsRNA band was almost the same as the control treatment was detected, 
suggesting no degradation. Intact dsRNA can still be detected in the diet after 72h 
exposure to aphid feeding, although partial dsRNA degradation was observed 
compared to control treatment. 
 
5.2.2 The stability of dsRNA in A. pisum honeydew in vitro  
Aphid honeydew was collected from insects confined in a 1.5ml plastic tube. Total 
protein from collected honeydew was measured by BCA assay and 20µg, 50µg and 
100µg total protein was incubated with dsRNA in a 20µl reaction at 25°C for 30 min. 
The result in Figure 5-3 shows that slightly degraded dsRNA signal was found in 
reaction containing 100µg total protein, but degradation by the lower amounts of 
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honeydew protein is very limited. The result shows that dsRNA degradation by A. 
pisum gut contents is limited in extent.  
 
5.2.3 Protein estimation of insect haemolymph and gut samples 
Gut samples were dissected from 50 late stage A. pisum, 30 T. castaneum larvae at 
the pre-pupal stage, and 20 D. radicum at pre-pupal larvae stage; soluble protein 
extracts were prepared from each sample, in total volumes of 50µl 1XPBS, in 60µl 
1XPBS and 100µl 1XPBS respectively. Protein concentrations in the extracts were 
6µg/µl in A. pisum gut sample, 7µg/µl in T. castaneum larvae gut sample and 16µg/µl in 
D. radicum larvae gut sample. Each A. pisum gut contained about 6µg protein whereas 
flour beetle larvae gut and D. radicum larval guts contained approx. 15µg and 80µg 
respectively. Haemolymph samples were collected from 50 late stage A. pisum    s and 
50 T. castaneum pre-pupal stage larvae in a final volume of 80µl 1XPBS containing 
PTU, and from 40 D. radicum pre-pupa stage larvae in 80µl 1XPBS containing PTU. 
Protein concentrations in A. pisum and T. castaneum larvae haemolymph samples 
were approximately 10µg/µl, and in the D. radicum larvae haemolymph sample the 
total protein concentration was approx. 50µg/µl according to the BCA assay. 
 
5.2.4 dsRNA is rapidly degraded in A. pisum and D. radicum gut extract but not 
in T. castaneum  (In vitro) 
An In vitro experiment was performed to investigate the persistence of dsRNA in 
insects’ gut. Initial experiments contained 200ng dsRNA incubated with an increasing 
amount of protein presented in insects gut extracts. 200ng dsRNA were incubated with 
D. radicum and T. castaneum larval gut extracts containing 3µg, 7µg, 14µg, 21µg and 
28µg total proteins. A. pisum gut extract contain 1µg, 2µg, 4µg, 8µg and 10µg protein 
was used for incubating dsRNA. The reactions were incubated at 25°C for 30 minutes 
and the integrity of dsRNA was examined on agarose gel (Figure 5-4. Incubation of 
dsRNA in gut extract isolated from late stage A. pisum and D. radicum larvae, resulted 
in fading and smearing of dsRNA on the gel (Figure 5-4 A and B). Weakening and 
smearing of dsRNA began to occur after incubation in A. pisum and D. radicum gut 
extract containing 3µg protein. More significant decrease of dsRNA signal was 
observed with higher amount of protein presented in gut extracts. dsRNA was 
completely undetectable after incubation with extract contain 4µg protein in A. pisum     
gut and 12µg protein in D. radicum gut in vitro. The control treatments indicated that 
dsRNA is relatively stable molecule and is not liable to degradation, whereas dsRNA 
was degraded rapidly in insects gut extract from A. pisum and D. radicum larvae 
extracts. 
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However, the situation in T. castaneum showed different pattern (Figure 5-4.C). When 
incubating dsRNA with 3µg, 7µg and 14µg T. castaneum larval gut extract, dsRNA 
showed decreased size gradually rather than smearing and weakening on the gel. The 
smaller dsRNA began to show weak signal after incubating with gut extract containing 
21µg protein and became undetectable when incubating with gut extract containing 
28µg protein. The results could be interpreted as a result of different types of 
ribonucleases present in insects gut that are able to degrade dsRNA. It is predicted as 
endoribonucleases in aphid gut and D. radicum larvae gut that degrades dsRNA 
internally whereas exoribonucleases in T. castaneum gut sample degrades dsRNA on 
5’ and 3’ prime ends of it.  
 
5.2.5 The rates of persistence of dsRNA against insect gut extract are different 
Another assay was carried out for comparing the degradation efficiency of dsRNA of 
ribonucleases presented in different insects. Firstly, gut extract from different insects 
were normalised to same amount (3µg) followed by incubating dsRNA in gut extracts 
for different time points. 200ng dsRNA were incubated in gut extracts containing 3µg 
total protein for 1min, 5min, 15min and 30min. The result is shown in Figure 5-5. After 1 
min incubation, dsRNA incubated with A. pisum gut extract showed weakening signal 
which can be interpreted as degradation whereas dsRNA incubated with other two gut 
extracts containing same amount of protein were not affected. dsRNA was completedly 
degraded in A. pisum gut extract after 5min and partly degraded dsRNA in D. radicum 
gut extract was observed. Smaller size of dsRNA was found in reaction containing T. 
castaneum gut extract after 15min incubation whereas dsRNA in other two gut samples 
were completely degraded. A significantly smaller size of dsRNA was presented in T. 
castaneum gut extract after 30 min incubation.   
 
A similar assay was performed to investigate the persistence of dsRNA when exposed 
to an amount of gut extract containing total protein equivalent to a single gut of each 
insect species (Figure 5-6). Each A. pisum gut contains about 6µg protein, whereas 
flour beetle larvae gut and D. radicum larvae contain 15µg and 80µg respectively. The 
reactions were incubated for 1min, 15min and 30min. dsRNA was degraded completely 
after incubation with D. radicum larval gut extract for 1min whereas dsRNA incubated 
with A. pisum extract shows weaken signal after 1min. The strongest signal was 
detected in reaction that dsRNA incubated with T. castaneum larval gut extract after 1 
min. After 15min incubation, dsRNA incubated with A. pisum gut extract was fully 
degraded whereas partly degraded dsRNA was observed in reaction that incubated 
with T. castaneum larval gut extract. Smaller size of dsRNA was more obvious in 
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reaction contain T. castaneum larval gut extract after 30 min incubation.  
 
5.2.6 The rates of persistence of dsRNA against insects haemolymph are variable 
The persistence of dsRNA in insect haemolymph were also investigated. DsRNAs were 
incubated with same amount of protein (25µg) present in insect haemolymph samples. 
The result in Figure 5-7 shows that dsRNA is degraded rapidly in A. pisum     
haemolymph, as a weaker signal was observed after 1min incubation. The band had 
completed disappeared in A. pisum haemolymph after 5 min incubation. Weakened 
dsRNA bands with decreased sizes were detected in both D. radicum and T. 
castaneum larval haemolymph after 5 min incubation. However, the signal was much 
stronger in T. castaneum larval haemolymph than D. radicum sample. After incubation 
for 30min, dsRNA with decreased size in intact form still can be detected in T. 
castaneum treatment whereas smearing of dsRNA was shown in D. radicum treatment.  
The results regarding stability of dsRNA in insect haemolymph and gut samples 
suggest that dsRNA was relatively stable and did not degrade under the experimental 
conditions utilized unless insect gut extract or haemolymph was present. Intact 
dsRNAs as positive controls were observed in each experiment eliminating the 
possibility that PBS responsible for dsRNA degradation, rather than insect 
haemolymph and gut extract. 
 
5.2.7 Improvement of stability of dsRNA by conjugation with Trx/RBD3 against 
degradation by insect haemolymph in vitro 
Experiments were carried out to determine whether the Trx/RBD3 fusion protein was 
able to improve the stability of dsRNA against degradation by enzymes present in 
insect haemolymph, through the formation of a complex which protected the RNA from 
the activity of RNases. DsRNA (200ng; approx. 1 pmole) or dsRNA conjugated with 
Trx/RBD3 (200ng plus 10µg protein; approx. 300-fold molar excess of protein) were 
mixed with different insect haemolymph samples. 
Without the protection of Trx/RBD3, 200ng Ap VTE dsRNA started to be degraded by A. 
pisum haemolymph containing 5µg protein after 1 minute, as non-degraded and partly 
degraded dsRNA are both presented in reaction according to the result shown in 
Figure 5-8. Degradation is seen as a reduction in the band intensity of intact dsRNA, 
and appearance of a "smear" of RNA of lower molecular weight. After incubation with 
haemolymph for 15min, no intact dsRNA remains, although an RNA band at a smaller 
size than the positive control is present, indicating that dsRNA is degraded by 
exoribonucleases presented in A. pisum haemolymph. When conjugated with 10µg 
Trx/RBD3, dsRNA is able to maintain its intact form against ribonucleases for at least 
15 minutes. Even after 30 minutes, dsRNA conjugated with Trx/RBD3 can still protect 
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part of dsRNA from cleavage by ribonucleases whereas dsRNA alone without any 
protection by Trx/RBD3 shows extensive degradation, with reduction to smaller size 
and weak signal. Trx was used as a negative control which shows no inhibition activity 
at all. The result shows that the RBD3 domain in the fusion protein Trx/RBD3 improves 
the stability of dsRNA against degradation by enzymes present in A. pisum     
haemolymph.  
Similar experiments were performed using haemolymph collected from T. castaneum 
larvae. Results are shown in Figure 5-9. Haemolymph of T. castaneum was found to 
contain comparatively little RNase activity, and an amount equivalent to 25µg protein 
had to be used to observe significant degradation in controls. Under these conditions, 
dsRNA started to be degraded by ribonucleases after 15min incubation, and dsRNA 
size difference is observed, similar to that seen for A. pisum. With conjugated with 
Trx/RBD3, dsRNA is fully protected as intact form against T. castaneum haemolymph 
until 30 minutes, the latest time point investigated.  
In contrast to T. castaneum haemolymph, haemolymph from D. radicum contained high 
levels of RNase activity, as shown in the results in Figure 5-10, where effects of an 
amount of haemolymph containing 25µg protein was used. DsRNA was completely 
degraded in haemolymph containing 25µg protein without being conjugated with 
Trx/RBD3 at 1 minute, the earliest time point tested. Trx/RBD3 was able to inhibit the 
degradation against D. radicum haemolymph for up to 15 minutes, as shown by intact 
dsRNA still being detectable. 
The differing activities of RNases in the different insect haemolymph samples was a 
feature of these assays. Five times more protein in T. castaneum haemolymph sample 
than A. pisum was used to achieve a similar level of degradation. DsRNA was partly 
degraded in A. pisum haemolymph containing 5ug protein after 1min (Figure 5-8) but 
not in T. castaneum haemolymph containing 25µg protein at this time point. However, 
after 15 min and 30 min the quantitative level of degradation is similar, although there 
are qualitative differences in that dsRNA shows two different sized bands with T. 
castaneum haemolymph (Figure 5-9), but not with aphid haemolymph. Compared to 
the ribonucleases presented T. castaneum haemolymph, D. radicum shows more 
efficient degradation when same amount of protein was tested. DsRNA was entirely 
degraded in D. radicum haemolymph after 1min (Figure 5-10) whereas dsRNA partly 
degraded in T. castaneum sample after 30 minutes (Figure 5-9). To conclude, the 
ribonucleases in A. pisum haemolymph shows the highest efficiency between the other 
two species, and the ribonucleases in D. radicum haemolymph are more efficient as 
degrading dsRNA than T. castaneum.    
All the haemolymph assays agree in showing that the RBD3 domain of fusion protein 
Trx/RBD3 is able to improve the stability of dsRNA and reduce the rate of degradation 
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of dsRNA by insect haemolymph, whereas an equivalent amount of Trx alone does not 
do so.  
 
5.2.8 Improvement of stability of dsRNA by conjugated with Trx/RBD3 against 
degradation by insect gut extract in vitro. 
Protection of dsRNA against degradation by RNases present in insect gut extracts was 
investigated by assays similar to those described for haemolymph extracts. DsRNA 
(200ng; approx. 1 pmole) or dsRNA conjugated with Trx/RBD3 (200ng plus 10µg 
protein; approx. 300-fold molar excess of protein) were mixed with different insect gut 
extract samples.  
A. pisum gut extract containing 2µg protein was incubated with dsRNA or dsRNA-
Trx/RBD3 conjugate for 1min, 15min and 30min. After incubation, all reactions were 
subjected to phenol / chloroform/ isoamyl alcohol (25:24:1) to recover the residual 
dsRNA.  The result in Figure 5-11 shows that dsRNA is degraded gradually by A. 
pisum gut extract containing 2µg protein after 1 min, with little intact dsRNA left at 15 
min. Two hundard nanograms dsRNA is completed degraded after 30 min. However, 
ApVTE dsRNA after conjugation with 10ug Trx/RBD3 is effectively protected against 
RNases in A. pisum gut extract for 30 minutes, with minimal degradation being 
observed. 
T. castaneum  gut extract containing 25µg protein was used for testing the activity of 
Trx/RBD3 (Figure 5-12, A). Reactions were prepared as same as A. pisum. TcAPIN 
dsRNA was completely degraded in 25µg gut extract after 1min. After conjugated with 
Trx/RBD3, dsRNA was effectively protected. There is a rapid degradation to produce 
RNAs of two different sizes (1min time point), but after this initial reaction, no further 
degradation of the smaller band is observed over 30 mins, showing that the greater 
part of the dsRNA is protected. An additional experiment was performed to confirm that 
stabilization of dsRNA was "dose dependent" and could be increased by conjugating 
with increasing amount of Trx/RBD3. 200ng Tc APIN dsRNA was conjugated with 
increasing amount of Trx/RBD3 (0µg, 2µg, 4µg, 8µg, 10µg, 14µg) against 25µg gut 
extract. The experiment was carried out at 25 °C for 30 minutes. Result shown in 
Figure 5-12B. The conjugates with higher amounts of RBD3 gave a distinct RNA band, 
as observed previously, but with amounts of Trx/RBD3 <10µg, there was evidence of 
degradation of this band, which were "dose dependent" in that the less protein was 
present, the more degradation was seen. These results establish the dsRNA protection 
conferred by RBD3, and show that the stability of dsRNA can be improved when more 
Trx/RBD3 is present in the reaction, probably as more binding reaction occurs. 
The D. radicum gut extract contained a high level of RNase activity as shown in the 
results of Figure 5-13). DrAPIN dsRNA is completely degraded in gut extract containing 
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15µg protein after 1min. Part of dsRNA is protected by Trx/RBD3 against gut extract for 
1min. However, no intact dsRNA is detected after 15min even when conjugated with 
Trx/RBD3.  
 
5.2.9 Stability of dsRNA conjugated with RBD3/GNA from P. pastoris against 
degradation by A. pisum     gut extract in vitro. 
Two-hundard nanograms ApVTE dsRNA was incubated with 10µg Trx/RBD3/GNA or 
RBD3/GNA against 2µg protein from A. pisum gut extract. However, neither of the 
conjugates were able to reduce the degradation of dsRNA by A. pisum extract (Figure 
5-14 A and B). In terms of dsRNA incubated with Trx/RBD3/GNA, smearing and 
weakening of the dsRNA band began to present after incubation in gut extract for just 
1min in both treatment without Trx/RBD3/GNA (Figure 5-14A, lane 2) and with 
Tx/RBD3/GNA (Figure 5-14A, lane 5), after 15min the dsRNA band in all tested 
samples had completely disappeared (Figure 5-14A, lanes 4 and 7). The result 
indicates that dsRNA was not conjugated or protected by Trx/RBD3/GNA which 
confirm that Trx/RBD3/GNA does not bind dsRNA. 
In Figure 5-14, B, dsRNA alone shows smearing on the gel and partial degradation 
after incubation with gut extract for 1 min (Lane 2), and no intact dsRNA is present after 
15 min (Lane 4). Pre-treatment by conjugation with RBD3/GNA resulted in complete 
degradation (Lanes: 5-7) of the nucleic acid at all time points. It is possible that the 
purified RBD3/GNA actually contained RNase activity, since inclusion of the fusion 
protein enhanced degradation rather than retarding it. 
 
5.2.10 Comparison of gene downregulation by dsRNA and dsRNA-Trx/RBD3 
conjugates. 
In order to show that conjugation with RBD3 did not prevent dsRNA from producing an 
RNAi effect, experiments were carried out in which the effects of injecting similar 
amounts of conjugated and non-conjugated dsRNA into insects were compared. 
 
Previous results in A. pisum suggested that approx. 50% downregulation of the ApVTE 
gene can be achieved by injection of 7.5ng ApVTE dsRNA. Therefore ApVTE dsRNA 
was selected to compare the gene downregulation by conjugating with Trx/RBD3. After 
injection, total RNA was isolated from aphids and analysed by real-time PCR. Results 
are shown in Figure 5-15. Insects injected with 5ng ApVTE dsRNA showed 40% 
downregulation of gene expression after 48h, consistent with previous results.  Insects 
injected with the same amount of dsRNA in the form of ApVTE-Trx/RBD3 conjugates 
showed no decrease in ApVTE gene expression, similar to the control treatments 
(Aphids injected with buffer or Trx/RBD3). At 72h post injection, the gene expression 
  
  
169 
level was similar in all treatments; neither the dsRNA-injected, nor conjugate-injected 
insects, differed from control treatments (ANOVA). These results suggested that 
conjugation could interfere with the RNAi effect in aphids, although there is only a weak 
RNAi effect under any circumstances.  
 
Experiments carried out in T. castaneum, using the TcAPIN gene as target for 
downregulation, gave a different outcome. Ten nanograms dsRNA with or without 
conjugation to RBD3, was injected into pre-pupal stage larvae and samples were 
collected at four different time points, including 2h and 5h post injection, to determine 
whether conjugation affected short-term RNAi effects. The results shown in  
Figure 5-16 demonstrate that 10ng APIN dsRNA causes gene downregulation as early 
as 5h after dsRNA injection, but not after 2h. When conjugated with Trx/RBD3, TcAPIN 
dsRNA causes approx. 40% APIN gene downregulation after 2h, while TcAPIN dsRNA 
only shows no downregulation when compared to control treatments (ANOVA, 
p<0.0001). At the 5h and subsequent timepoints, the RNAi effect caused by dsRNA is 
similar whether or not it is conjugated to RBD3. At 10days after injection, approx.75% 
APIN gene downregulation is observed in insects injected with either dsRNA or 
dsRNA-conjugates compare same treatmens at 5h and 24h timepoints  (ANOVA, 
p<0.0001). APIN gene downregulation is more effective at 10days than 5h after 
injection which illustrates the systemic, long-lasting RNAi effect produced by dsRNA in 
Tribolium spp., as described by other workers.  
 
Results obtained from injected conjugated and non-conjugated dsRNA into D. radicum 
larvae also suggested that conjugation does not prevent observation of an RNAi effect, 
as shown in Figure 5-17. This experiment only used a single time point after injection, 
but approx. 40% down-regulation of the DrAPIN gene was observed for both APIN 
dsRNA compared to control Trx/RBD3 treatment, difference is significant (ANOVA with 
P<0.05), but difference is not significant between control Trx/RBD3 treatment and APIN 
dsRNA-Trx/RBD3 conjugate treatment (ANOVA test). 
 
To conclude, the balance of evidence suggests that the RBD3/dsRNA conjugate is still 
capable of producing an RNAi effect; the failure to observe this in aphids may be due to 
choice of time points for sampling, or the poor RNAi response in these insects.  
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Figure 5-1 Stability of dsRNA wheat flour disks exposed to T. castaneum larvae. 
Lane +ve denotes 200ng dsRNA control in nuclease free water (i.e. no flour mixed or T. 
castaneum larvae fed on), Lane -ve control shows flour diet with T. castaneum larvae, 
but without dsRNA. Total RNA was extracted from disks exposed for the times 
indicated, 2µl from samples of each timepoints were loaded and analysed by agarose 
gel electrophoresis. Decreased signal was detected after 20h compared to 1h and 3h 
time points, which suggest dsRNA was partially degraded. The results for the 120h 
time point are from a separate gel, with a different molecular weight marker scale (two 
lanes on right of figure). After 120h, no intact band on gel was shown, indicating 
dsRNA degradation.  
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Figure 5-2 dsRNA was degraded in diet after feeding A. pisum for 72h. 
dsRNA was mixed with A. pisum diet for 5h and 72h time point, diet with A. pisum     
fed on was collected after 5h and 72h time points as indicated. +ve control denotes diet 
mixed with dsRNA collected after 72h without A. pisum fed on. Afterwards, A. pisum     
diet containing dsRNA was extracted by chloroform extraction and analysised on 6% 
TBE polyacrylamide gel.  
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Figure 5-3 In vitro experiment suggest dsRNA was degraded by the RNase 
presented in aphid honeydew 
An amount of 200ng dsRNA were incubated with 20µg, 50µg and 100µg total protein 
from honeydew in 20µl reaction at 25°C for 30min. Lane +ve control denotes 200ng 
dsRNA in 1XPBS (i.e. no honeydew added), Lane -ve control shows honeydew 
containing 100µg total protein with no added dsRNA. 
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                                      A                                                                  B                                
 
                                       C 
Figure 5-4 In vitro experiment indicated that dsRNA is rapidly degraded in A. 
pisum and D. radicum larval gut but not in T. castaneum larval gut extract.  
Aliquots (200 ng) of dsRNA were incubated with gut extracts prepared from A. pisum     
(Ap), T. castaneum (Tc) and D. radicum (Dr) larval guts for 30 minutes. +ve denotes 
dsRNA control (i.e. no added protein), -ve control shows gut extracts with no added 
dsRNA. A: An amount of 200ng dsRNA incubated with A. pisum gut extract containing 
1µg, 2µg, 4µg, 8µg and 10µg protein. B: 200ng dsRNA were incubated with D. radicum 
larval gut extract. C: T. castaneum larval gut extract containing 3µg, 7µg, 14µg, 21µg 
and 28µg total proteins. Rapid and complete dsRNA degradation were detected in A. 
pisum (A) and D. radicum extract (B). dsRNA was degraded at slow rate with size-
decreasing pattern in T. castaneum  gut extract (C).  
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Figure 5-5 In vitro experiment showing variability in the persistence and stability 
of dsRNA in gut extracts from different insect species. Aliquots (200 ng) of dsRNA 
were incubated with gut extracts (3 ug total protein in each case) prepared from A. 
pisum (Ap), T. castaneum  (Tc) and D. radicum larval guts for specified time points. 
+ve denotes dsRNA control (i.e. no added protein), -ve control shows gut extracts with 
no added dsRNA. The RNase presented in A. pisum gut extract showed the most rapid 
RNA degradation ability as dsRNA was partly degraded after 1min incubation. After 
5min incubation, dsRNA incubated with D. radicum larval gut extract showed smearing 
signal. dsRNA were detectable in reaction contain T. castaneum  larval gut extract after 
15min. Instead of showing smearing and weaken signal in A. pisum and D. radicum gut 
extract, gradually decreased size of dsRNA was observed in T. castaneum until 30 min 
after incubation.  
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Figure 5-6 In vitro experiment showing variability in the persistence and stability 
of dsRNA in gut extracts from different insect species.  
Aliquots (200 ng) of dsRNA were incubated with gut extracts (the amount of total 
protein equal to sigle gut in each insects in each case) prepared from A. pisum (Ap), T. 
castaneum  (Tc) and D. radicum (Dr) larval guts for specified time points. +ve denotes 
dsRNA control (i.e. no added protein), -ve control shows gut extracts with no added 
dsRNA. dsRNA was not detectable in D. radicum reaction after 1min incubation, and 
weaken signal was shown in A. pisum reaction after 1min. After 15 min incubation, 
dsRNA was completely degraded in A. pisum reaction. dsRNA in T. castaneum  
reaction showed signal with decreased size after 30min.  
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Figure 5-7 In vitro experiment showing variability in the persistence and stability 
of dsRNA in cell-free haemolymph efrom different insect species. 
Aliquots (200 ng) of dsRNA were incubated with cell-free insect haemolymph (25ug 
total protein in each case) prepared from A. pisum (Ap), T. castaneum  (Tc) and D. 
radicum (Dr) larval haemolymph for specified time points. +ve denotes dsRNA control 
(i.e. no added protein), -ve control shows gut extracts with no added dsRNA. 
When dsRNA incubated with insect haemolymph extract, A. pisum extract degrades 
dsRNA at the highest rate than other two species. Smearing and weakening signal 
from A. pisum treatment was detected after 1 min incubation; the signal was completely 
disappeared after 5mins. dsRNA incubated with D. radicum larval haemolymph extract 
showed relatively slow rate of degradation. Weakening signal is still detectable after 15 
min. In terms of T. castaneum larval extract, a slow rate of degradation was observed. 
As the figure shows dsRNA with partly intact form was still detectable after 30min 
incubation, the latest time point assayed.  
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Figure 5-8 Improvement of stability of dsRNA by Trx/RBD3 against A. pisum     
haemolymph. 
Aliquots (200 ng) of ApVTE dsRNA were incubated with cell-free A. pisum (Ap) 
haemolymph at 25°C for specified time points. +ve denotes dsRNA control incubated in 
1XPBS containing PTU (i.e. no added haemolymph or Trx/RBD3) for 30 min (Lane 1). 
-ve control shows dsRNA incubated with 10µg Trx against haemolymph containing 5µg 
for 1min (Lane 8). Lanes 2-4 show 200ng ApVTE dsRNA incubated with A. pisum     
haemolymph containing 5µg protein for 1, 15 and 30 min. Lanes 5-7 show 200ng 
ApVTE dsRNA conjugated with 10µg Trx/RBD3 and incubated with A. pisum     
haemolymph containing 5µg protein for 1, 15 and 30 min.  
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Figure 5-9 Improvement of stability of dsRNA by Trx/RBD3 against T. castaneum 
haemolymph. 
Aliquots (200 ng) of TcAPIN dsRNA were incubated with cell-free T. castaneum  (Tc) 
larval haemolymph at 25°C for specified time points. +ve denotes dsRNA control 
incubated in 1XPBS containing PTU (i.e. no added haemolymph or Trx/RBD3) for 30 
min (Lane 1). -ve control shows dsRNA incubated with 10µg Trx against haemolymph 
containing 25µg for 1min (Lane 8). Lanes 2-4 show 200ng Tc APIN dsRNA incubated 
with T. castaneum haemolymph containing 25µg protein for 1, 15 and 30 min. Lanes 5-
7 show 200ng TcAPIN dsRNA conjugated with 10µg Trx/RBD3 and incubated with T. 
castaneum haemolymph containing 25µg protein for 1, 15 and 30 min. 
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Figure 5-10 Improvement of stability of dsRNA by Trx/RBD3 against D. radicum 
haemolymph 
Aliquots (200 ng) of DrAPIN dsRNA were incubated with cell-free D. radicum larval 
haemolymph at 25°C for specified time points. +ve denotes dsRNA control incubated in 
1XPBS containing PTU (i.e. no added haemolymph or Trx/RBD3) for 30 min (Lane 1). -
ve control shows dsRNA incubated with 10µg Trx against haemolymph for 1min (Lane 
8). Lanes 2-4 show 200ng DrAPIN dsRNA incubated with D. radicum haemolymph 
containing 25µg protein for 1, 15 and 30 min. Lanes 5-7 show 200ng DrAPIN dsRNA 
conjugated with 10µg Trx/RBD3 and incubated with D. radicum haemolymph 
containing 5µg protein for 1, 15 and 30 min. 
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Figure 5-11 Improvement of stability of dsRNA by Trx/RBD3 against A. pisum     
gut extract. 
Aliquots (200 ng) of ApVTE dsRNA were incubated with A. pisum     (Ap) gut extract at 
25°C for specified time points. +ve denotes dsRNA control incubated in 1XPBS (i.e. no 
added gut extract or Trx/RBD3) for 30 min (Lane 1). -ve control shows dsRNA 
incubated with 10µg Trx against gut extracts for 1min (Lane 8). Lanes 2-4 show 200ng 
ApVTE dsRNA in 1XPBS incubated with 2µg A. pisum gut extract at 25 °C for 1min, 
15min and 30min. Lanes 5-7 show 200ng ApVTE dsRNA conjugated with 10µg 
Trx/RBD3 and incubated with 2µg A. pisum gut extract at 25 °C for 1min, 15min and 
30min. 
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 (A) 
 
 (B) 
Figure 5-12 Improvement of stability of dsRNA by Trx/RBD3 against T. castaneum 
gut extract 
Aliquots (200 ng) of TcAPIN dsRNA were incubated with T. castaneum larval gut 
extract at 25°C for specified time points. +ve denotes dsRNA control incubated in 
1XPBS (i.e. no added gut extract or Trx/RBD3) for 30 min (A&B: Lane 1). -ve control 
shows dsRNA incubated with 10µg Trx (A: Lane 8) or 14µg Trx (B: Lane 8) against gut 
extracts for 1min (A) or 30min (B). (A): Lanes 2-4 show 200ng TcAPIN dsRNA in 
1XPBS incubated with 25µg T. castaneum gut extract at 25 °C for 3 different timpoints. 
Lanes 5-7 show 200ng TcAPIN dsRNA conjugated with 10µg Trx/RBD3 and incubated 
with 25µg T. castaneum gut extract at 25 °C for 3 different timepoints. 
(B): Lanes 2-7 show 200ng TcAPIN dsRNA conjugated with 0µg, 2µg, 4µg, 8µg, 10µg, 
14µg against 25µg gut extract at 25 °C for 30 minutes. 
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Figure 5-13 Improvement of stability of dsRNA by Trx/RBD3 against D. radicum 
gut extract 
Aliquots (200 ng) of dsRNA were incubated with D. radicum larval gut extract at 25°C 
for specified time points. +ve denotes dsRNA control incubated in 1XPBS (i.e. no 
added gut extract or Trx/RBD3) for 30 min (Lane 1). -ve control shows dsRNA 
incubated with 10µg Trx against gut extracts for 1min (Lane 8). Lanes 2-3 show 200ng 
DrAPIN dsRNA in 1XPBS incubated with 15µg D. radicum gut extract at 25 °C for 
1min, 15min. Lanes 4-5 show 200ng DrAPIN dsRNA conjugated with 10µg Trx/RBD3 
and incubated with 15µg D. radicum gut extract at 25 °C for 1min, 15min. 
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(A) 
(B) 
 
Figure 5-14 Stability of dsRNA conjugated with Trx/RBD3/GNA and RBD3/GNA 
against A. pisum     gut extract 
Aliquots (200 ng) of ApVTE dsRNA were incubated with A. pisum gut extract at 25°C 
for specified time points. +ve denotes dsRNA control incubated in 1XPBS (i.e. no 
added gut extract, Trx/RBD3GNA or RBD/GNA) for 30 min (A&B: Lane 1). -ve control 
shows dsRNA incubated with 10µg GNA against gut extracts for 1min (Lane 8). A&B:  
Lanes 2-4 show 200ng ApVTE dsRNA in 1XPBS incubated with 2µg A. pisum gut 
extract at 25 °C for 1min, 15min and 30min. Lanes 5-7 show 200ng ApVTE dsRNA in 
1XPBS conjugated with Trx/RBD3/GNA (A) or RBD3/GNA (B) against A. pisum gut 
extract at 25 °C for 1min, 15min and 30min.  
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Figure 5-15 Comparison of gene downregulation by injection of ApVTEdsRNA 
and ApVTE dsRNA-Trx/RBD3 conjugate by qRT-PCR. 
Five days old aphid nymphs injected with 20mM Sodium phosphate buffer (Naph) as 
negative control. Injections were carried out with protein Trx/RBD3 as an additional 
negative control. Nymphs injected with 5ng ApVTE dsRNA was treated as positive 
control. Trx/RBD3 was incubated with ApVTE dsRNA for binding prior injection. 
Columns show the levels of transcript relative to GADPH transcript (internal standard), 
normalised to Control (Naph) 48h=1.0. Error bars indicate standard errors of the mean 
for 3 technical replicates. Number of insects used for each treatment n=5. Difference 
between treatments is not significant (ANOVA). 
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Figure 5-16 Comparison of gene downregulation by injection of TcAPIN dsRNA 
and TcAPIN dsRNA-Trx/RBD3 conjugate by qRT-PCR. 
Pre-pupa stage T. castaneum larvae injected with 20mM Sodium phosphate buffer 
(Naph) and Trx/RBD3 were treated as negative control. Larvae injected with 10ng 
TcAPIN dsRNA was treated as positive control. Trx/RBD3 was incubated with TcAPIN 
dsRNA for binding prior injection. Columns show the levels of transcript relative to 
GADPH transcript (internal standard), normalised to Control (Naph) 48h= 1.0. Error 
bars indicate standard errors of the mean for 3 technical replicates. Number of insects 
used for each treatment n=5 (ANOVA with p<0.0001, ****). 
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Figure 5-17 Comparison of gene downregulation by injection of DrAPIN dsRNA 
and DrAPIN dsRNA-Trx/RBD3 conjugate by qRT-PCR 
Third instar D. radicum larvae injected with Trx/RBD3 were treated as negative control. 
Larvae injected with 100ng DrAPIN dsRNA was treated as positive control. Trx/RBD3 
was incubated with DrAPIN dsRNA for binding prior injection. Columns show the levels 
of transcript relative to GADPH transcript (internal standard), normalised to Control 
(Trx/RBR3) =1.0.  Error bars are mean value from 3 technical replicates. Number of 
insects used for each treatment n=5. Difference between Trx/RBD3 treatment and 
DrAPIN dsRNA treatment is significant by ANOVA test with p<0.05, *. No significant 
difference between Trx/RBD3 and conjugate treatment (ANOVA).  
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5.3 Discussion 
As various sensitivities of RNAi in insects were observed, efforts were made to 
investigate the potential parameters could be responsible for this difference. For 
efficient RNAi response, the persistence of intact dsRNA need to be long enough in 
extracellular environment for its uptake by cells after delivering by injection and 
feeding. The stability of dsRNA in insect diets were firstly investigated and results 
suggest that the amount of dsRNA exposed to A. pisum via feeding was less than 
expected. Intact dsRNA was found in aphid diet with aphids feeding, although some of 
the dsRNA was degraded. In T. castaneum diet, however, intact dsRNA was found to 
survive for much longer term. In vitro and in vivo experiments of persistence and 
stability of dsRNA in aphid salivary secretions and haemolymph were also examined by 
Christiaens et al. (2014). Degraded dsRNA in aphid diet was detected after 84h 
whereas rapid degradation was found in aphid haemolymph after 12h. Similar result 
was also reported by Allen and Walker III (2012) in another hemipteran, the tarnished 
plant bug Lygus lineolaris, that the secretions from salivary glands were able to 
degrades dsRNA in the diet. In this work, intact dsRNA was found in aphid diet with 
aphids feeding after 72h, although some of the dsRNA was degraded. Moreover, the 
stability of dsRNA was also tested in vitro against A. pisum honeydew, slightly 
degraded dsRNA was found which indicated that the RNase presented in gut cell 
degraded dsRNA rather than the RNase from ingested content in A. pisum.  
 
In vitro experiments using cell-free haemolymph and gut extract, which eliminating the 
possibility that any disappearance of dsRNA could be explained by uptake into cells. 
The result shows that synthetic dsRNA molecules are rapidly and completely degraded 
in A. pisum haemolymph extract, moderately degraded in D. radicum larval 
haemolymph extract, but degraded with a slow rate in T. castaneum haemolymph 
extract (Fig. 5.5). DsRNA in T. castaneum haemolymph extract presented a size-
decreasing pattern at different time points whereas completely smearing and 
weakening signals were observed in other two species. The result in T. castaneum 
haemolymph extract suggest that the nature of RNases could be exoribonuclease 
activity rather than endonuclease activity. It has already documented in previous 
literature that the action of endogenously expressed nucleases could be detrimental for 
RNAi response. Although robust systemic RNAi response has been proved in C. 
elegans, worm tissues such as gonad and neurons are unusually refractory to RNAi 
whereas all other tissues are susceptible to RNAi (Kennedy et al. 2004). In C. elegans, 
a nuclease encoded by the eri-1 (enhanced RNAi-1) gene was identified and it 
expresses at high level in worm gonad and neurons. Enhanced RNAi response and 
greater accumulation of siRNAs than wild type animals were found in eri-1 mutant 
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worms (Kennedy et al. 2004). Moreover, eri-1 homologues, meri-1 (mouse enhance 
RNAi-1) was found in mice and RNAi against meri-1 result in enhanced sensitivity of 
RNAi in mice (Hong et al. 2005). An enzyme with dsRNAse activity was also been 
identified in lepidopteran insect, the silkworm B. mori (Arimatsu et al. 2007). 
Furthermore, rapid degradation of dsRNA occurs in haemolymph of RNAi-insensitive A. 
pisum, and relatively fast degradation in D. radicum, but not in the haemolymph of the 
RNAi-sensitive T. castaneum larval extract indicates the persistence of dsRNA against 
nucleases in insect extracellular environment could be the key factor in determining the 
success of RNAi experiments. However, limited information of dsRNA-specific 
nucleases in insects that could interfere with RNAi is amendable. More efforts should 
be made to identify the endoribonucleases and exoribonucleases.  
 
Gene downregulation as well as mortality were observed in dsRNA fed T. castaneum, 
but not in other two species. Thus the persistence of dsRNA against A. pisumand D. 
radicum gut extracts were compared with T. castaneum gut extract as the insect gut is 
the first barrier for dsRNA after being ingested orally. When analysing dsRNA with 
same concentration of total protein from three insect gut extracts, the result revealed a 
rapid and completely dsRNA degradation in A. pisum gut extract, moderately fast 
degradation in D. radicum larval gut extract. However, in T. castaneum, larval gut 
extract degraded dsRNA at very slow rate. The result indicates that RNAi induced gene 
downregulation is restricted to cells in A. pisum and D. radicum guts. Similar to the 
result of dsRNA degradation in T. castaneum haemolymph extract, dsRNA was 
degraded with decreasing size and can survive for a much longer time than in other 
two insect gut extracts. The result could lead to hypothesis that dsRNA degraded by 
exoribonucleases rather than endoribonucleases at slow rate and remain partly intact 
and this allow form allow survival for a longer time and uptake of dsRNA by cells in T. 
castaneum larvae. The stability of dsRNA was also tested against total protein 
equivalent to single gut of each insect, and dsRNA was found to be degraded at 
highest rate in D. radicum larval gut extract due to the highest amount of protein 
(80µg). However, the total protein extracted and tested in this work may not truly reflect 
the real situation in vivo. 
Experiments in vitro showed that conjugation to Trx/RBD3 was able to reduce 
the rate of degradation of dsRNA when exposed to insect haemolymph. These results 
were consistent across different species, and gave direct evidence for the utility of 
conjugate formation in protecting dsRNA. The effects of conjugation of dsRNA to 
Trx/RBD3 in vivo after injection into haemolymph could thus be predicted to be 
extension or improvement of the RNAi effect induced by injected dsRNA. However, it is 
also possible that the dsRNA could be prevented from showing any RNAi effect as a 
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result of conjugation, due to lack of uptake into cells, or availability for the RNAi 
machinery being blocked. The results in A. pisum suggest that conjugation with 
Trx/RBD3 does somehow interfere with RNAi effect. However, the injected T. 
castaneum shows different result pattern. DsRNA-Trx/RBD3 conjugate injection shows 
a faster RNAi response than dsRNA injection only (from results at 2h post injection). 
The improved RNAi response could due to more intact dsRNAs being maintained in T. 
castaneum haemolymph before they are transported into different cells.  
In terms of using RBD3 to protect dsRNA from biodegradation, dsRNA-
Trx/RBD3 complexes were assayed against different insect haemolymph and gut 
extracts. The results demonstrated that Trx/RBD3 is able to improve the stability of 
dsRNA and reduce the rate of degradation by the ribonucleases present in insect 
haemolymph and gut extract. A recent study investigated improvement of the stability of 
dsRNA by conjugating RBD3 from the Mus musculus Staufen (Kawaguchi et al. 2009). 
Unexpectedly, the recombinant RBD3 was not able to improve the stability of siRNA 
against fetal bovine serum (FBS), but showed some protection of shRNA that has a 
stem loop structure. The amino acid sequence alignment between D. melanogaster 
and M. musculus is shown in figure 4.43 (in chapter 4). As figure 4.43, indicates that 
RBD3 from Mus musculus chosen by Kawaguchi et al. (2009), contained only the 65 
amino acid domain. This could be one of the reasons for inefficient binding in their 
results. Another issue could be RBD3 from different species shows different efficiency 
of dsRNA binding activity. For example, both of the domains are required for optimal 
dsRNA binding by human dsRNA-dependent protein kinase (PKR), and mutations in 
one domain are more damaging than in the other (Green and Mathews 1992). 
However, a synthetic 24 amino acid peptide containing only part of the RNA-binding 
domain from intact 345 amino acid human immunodeficiency virus type 1 
transactivation response RNA binding protein (TRBP) shows efficient dsRNA binding 
activity (Gatignol et al. 1993). 
 
Positive results were obtained with insect gut extracts in vitro, showing that 
dsRNA in Trx/RBD3 conjugates showed enhanced resistance to nuclease activity in all 
the insect species examined. However, neither Trx/RBD3/GNA nor RBD3/GNA were 
able to improve dsRNA stability against A. pisum gut extract. This could due to the bad 
protein sample preparation, as little soluble Trx/RBD3/GNA from induced E. coli cells 
can be purified and large amount of protein precipitation was observed during dialysis 
and concentrating steps. Although RBD3/GNA can be produced as a soluble protein 
from P. pastoris, REMSA assays do not show consistent evidence for dsRNA binding 
activity, and the assays with aphid gut extract showed no evidence for improving 
dsRNA stability. Indeed, results from REMSA (chapter 4) and other assays suggest that 
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RBD3/GNA from P. pastoris may itself be contaminated with nuclease activity, making 
any protective effect difficult to observe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
191 
Chapter 6 General discussion  
 
Gene silencing through RNAi is a useful reverse genetic technique that has 
revolutionized the study of gene function in insect species, particularly in non-model 
insects. The generation of a loss-of-function phenotype by depletion of a chosen 
transcript has been recognised as a potential method for linking genes to processes in 
many different fields of insect biology (Bellés 2010), as well as for developing medical 
treatments (Tiemann and Rossi 2009). Unfortunately, recent studies regarding RNAi in 
insects have revealed that there is clear variability in the susceptibility of insect species 
to RNAi. Terenius et al. (2011) reviewed RNAi experiments in Lepidopteran species, 
and concluded that there is variation in RNAi efficiency of the technique related to 
insect species, tissues and target gene selected. Moreover, cases of contrasting 
results from similar experiments have also been reported. Low reproducibility of RNAi 
experiments in Hemipteran insects, such as aphids, were also noticed.  
This thesis describes work that has attempted to explore the mechanistic reason 
underlying the differing susceptibility to RNAi in different insects, in the context of 
testing the potential for using RNAi for crop protection. RNAi responses in insects from 
three different orders (T. castaneum, Coleopteran; M. domestica and D. radicum, 
Dipteran and A. pisum from Hemiptera) were selected and compared. To standardise 
the RNAi experimental parameters in insects, a conserved region from the sequence of 
V-type ATPase E subunit of insects was chosen for designing dsRNA with same length 
(277bp). Similarly, comparable dsRNAs were also selected from the APIN (Inhibitor of 
Apoptosis) gene, although in this case the sequences were more variable in length due 
to differences in the target genes. The dose of dsRNA used was considered in relation 
to the relative sizes of the insects on a weight basis. Assessment of the efficacy of 
gene knockdowns was determined by using real time qPCR.  
In this work, a robust systemic RNAi response was observed in T. castaneum larvae by 
both injection and feeding of dsRNAs against TcVTE and TcAPIN genes. A phenotype 
resulting from the RNAi effect was observed, and down-regulation of target genes was 
confirmed by qPCR. These results (Chapter 3) agree well with previous studies 
(Tomoyasu and Denell (2004); Arakane et al. (2005); Whyard et al. (2009); (Miller et al. 
2012)). Successful target APIN downregulation and phenotype were also achieved in 
two Dipteran species which are M. domestica and D. radicum larvae, however the 
RNAi effect rely on microinjection of dsRNA and was found to be stage dependent 
(RNAi response was not detected in M. domestica adult). Feeding dsRNA to Dipteran 
larvae failed to provoke any RNAi response (Chapter 3). In terms of A. pisum, limited 
silencing was observed (Chapter 3). ‘Weak’ gene downregulation and phenotype were 
achieved only by injection of ApVTE dsRNA. Feeding ApVTE dsRNA did not result in 
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any phenotype effects on either survival or fitness parameters. Attempts to silence 
ApAPIN gene was completely unsuccessful either by injection or feeding. The results 
with aphids contrast with those for flour beetle, and cannot be explained by stability of 
dsRNA in the diet; even though dsRNA survived for a longer time during feeding in T. 
confusum diet than in A. pisum liquid diet, it was present in both for long enough to 
produce an RNAi effect if the timescale of the effect produced by injection is indicative.  
For a better understanding the various sensitivities to RNAi in these three insects, 
attempts were made to investigate the persistence of dsRNA in both insect 
haemolymph and gut extract. Rapid and complete degradation of dsRNA was found to 
occur in RNAi insensitive A. pisum haemolymph. Previous studies performed by 
Christiaens et al. (2014) also demonstrated a fast dsRNA degradation in A. pisum     
haemolymph. Compared to A. pisum haemolymph, dsRNA is degraded slower rate in 
D. radicum larval haemolymph. In the haemolymph of the RNAi-sensitive T. castaneum 
larvae, partial degradation of dsRNA was observed at a slow rate than other two tested 
insects. These findings could explain the weak RNAi effects in A. pisum, as exogenous 
dsRNA delivered by injection was broken down rapidly in aphid haemolymph before its 
uptake by cells where the RNAi process takes place. Fast degradation was also 
observed in larval haemolymph of D. radicum. However, significant RNAi response was 
achieved after injection of dsRNA into D. radicum larvae. This indicated that dsRNA 
survived for sufficiently long for its uptake by cells in D. radicum larvae. In terms of T. 
castaneum, dsRNA with a long survival period could be the first parameter for RNAi, as 
a result of sufficient dsRNA uptake by cells.  
Rapid degradation of dsRNA in haemolymph could be an adaption for evolutionary 
response to a heavy viral loads that led to the constitutive expression of active RNases 
against viral RNAs. Aphids are sap-sucking insects that can damage crops by 
transmitting viral diseases. Historical exposure of A. pisum to viral infection may have 
resulted in an active RNA degradation ability against virus. The result of dsRNA 
feeding experiment also indicated that the products of A. pisum salivary glands were 
able to degrade some of dsRNA in the diet. In Dipteran species, the model insect D. 
melanogaster is relatively insensitive to exogenous dsRNA. The effectiveness of 
dsRNA in this species appears to differ over different developmental stages; in larvae 
dsRNA was found to be only incorporated in hemocyte cells in the hemolymph (Miller 
et al. 2008), but in adults and embryos it is able to penetrate into different tissues 
(Tomoyasu et al. 2008).  
Apart from the differences in dsRNA degradation mechanism in insects’ extracellular 
environment, another most important factor for a robust RNAi response is the 
amplification and export of the dsRNA signal in the cells initially targetted, so that the 
RNAi effect spreads through cells and tissues in the organism. As mentioned in chapter 
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1, the transitive RNAi in C. elegans relies on the production of secondary dsRNA by an 
RNA-dependent RNA polymerase (RdRP) whereas the systemic property is dependent 
on the gene sid-1, which encodes a multitransmembrane domain protein and is 
recognized as a channel for transporting dsRNA.  A comparison of RNAi related genes 
between C. elegans and insects revealed that the core RNAi machinery enzymes like 
Dicer and Argonaute are conserved in C. elegans and insects (Tomoyasu et al. 2008), 
which indicated that the poor sensitivity in some insect species is restricted to 
transmission of interfering signal though cells and tissues rather than core machinery 
(Bellés 2010). The evidence from Miller et al. (2008) demonstrated that over-
expression of dsRNA within the cells could trigger RNAi responses in D. melanogaster 
tissues that are known for resistance to systemic RNAi. In terms of SID genes, a single 
orthologue of sid-1 is identified in each of the bee (Winston et al. 2002), louse and 
aphid genomes, whereas three orthologues are observed in moth Bombyx and the 
beetle Tribolium (Tomoyasu et al. 2008). The variation in the number of sid-1 genes 
could lead to different susceptibility to RNAi in different insect species.  
 
It is necessary to identify and compare the identity of the enzymes responsible for 
dsRNA degradation in insect haemolymph and gut of A. pisum     and T. castaneum. 
Ion exchange chromatography and affinity chromatography could be applied to 
separated protein fractions. The ability of dsRNA degradation of the isolated protein 
fraction could be assessed by incubating protein sample with dsRNA using agarose 
gel-based system validated in chapter 5. Fractionation of protein may require several 
repeated experiments using sensitive affinity chromatography to achieve a sample only 
containing one protein. Identification of the protein sequence and domain could be 
examined by loading onto SDS-PAGE followed by MALDI-TOF mass spectrometry.  
 
A strategy based on RNA-binding proteins was explored in this thesis to stabilise 
dsRNA by protecting it from degradation Trx/RBD3 was expressed as soluble active 
fusion protein from E. coli system and the dsRNA binding property was confirmed by 
REMSA system. The estimated binding constant Kd is approx. 8x10-8M in this work 
(Chapter 4). Compared to previous study using short dsRNA (12bp) with extra tetraloop, 
longer dsRNA with sufficient length 277bp to induce RNAi response resulted in 
stronger binding. The stability of dsRNA was successfully improved by Trx/RBD3 
conjugation against RNases from tested insects haemolymph and gut extract (Chapter 
4). However, since the RNAi response is a cellular process, dsRNA needs to be 
recognized and processed by Dicer and Argonaute protein in the pathway after being 
imported into cells. Conjugation with Trx/RBD3 could lead to a potential risk of blocking 
the process of dsRNA uptake into cells, since there is a possibility that Trx/RBD3-
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dsRNA would fail to be taken up by the cell as a conjugated form. Luckily, the 
conjugate showed more rapid RNAi response than dsRNA injection however only in T. 
castaneum  (Chapter 4), but not in A. pisum.  The result in A. pisum suggest that the 
conjugate does somehow interfere with RNAi effect (Chapter 4), although the RNAi 
induced gene downregulation in A. pisum is limited (Chapter 3).  
Alternative strategies to stabilise dsRNA by using chemical modification were 
investigated by previous researchers. Morrissey et al. (2005a), (Morrissey et al. 2005b) 
chemically substituted all 2'-OH residues on siRNA targeted to hepatitis B virus with 2'F, 
2'O-Me or 2'H residues. The stabilized siRNA was then incorporated in a specialized 
liposome to form a stable nucleic-acid-lipid particle (SNALP). The authors reported that 
a longer half-life of siRNA-SNALP in mice plasma and liver (in vivo) after administration 
which led to an RNAi effect after applying lower doses with less frequency.  Another 
study performed by Layzer et al. (2004) modified siRNA with 2’-flouro (2’-F) pyrimidine 
result in increased stability and a prolonged half-life in human plasma compared to 2’-
OH containing siRNAs. But improved stability did not lead to enhanced gene inhibition 
in mice after injection. Liu et al. (2012) developed a solid phase method for peptide-
siRNA covalent conjuagets based on click chemistry. The conjugation of peptides and 
siRNAs through a 1,2,3,-triazole linker. Alkynyl nucleoside analogue ’clikced’ onto a 
peptide-derivatized Controlled Pore Glass (CPG) followed by oligonucleotides 
synthesis. The results show that the 3’-snese strand conjugate maintained gene 
silencing activity. However, the silencing activity of 3’-antisense strand conjuagate is 
decreased (Liu et al., 2012). 
 
In order to address limitations of RNAi effects after feeding dsRNA in insects due to the 
poor transport of RNA to the circulatory system, recombinant proteins Trx/RBD3/GNA 
and RBD3/GNA were expressed in E. coli and P. pastoris, respectively. However, due 
to the insolubility of Trx/RBD3/GNA, the dsRNA binding assay of Trx/RBD3/GNA did 
not show convincing binding ability (Chapter 4). Although RBD3/GNA can be produced 
from yeast as soluble protein, REMSA indicates that RBD3/GNA degrades dsRNA 
rather than protecting dsRNA from degradation. Moreover, neither the assays with 
aphid gut extract showed evidence for improving dsRNA stability (Chapter 4). 
Previous studies indicated that production of GNA in E. coli system could be 
problematic, but soluble and active GNA was successfully purified and refolded from 
inclusion bodies of induced E. coli cells by Longstaff et al. (1998). Briefly, induced cells 
pellet was lysed and inclusion bodies were prepared in 10mM MgCl2 and 1mM MnCl2 
to increase enzyme activity.  The inclusion bodies were then precipitated by adding 2 
vol. 0.2M NaCl, 1% deoxycholate, 1% Nonidet P-40, 20 mM Tris/HCl pH 7.5, 2 mM 
EDTA followed by centrifugation. The inclusion bodies were then solubilised in buffer 
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containing 6M urea and purified from metal-affinity column. Unbound protein was 
washed off by buffer containing 6M urea and column was was rinsed with 60Mm 
imidazole in buffer containing decreasing amounts of urea (6, 4, 2, 1, 0.5, 0.25 and 
0.125M). Refolded GNA was eluted with buffer containing 300mM imidazole and 
dialysed against 50mm Tris/HCl pH 7.9. GNA purified from this method showed activity 
of specific mannose binding property and toxicity towards rice brown planthopper (N. 
lugens) (Longstaff et al. 1998). The inclusion bodies from induced Trx/RBD3/GNA in 
this work shows a single and clean product (Chapter 4). Refolding Trx/RBD3/GNA from 
induced inclusion bodies according to method developed by Longstaff et al. (1998) may 
lead to active fusion protein product.  
 
Different approaches could be also applied for transporting dsRNA according to 
previous literature. Fusion proteins with two cell-penetrating peptides (CPP): human 
transcriptional factor Hph-1-Hph-1, and a double-stranded RNA binding domain from 
human Dicer was constructed for siRNA delivery to a heart transplant model (Li et al. 
2014). CPP transfers siRNA through covalent and noncovalent associations and 
should able to transport the dsRBD/siRNA complex into cells. A much higher 
percentage of target GAPDH mRNA in Hela cells was downregulated by Hph-1-Hph-1-
dsRBD-siRNA than either siRNA only or treatment using LipofectamineTM  RNAiMAX 
for siRNA delivery (Li et al. 2014). In vivo evidence by using FAM-siRNA bound with 
Hph-1-Hph-1-dsRBD-siRNA demonstrated that the complex entered the heart and was 
distributed throughout (Li et al. 2014). Another successful delivery method was use 
chitosan/dsRNA nanoparticle to silence chitin synthase genes though feeding in the 
African malaria mosquito, Anopheles gambiae (Zhang et al. 2010). Chitosan/dsRNA 
nanoparticles were formed by self-assembly of polycations with dsRNA though 
electrostatic interaction between amino groups of chitosan and phosphate groups of 
dsRNA (Zhang et al. 2010). After feeding chitosan/dsRNA against chitin synthesis 
particles to third instar mosquito larvae, chitin content is decreased by 33.8%, and 
resulted in increased susceptibility of the larvae to diflubenzuron, and calcofluor white 
or dithiothreitol (Zhang et al. 2010).  
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Appendix A.  
GAPDH gene sequence cloned from D. radicum 
ATCCATCGGCGCTGGTTTTGCGGTGCCGCCGTCGATAAAGGTGCTGCCGTTGGTAGCTGTTAAC
GATCCCTTCATCGATGTTAACTACATGGTATACTTGTTCAAATTCGATTCGACCCACGGTCGTT
TCAAGGGCACCGTCGCTGCTGAAGATGGCAAATTGGTAGTCAACGGTCAAAAGATCACCGTTTT
CAGTGAACGCGACCCTGCCAACATTAACTGGGCTAGCGCTGGCGCTGAATATGTTGTAGAATCG
ACTGGTGTCTTCACCACCATCGAAAAAGCTTCTCTCCATTTCAAGGGTGGTGCCAAGAAGGTAG
TCATCTCTGCCCCCTCTGCTGATGCCCCCATGTTTGTGTGCGGTGTTAACTTGGATGCCTACAC
ACCCGACATGAAGGTAGTCTCCAATGCTTCCTGCACAACCAACTGTTTGGCTCCCTTGGCCAAG
GTTATCAACGATAACTGGGAAATCGTAGAGGGTTTCATGATCCACTGTCCATGCCACTACTGCC
ACCCAAAAGACCGTTGACGGTCCATCTGGCAAATTGTGGCGCGATGGACGTGGCATCTTGCTGA
AAAACTCGAGCC 
 
qPCR primers are highlighted in yellow (Forward) and green (Reverse)  
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Appendix B.  
Drosophilia thread (APIN) and V-type ATPase E subunit 
expression atlas  
http://flyatlas.org/atlas.cgi 
 
thread (CG12284)  = 500-1500 in different larval tissues 
V-type ATPase E (CG1088) = 1500-5000 in different larval tissues = 2-4x higher 
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